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1.   PUBLIC HEALTH STATEMENT
This public health statement tells you about chlorophenols and the effects of exposure.
The Environmental Protection Agency (EPA) identifies the most serious hazardous waste sites in
the nation These sites make up the National Priorities List (NPL) and are the sites targeted for
long-term federal cleanup activities. Chlorophenols has been found in at least 116 of the
1,467 current or former NPL sites. However, the total number of NPL sites evaluated for this
substance is not known. As more sites are evaluated, the sites at which chlorophenols are found
may increase. This information is important because exposure to this substance may harm you and
because these sites may be sources of exposure.
When a substance is released from a large area, such as an industrial plant, or from a container,
such as a drum or bottle, it enters the environment. This release does not always lead to
exposure. You are exposed to a substance only when you come in contact with it. You may be
exposed by breathing, eating, or drinking the substance or by skin contact.
If you are exposed to chlorophenols, many factors determine whether you’ll be harmed. These
factors include the dose (how much), the duration (how long), and how you come in contact with
it. You must also consider the other chemicals you’re exposed to and your age, sex, diet, family
traits, lifestyle, and state of health.
1.1 WHAT ARE CHLOROPHENOLS?
Chlorophenols are a group of chemicals in which chlorines (between one and five) have been
added to phenol. Phenol is an aromatic compound derived from benzene, the simplest aromatic
hydrocarbon, by adding a hydroxy group to a carbon to replace a hydrogen. There are five basic
types of chlorophenols: mono[one]chlorophenols, di[two]chlorophenols, tri[three]chlorophenols,
tetra[four]chlorophenols, and penta[five]chlorophenols. In all, there are 19 different
chlorophenols. Eight are discussed in this document: 2-chlorophenol, 4-chlorophenol, 2,4-
dichlorophenol, 2,4,5-trichlorophenol, 2,4,6-trichlorophenol, 2,3,4,5-tetrachlorophenol, 2,3,4,6-
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tetrachlorophenol, and 2,3,5,6-tetraohlorophenol. Pentachlorophenol is discussed in another
document.
Except for 2-chlorophenol, which is a liquid at room temperature, all of the chlorophenols are
solids. The chlorophenols have a strong medicinal taste and odor; small amounts (at parts per
billion [ppb] to parts per million [ppm] concentrations) can be tasted in water. Very small
amounts of chlorophenols can also make fish taste bad. All the compounds discussed are or were
produced commercially.
Chlorophenols with at least two chlorines either have been used directly as pesticides or converted
into pesticides. Also, chlorophenols, especially 4-chlorophenol, have been used as antiseptics. In
addition to being produced commercially, small amounts of some chlorophenols, especially the
mono- and dichlorophenols, may be produced when waste water or drinking water is disinfected
with chlorine, if certain contaminants are present in the raw water. They are also produced during
the bleaching of wood pulp with chlorine when paper is being produced. More information on the
physical and chemical properties and on the production and use of chlorophenols is found in
Chapters 3 and 4.
1.2    WHAT HAPPENS TO CHLOROPHENOLS WHEN THEY ENTER THE
         ENVIRONMENT?
Chlorophenols can enter the environment while they are being made or used as pesticides. Most
of the chlorophenols released into the environment go into water, with very little entering the air.
The compounds that are most likely to go into the air are the mono- and dichlorophenols because
they are the most volatile (that is, have the greatest tendency to form vapors or gases). Once in
the air, sunlight helps destroy these compounds and rain washes them out of the air. Chlorophenols
stick to soil and to sediments at the bottom of lakes, rivers, or streams. However, low
levels of chlorophenols in water, soil, or sediment are broken down by microorganisms and are
removed from the environment within a few days or weeks. Further information regarding the
release and environmental fate of chlorophenols can be found in Chapters 4 and 5.
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1.3    HOW MIGHT I BE EXPOSED TO CHLOROPHENOLS?
Most people are exposed to very low levels of chlorophenols in drinking water that has been ’
disinfected with chlorine (chlorinated drinking water). Chlorophenols have been measured in
chlorinated drinking water at parts per trillion (ppt) concentrations (that is, the amount [weight]
of chlorophenols per trillion parts [volume] of water). In lakes, rivers, and streams, chlorophenols
were found in less than 1 percent of the water that was tested. Chlorophenols have been
measured in city air at concentrations of less than a part per trillion (the amount of chlorophenols
[volume] per trillion parts [volume] of air).
It has been estimated during the National Occupational Exposure Survey (NOES) from
1981-1983 that about 5,000 people in the United States are exposed to 4-chlorophenol,
2,4,5-trichlorophenol, or 2,4,6-trichlorophenol at work (NOES 1990). It has not been estimated
how many people are exposed at work to the other chlorophenols. People who make
chlorophenols or use them as pesticides are most likely to have high exposure to these chemicals.
For example, mixtures of tetrachlorophenols are used at sawmills as wood preservatives. Skim
contact while treating wood with the tetrachlorophenols is the most likely route of exposure.
Another likely route of exposure is breathing air contaminated by mono- and dichlorophenols.
Further information regarding exposure to chlorophenols can be found in Chapter 5.
1.4  HOW CAN CHLOROPHENOLS ENTER AND LEAVE MY BODY?
When chlorophenols are eaten, almost all of the compounds quickly enter the body.
Chlorophenols also rapidly enter the body through the skin. Little is known about how much of
the chlorophenols enter the body if one breathes air containing them. The monochlorophenols do
not stay inside the body very long. They are changed to less harmful products, and most leave
through the urine within 24 hours. The other chlorophenols (dichlorophenol, trichlorophenols,
tetrachlorophenols), which also leave through the urine as less harmful chemicals, can stay in the
body for several days. For further discussion about how the chlorophenols enter and leave the
body, see Chapter 2.
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1.5    HOW CAN CHLOROPHENOLS AFFECT MY HEALTH?
To protect the public from the harmful effects of toxic chemicals and to find ways to treat people
who have been harmed, scientists use many tests.
One way to see if a chemical will hurt people is to learn how the chemical is absorbed, used, and
released by the body; for some chemicals, animal testing may be necessary. Animal testing may
also be used to identify health effects such as cancer or birth defects. Without laboratory animals,
scientists would lose a basic method to get information needed to make wise decisions to protect
public health. Scientists have the responsibility to treat research animals with care and compassion. Laws 
today protect the welfare of research animals, and scientists must comply with strict animal care guidelines.
One man who splashed pure 2,4-dichlorophenol on his arm and leg died shortly after the accident.
Workers who made pesticides from chlorophenols and were exposed to chlorophenols as well as
other chemicals through breathing and through the skin developed acne and mild injury to their
livers. According to some studies, the risk of cancer was also slightly higher among workers who
had made pesticides for a long time. These workers were exposed to very high levels of other
chemicals as well as chlorophenols, so it is not certain whether the effects were caused by the
chlorophenols or the other chemicals.
Animals that were given food or drinking water containing chlorophenols at high levels developed
adverse or negative health effects. The major effects with exposure to high levels of
chlorophenols were on the liver and the immune system. Also, the animals that ate or drank
chlorophenols did not gain as much weight as the animals that ate food and drank water not
containing chlorophenols.
Feeding rats and mice high doses of 2,4-dichlorophenol for a long time did not cause cancer.
However, long-term treatment of rats and mice with high doses of 2,4,6-trichlorophenol in food
caused leukemia in rats and liver cancer in mice, suggesting that 2,4,6-trichlorophenol may be a
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carcinogen. The Department of Health and Human Services has determined that 2,4,6-trichlorophenol
may reasonably be anticipated to be a carcinogen. The International Agency for Research on Cancer (IARC) has
determined that the chlorophenols as a group, are possibly carcinogenic to man. The Environmental Protection
Agency (EPA) has determined that 2,4,6-trichlorophenol is a probable carcinogen.
Putting chlorophenols on the skin or eyes of animals causes severe injuries. Injury is greatest with
exposure to the mono- and dichlorophenols. The signs of severe skin injury include redness,
swelling, scabbing, and scar formation. The cornea was damaged when monochlorophenols were
placed directly onto the eyes of rabbits. Further information about the health effects following
exposure to chlorophenols can be found in Chapter 2.
1.6 HOW CAN CHLOROPHENOLS AFFECT CHILDREN?
This section discusses potential health effects from exposures during the period from conception
to maturity at 18 years of age in humans. Potential effects on children resulting from exposures of
the parents are also considered.
The most likely source from which children could be exposed to chlorophenols is water that has
been disinfected with chlorine. Children could receive larger doses because they consume more
fluids per bodyweight than adults. Children may also be exposed in areas where chlorophenols
have been sprayed as pesticides or herbicides. Children playing outdoors in areas with
contaminated soil could be at risk for exposure because they often put objects or hands in their
mouths. Monochlorophenols are used as household antiseptics, and 2,4-DCP is used for
mothproofing. More complex chlorophenols are used as biocides. Biocides are substances used
to kill organisms.
We do not know whether chlorophenols cause birth defects in humans; chlorophenols have not
been shown to cause birth defects in animals, even at high doses. High levels of chlorophenols
given to pregnant female rats in the drinking water have tended to reduce the number of their
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newborn animals and to decrease the weights of the newborn. In one study animals exposed to
chlorophenols showed delayed hardening of some bones. Section 2.6 of this profile contains
further details on animal-based developmental effects studies. We do not know whether
chlorophenols can cross the placenta or get into breast milk.
1.7 HOW CAN FAMILIES REDUCE THE RISK OF EXPOSURE TO
      CHLOROPHENOLS?
If your doctor finds that you have been exposed to significant amounts of chlorophenols, ask if
children may also be exposed. When necessary your doctor may need to ask your state
department of public health to investigate.
The chlorophenols presented in this profile exist in eight different forms, each one having different
properties and uses. Therefore, different routes exist in which a family may be exposed to chlorophenols.
Chlorophenols are primarily used as antiseptics, disinfectants, herbicides, pesticides, and wood
preservatives. People are at greater risk of exposure if they live near industrial facilities that
use or manufacture chlorophenols or waste sites that could be releasing it into the environment.
Most released chlorophenols are found in surface water or in soil near the release point. Children
should be kept from coming in contact with water or dirt in an area that could be contaminated.
You should prevent your children from eating dirt. Make sure they wash their hands frequently
and before eating. Discourage your children from putting their hands in their mouths or other
hand-to-mouth activity.
People who do not live near production or waste sites can still be exposed to chlorophenols
through other routes. Chlorophenols can be present in drinking water when chlorine is used to
disinfect it. The safe drinking water standard for 2-chlorophenol is included in Table 7-l. At low
concentrations, chlorophenols give water an unpleasant, medicinal taste.
Chlorophenols and other related chemicals are often used as herbicides and pesticides. 2,4-D and
2,4,5-T, the latter of which has been banned, are herbicides often used on food crops that can
break down to form 2,4-DCP. Children should be deterred from playing in areas where 2,4-D or
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other chlorophenol based herbicides or pesticides have been sprayed. Children are lower to the
ground than adults and may be exposed because they often get dirt, grass, and other outdoor
material on their skin and in their mouths. Also, your children may be exposed to chlorophenols if
an unqualified person applies pesticides containing them around your home. In some cases, the
improper use of pesticides banned for use in homes has turned homes into hazardous waste sites.
Make sure that any person you hire is licensed and, if appropriate, certified to apply pesticides.
Your state licenses each person who is qualified to apply pesticides according to EPA standards
and further certifies each person who is qualified to apply “restricted use” pesticides. Ask to see
the license and certification. Also ask for the brand name of the pesticide, a Material Safety Data
Sheet (MSDS), the name of the product’s active ingredient, and the EPA registration number.
Ask whether EPA has designated the pesticide “for restricted use” and what the approved uses
are. This information is important if you or your family react to the product.
If you buy over-the-counter pesticide products to apply yourself, be sure the products are in
unopened pesticide containers that are labeled and contain an EPA registration number. Carefully
follow the instructions on the label. If you plan to spray inside, make sure the pesticide is
intended for indoor use.
If you feel sick after a pesticide has been used in your home, consult your doctor or local poison
control center.
Chlorophenols may also be present in many household products. 2,4-DCP is commonly used for
mothproofing. 4-CP is used as a disinfectant in homes, farms, hospitals, and as an antiseptic for
root canal treatment. Monochlorophenols have been used as antiseptics, although they have
largely been replaced by other chemicals. Pesticides and household chemicals should be stored
out of reach of young children to prevent unintentional poisonings. Always store pesticides and
household chemicals in their original labeled containers. Never store pesticides or household
chemicals in containers children would find attractive to eat or drink from, such as old soda
bottles.
CHLOROPHENOLS            8
1. PUBLIC HEALTH STATEMENT
1.8   IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN
        EXPOSED TO CHLOROPHENOLS?
There is no medical test that is specific for chlorophenols to determine whether you have been
exposed to these chemicals. Compounds that have been made by your body from chlorophenols
can be measured in the urine. However, these compounds can also be found in the urine when
you are exposed to other chemicals such as lindane (an insecticide) or to 2,4-dichlorophenoxyacetic
acid (a chemical that kills weeds). More information about measuring exposure to
chlorophenols can be found in Chapter 2.
1.9   WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO
        PROTECT HUMAN HEALTH?
The federal government develops regulations and recommendations to protect public health.
Regulations can be enforced by law. Federal agencies that develop regulations for toxic
substances include the Environmental Protection Agency (EPA), the Occupational Safety and
Health Administration (OSHA), and the Food and Drug Administration (FDA).
Recommendations provide valuable guidelines to protect public health but cannot be enforced by
law. Federal organizations that develop recommendations for toxic substances include the
Agency for Toxic Substances and Disease Registry (ATSDR) and the National Institute for
Occupational Safety and Health (NIOSH).
Regulations and recommendations can be expressed in not-to-exceed levels in air, water, soil, or
food that are usually based on levels that affect animals, then they are adjusted to help protect
people. Sometimes these not-to-exceed levels differ among federal organizations because of
different exposure times (an 8-hour workday or a 24-hour day), the use of different animal
studies, or other factors.
Recommendations and regulations are also periodically updated as more information becomes
available. For the most current information, check with the federal agency or organization that
provides it. Some regulations and recommendations for chlorophenols include the following:
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The EPA recommends that drinking water concentrations of 2-chlorophenol should not be more
than 0.04 part per million (ppm), and concentrations of 2,4-dichlorophenol should not be more
than 0.02 ppm; these are levels that can be tasted. In order for chlorophenols to be lower than
levels that can be tasted, the EPA recommends levels of 0.1 part per billion (ppb; the amount of
chlorophenols per billion parts of water) for monochlorophenols, 0.3 ppb for 2,4-dichlorophenols,
and 1 ppb for 2,4,5-trichlorophenol and 2,3,4,6-tetrachlorophenol. More information about
regulations and guidelines for chlorophenols can be found in Chapter 7.
1.10 WHERE CAN I GET MORE INFORMATION?
If you have any more questions or concerns, please contact your community or state health or
environmental quality department or
   Agency for Toxic Substances and Disease Registry
   Division of Toxicology
   1600 Clifton Road NE, Mailstop E-29
   Atlanta, GA 30333
* Information line and technical assistance
   Phone: l-800-447-1544
   Fax: (404) 639-6359
ATSDR can also tell you the location of occupational and environmental health clinics. These
clinics specialize in recognizing, evaluating, and treating illnesses resulting from exposure to
hazardous substances.
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* To order toxicological profiles, contact
   National Technical Information Service
   5285 Port Royal Road
   Springfield, VA 22161
   Phone: (800) 553-6847 or (703) 487-4650
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2.1 INTRODUCTION
The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and
other interested individuals and groups with an overall perspective on the toxicology of
chlorophenols. It contains descriptions and evaluations of toxicological studies and epidemiological
investigations and provides conclusions, where possible, on the relevance of toxicity and
toxicokinetic data to public health.
A glossary and list of acronyms, abbreviations, and symbols can be found at the end of this profile.
2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE
To help public health professionals and others address the needs of persons living or working near
hazardous waste sites, the information in this section is organized first by route of exposure-
inhalation, oral, and dermal; and then by health effect-death, systemic, immunological, neurological,
reproductive, developmental, genotoxic, and carcinogenic effects. These data are discussed in terms
of three exposure periods-acute (14 days or less), intermediate (15-364 days), and chronic (365 days
or more).
Levels of significant exposure for each route and duration are presented in tables and illustrated in
figures. The points in the figures showing no-observed-adverse-effect levels (NOAELs) or lowest-
observed-adverse effect levels (LOAELs) reflect the actual doses (levels of exposure) used in the
studies. LOAELS have been classified into “less serious” or “serious” effects. “Serious” effects are
those that evoke failure in a biological system and can lead to morbidity or mortality (e.g., acute
respiratory distress or death). “Less serious” effects are those that are not expected to cause
significant dysfunction or death, or those whose significance to the organism is not entirely clear.
ATSDR acknowledges that a considerable amount of judgment may be required in establishing
whether an end point should be classified as a NOAEL, “less serious” LOAEL, or “serious” LOAEL,
and that in some cases, there will be insufficient data to decide whether the effect is indicative of
significant dysfunction. However, the Agency has established guidelines and policies that are used to
classify these end points. ATSDR believes that there is sufficient merit in this approach to warrant an
attempt at distinguishing between “less serious” and “serious” effects. The distinction between “less
serious” effects and “serious” effects is considered to be important because it helps the users of the
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profiles to identify levels of exposure at which major health effects start to appear. LOAELs or NOAELs should
also help in determining whether or not the effects vary with dose and/or duration, and place into perspective the
possible significance of these effects to human health.
The significance of the exposure levels shown in the Levels of Significant Exposure (LSE) tables and figures
may differ depending on the user’s perspective, Public health officials and others concerned with appropriate
actions to take at hazardous waste sites may want information on levels of exposure associated with more subtle
effects in humans or animals (LOAEL) or exposure levels below which no adverse effects (NOAELs) have been
observed. Estimates of levels posing minimal risk to humans (Minimal Risk Levels or MRLs) may be of interest
to health professionals and citizens alike.
Levels of exposure associated with carcinogenic effects (Cancer Effect Levels, CELs) of chlorophenols are
indicated in Table 2-1 and Figure 2-1. Because cancer effects could occur at lower exposure levels, the figure
also shows a range for the upper bound of estimated excess risks, ranging from a risk of 1 in 10,000 to 1 in
10,000,000 (10-4-10-7), as developed by EPA.
Estimates of exposure levels posing minimal risk to humans (Minimal Risk Levels or MRLs) have been made
for chlorophenols. An MRL is defined as an estimate of daily human exposure to a substance that is likely to be
without an appreciable risk of adverse effects (noncarcinogenic) over a specified duration of exposure. MRLs
are derived when reliable and sufficient data exist to identify the target organ(s) of effect or the most sensitive
health effect(s) for a specific duration within a given route of exposure. MRLs are based on noncancerous health
effects only and do not consider carcinogenic effects. MRLs can be derived for acute, intermediate, and chronic
duration exposures for inhalation and oral routes. Appropriate methodology does not exist to develop MRLs for
dermal exposure.
Although methods have been established to derive these levels (Barnes and Dourson 1988; EPA 1990a),
uncertainties are associated with these techniques. Furthermore, ATSDR acknowledges additional uncertainties
inherent in the application of the procedures to derive less than lifetime MRLs. As an example, acute inhalation
MRLs may not be protective for health effects that are delayed in development or are acquired following
repeated acute insults, such as hypersensitivity reactions, asthma, or chronic bronchitis. As these kinds of health
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A User’s Guide has been provided at the end of this profile (see Appendix B). This guide should aid in the
interpretation of the tables and figures for Levels of Significant Exposure and the MRLs.
There are 19 isomers of the chlorophenols, each containing between 1 and 5 chlorines. All members of the series
are chlorine derivatives of phenol, the simplest aromatic alcohol, i.e., hydroxybenzene. They possess both acute
and chronic toxicity which varies with the number of chlorines present. However, this profile is concerned with
only eight of these isomers, chosen on the basis of the following three criteria: (1) toxicity, (2) potential for
human exposure, and (3) frequency of occurrence at NPL hazardous waste sites.
Because many of the isomers typically co-occur in the environment and have qualitatively (but not
quantitatively) similar toxicological effects, they are combined into one profile to avoid repetition across
multiple profiles. The isomers discussed include two monochlorinated compounds (2- and 4-chlorophenol, or 2-
CP and 4-CP), one dichlorinated compound (2,4-dichlorophenol, or 2,4-DCP), two trichlorinated compounds
(2,4,5- and 2,4,6-trichlorophenol, or 2,4,5-TCP and 2,4,6-TCP), and three tetrachlorinated compounds (2,3,4,5-,
2,3,4,6-, and 2,3,5,6-tetrachlorophenol, or 2,3,4,5-TeCP, 2,3,4,6-TeCP, and 2,3,5,6-TeCP). The information in
the profile is organized by isomer (mono-, di-, tri-, tetrachlorophenols), and for each isomer the available data
are then presented by duration (acute [14 days or less], intermediate [15 to 364 days], chronic [365 days or
more]). In this text, the term “chlorophenols” will refer to any two or more of these eight isomers. The most
commercially and toxicologically significant isomer, pentachlorophenol, is not included in this document
because it is the subject of a separate profile.
2.2.1 Inhalation Exposure
2.2.1.l   Death
Mortality studies of workers at phenoxy herbicide factories where exposure to chlorinated phenols
(2,4,5-TCP, 2,4,6-TCP, and 2,4-DCP) occurred, have not shown increased mortality from any cause (Coggen et
al. 1991; Ott et al. 1987). Additional occupational studies that focus on cancer-related deaths are discussed in
Section 2.2.1.8. No studies were located regarding death in humans following inhalation exposure to any of the
chlorophenols discussed in this profile.
Nose-only exposure of male and female Wistar rats to 2-CP for 4 hours to a concentration of 908 ppm
(Duchosal and Biederman 1991) and whole-body exposure of Sprague-Dawley rats to 2-CP for 6 hours
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at 620 ppm (Younger Labs 1975) did not result in any deaths. These studies are limited by a lack of
experimental detail. Additional studies regarding lethality in animals following inhalation exposure to
chlorophenols were not located.
2.2.1.2 Systemic Effects
No studies were located regarding musculoskeletal or renal effects in humans or animals after inhalation
exposure to any of the eight chlorophenols discussed in this profile.
The limited studies examining systemic effects following inhalation exposure to chlorophenols are described
below. The NOAEL and LOAEL values from the single reliable study are recorded in Table 2-1 and plotted in
Figure 2-1.
Respiratory Effects. No studies were located regarding respiratory effects in humans after inhalation
exposure to any of the eight chlorophenols discussed in this profile. Very limited studies of respiratory
effects in workers exposed by inhalation to one or more of the chlorophenols in conjunction with other
substances have been completed.
When compared to 260 unexposed referents, 281 workers involved in the production of sodium
trichlorophenol and its derivatives for 18 years had no increased incidence of chronic bronchitis, chronic
obstructive pulmonary disease, or altered measures of pulmonary function (Calvert et al. 1991). Exposure
occurred 15 years before pulmonary function was examined. Because trichloro-phenols are rapidly cleared,
serum 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), which was produced as a contaminant in the
manufacture of 2,4,5-TCP and its derivatives, was used to indicate that the workers had actually been
exposed. The mean lipid adjusted TCDD serum concentration in exposed workers was 200 ppt relative to 7
ppt in the controls.
Occupational exposure of seven workers to an unspecified trichlorophenol isomer, in addition to other
chemicals, by chronic inhalation was associated with adverse upper airway and chest symptoms (cough,
chronic bronchitis, chest wheezing), altered pulmonary function (reduced expiratory flow rate of the lung,
increased closing volume of the lung, increased elastic recoil pressure of the lung), and pulmonary lesions
(interstitial densities) (Alexandersson and Hedenstierna 1982). The workers were exposed for 2-10 years
and exposure concentrations were not well characterized. The study indicates that exposure concentrations
were 0.003 mg/L (0.02 ppm) or less, and they may have varied considerably. The study was also limited
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because of the small number of subjects (seven), which included three smokers. Therefore, it is not possible to
determine whether the exposure to TCP alone induced the reported respiratory effects or whether smoking
contributed to the effects. The authors (Alexandersson and Hedenstierna 1982) concluded that inhalation
exposure to trichlorophenol may cause pulmonary dysfunction and possibly fibrosis following chronicduration
exposure.
Lumber mill workers exposed to a mixture of tetrachlorophenols (specific isomers not stated) and
pentachlorophenol reported upper respiratory tract irritation more frequently than unexposed workers
(Kleinman et al. 1986). Tetrachlorophenol air concentrations ranged from 0.8 to 12.2 µg/m3, and
pentachlorophenol concentrations were below the limit of detection (0.5 µg/m3).
Tachypnea was observed in one of five male rats exposed (nose-only) to 2-CP at 908 ppm for 4 hours
(Duchosal and Biederman 1991). Tachypnea was not observed in any female rats exposed in the same
manner. Dark red foci observed in the lungs (right caudal, median, or left lobe) of male and female rats
exposed to 17 (2/5 males, 2/5 females) or 104 ppm (4/5 males, 2/5 females) were not found at 908 ppm
(Duchosal and Biederman 1991). No controls were used in this study. The LOAEL for tachypnea and a NOAEL
for respiratory effects identified in this limited study are presented in Table 2-l and Figure 2-l.
Cardiovascular Effects. Electrocardiograms were normal in three individuals who developed chloracne
following occupational exposure (inhalation and dermal) to chlorophenols and other compounds during the
manufacture of 2,4-DCP and 2,4,5-TCP (Bleiberg et al. 1964). No additional studies were located regarding
cardiovascular effects in humans following inhalation exposure to any of the eight chlorophenols discussed in
this profile.
No studies were located regarding cardiovascular effects in animals following inhalation exposure to any of the
eight chlorophenols discussed in this profile.
Gastrointestinal Effects. The self-reported prevalence of gastrointestinal disease was not increased
among 281 TCP production workers with elevated serum TCDD levels (Calvert et al. 1992). The workers had
been exposed to a mixture of TCPs at least 15 years prior to the survey. However, the long time lag between
exposure and examination of gastrointestinal symptoms may invalidate the study.
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No studies were located regarding gastrointestinal effects in animals after inhalation exposure to any of the eight
chlorophenols discussed in this profile.
Hematological Effects. Clinical assessment of two patients occupationally exposed during the manufacture of
2,4-DCP- and 2,4,5-TCP-based herbicides revealed hematology and blood chemistry parameters (blood counts,
bleeding and clotting time, serum bilirubin, blood urea nitrogen, and others) to be within normal ranges
(Bleiberg et al. 1964).
No studies were located regarding hematological effects in animals after inhalation exposure to any of the eight
chlorophenols discussed in this profile.
Hepatic Effects. Porphyria cutanea tarda has been reported in workers employed in the manufacture of
2,4-DCP and 2,4,5-TCP (Bleiberg et al. 1964). Exposure to chlorophenols and intermediates was probably
through inhalation and dermal contact. Eleven cases of porphyria were identified, based on urinary porphyrin
excretion, in a survey of 29 workers. Elevated serum transaminase levels and evidence of liver damage, e.g.,
regeneration of liver cells and hemofuscin (a brownish-yellow pigment that results from the decomposition of
hemoglobin) deposition, were detected from liver biopsies in two cases that were studied in detail. Thus, the
exposure was probably related to liver injury. Definitive conclusions regarding the connection between the
porphyria or liver injury and exposure to chlorophenols in this group of workers cannot be made since the
workers were exposed to a variety of chlorinated compounds, including a highly volatile chlorinated phenolic
ether with six chlorines formed during the manufacturing process. The data provide an alert for potential human
risk, however. Information on exposure to other liver toxicants, including the chronic ingestion of alcohol, was
not obtained.
The results of a cross-sectional study of trichlorophenol production workers indicated an increased risk of
elevated gamma-glutamyltransferase (GGT) activity in these workers (Calvert et al. 1992). GGT is a liver
enzyme that is a potential marker of hepatobiliary disease. An interaction between alcohol consumption and
exposure was related to increased GGT activity in these production workers (Calvert et al. 1992). However, the
absence of increases in other hepatic enzymes may limit the diagnostic potential of the GGT findings in this
study.
No studies were located regarding hepatic effects in animals following inhalation exposure to any of the eight
chlorophenols discussed in this profile.
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Dermal Effects. Chloracne, evidence of acquired porphyria cutanea tardia, hyperpigmentation, folliculitis,
keratosis, and hirsutism have been observed in workers employed in the manufacture of 2,4-DCP- and 2,4,5-
TCP-based herbicides (Bleiberg et al. 1964; Bond et al. 1989). As noted above in the discussion of hepatic
effects, exposure to chlorophenols may have been through either inhalation or dermal contact or both.
Furthermore, the subjects were exposed to several chlorinated compounds (e.g., dioxin) in addition to
chlorophenols; therefore, the chloracne and other dermal effects cannot be ascribed specifically to chlorophenol
exposure since chloracne is known to occur following exposure to TCDD.
No studies were located regarding dermal effects in animals following inhalation exposure to any of the eight
chlorophenols discussed in this profile.
Ocular Effects. Lumber mill workers exposed to a mixture of tetrachlorophenols (specific isomers not
stated) and pentachlorophenol reported eye irritation more frequently than unexposed workers (Kleinman et al.
1986). Tetrachlorophenol air concentrations ranged from 0.8 to 12.2 µg/m3, and pentachlorophenol
concentrations were below the limit of detection (0.5 µg/m3). Industrial hygienists indicated that improvements
in protective equipment were necessary at this mill, which suggests that ocular irritation could have resulted in
part from contact with contaminated surfaces (e.g., hands, clothing).
No studies were located regarding ocular effects in animals following inhalation exposure to any of the eight
chlorophenols discussed in this profile.
Body Weight Effects. No studies were located regarding body weight effects in humans following
inhalation exposure to any of the eight chlorophenols discussed in this profile.
No changes in body weight were observed during the 15-day observation period after rats were exposed (nose-
only) to 2-CP at 908 ppm for 4 hours (Duchosal and Biedermann 1991). No controls were included in this study.
This NOAEL for body weight effects is recorded in Table 2-l and plotted in Figure 2-1.
2.2.1.3    Immunological and Lymphoreticular Effects
No studies were located regarding immunological and lymphoreticular effects in humans or animals after
inhalation exposure to any of the eight chlorophenols discussed in this profile.
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2.2.1.4    Neurological Effects
Lumber mill workers exposed to a mixture of tetrachlorophenols (specific isomers not stated) and
pentachlorophenol reported headaches more frequently than unexposed workers (Kleinman et al. 1986).
Monitoring of air and urinary concentrations of tetrachlorophenols suggested that exposure was principally
through the skin.
Rats exposed for 4 hours to 908 ppm 2-CP using nose-only exposure showed restlessness, a hunched posture,
and ruffled fur (Duchosal and Biedermann 1991). These effects were not observed at 104 ppm. The LOAEL and
NOAEL for neurological effects is recorded in Table 2-l and plotted in Figure 2-l.
2.2.1.5    Reproductive Effects
No studies were located regarding reproductive effects in humans or animals after inhalation exposure to any of
the eight chlorophenols discussed in this profile.
2.2.1.6 Developmental Effects
No studies were located regarding developmental health effects in humans or animals after inhalation
exposure to any of the eight chlorophenols discussed in this profile.
2.2.1.7    Genotoxic Effects
Genotoxicity studies are discussed in Section 2.5.
2.2.1.8    Cancer
A number of investigators have studied the potential association between chlorophenol-based pesticide
production and carcinogenicity (Eriksson et al. 1981, 1990; Hardell et al. 1981; Hoar et al. 1986; Honchar and
Halperin 1981; Kogevinas et al. 1992; Lynge 1985; Smith et al. 1984; Woods et al. 1987). Reports from
Sweden indicate significantly increased relative risk ratios for soft tissue sarcomas (STS) and/or non-
Hodgkin’s lymphomas (NHLs) in exposed workers (Eriksson et al. 1981, 1990; Hardell et al. 1981). In a
retrospective cohort study on Danish workers exposed to 2,4-DCP and 4- chloro-o-tolyloxy-acetic
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The composite human results represent studies from a variety of occupational settings, with various degrees of
exposure to chlorophenols, dioxins, intermediates, and final products, such as chlorophenoxy pesticides. The
data are not sufficiently sensitive to support a relationship, per se, between any of the chlorophenol exposures
and tumor incidence. However, taken in composite, the human study results do suggest a possible concern for
increased tumorigenic risk in farm workers and production workers exposed to chlorophenols or their end-use
products (Woods et al. 1987).
No studies were located regarding cancer in animals after inhalation exposure to any of the eight chlorophenols
discussed in this profile.
2.2.2 Oral Exposure
2.2.2.1 Death
No studies were located regarding death in humans after oral exposure to any of the eight chlorophenols
discussed in this profile.
The lowest reported LD50 for a chlorophenol isomer was 89 mg/kg for male mice treated with 2,3,5,6 TeCP in
ethanol (Ahlborg and Larsson 1978). The highest reported LD50 was 2,960 mg/kg for male rats treated with
2,4,5-TCP in corn oil (McCollister et al. 1961). The range of LD50 values indicates that the chlorophenols are
slightly or moderately toxic according to the classification scheme of Hodge and Sterner (1949). Ahlborg and
Larssen (1978) examined the acute oral toxicity of the TeCPs in both ethanol and propylene glycol. The LD50s
were higher when propylene glycol was used as the vehicle rather than ethanol (e.g., the LD50 for 2,3,4,6-TeCP
in female mice was 131 when administered in ethanol and 735 mg/kg when administered in propylene glycol).
The Ahlborg and Larssen (1978) study highlights the importance of vehicle effects in acute gavage studies, and
because vehicles were different across studies and chlorophenol isomers, it is not possible to make definitive
conclusions about which isomer is more toxic following a single oral dose.
In the only known toxicity study involving repeated dosing of monochlorophenols, groups of male and female
ICR mice received daily gavage doses of 35, 69, or 175 mg/kg/day 2-CP in corn oil for 14 days. No exposure-
related deaths occurred at the two lower treatment levels. All mice exposed at 175 mg/kg/day died,
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suggesting a steep dose-response relationship between the mid- and high-treatment doses (Borzelleca et
al.1985a).
In repeated-dose studies of 2,4-DCP in corn oil, 4 out of 34 pregnant Fischer-344 rats treated by gavage at 750
mg/kg/day on gestation days 6-15 died (Rodwell et al. 1989), while all non-pregnant rats treated with 2,000
mg/kg/day in the diet for 14 days survived (NTP 1989). Although pregnant rats may be more susceptible, the
difference in effect may also be a result of differences in the rate of exposure between gavage and dietary
dosing.
All rats and mice exposed to 2,4-DCP in the diet for 13 weeks at doses of 2,000 or 2,600 mg/kg/day survived
(NTP 1989). However, all mice died when exposed to 5,200 mg/kg/day for 3 weeks (NTP 1989). In a 2-year
study, decreased survival was not observed in rats fed 2,4-DCP in the diet at doses up to 440 mg/kg/day or in
mice fed 2,4-DCP in the diet at doses up to 1,300 mg/kg/day for 103 weeks (NTP 1989).
No deaths were observed among rats treated by gavage (18 doses in olive oil) or in the diet with 2,4,5-TCP at
doses up to 1,000 mg/kg/day for 90 days (McCollister et al. 1961). In addition, no deaths were observed in
rabbits treated with 20 gavage doses of 500 mg/kg/day 2,4,5-TCP over 28 days (McCollister et al. 1961).
Deaths were observed during the first 4 weeks of treatment among female rats (3/40) and male rats (8/25)
exposed to 2,4,6-TCP in corn oil by gavage for 11 weeks at 1,000 but not at 500 mg/kg/day (Blackbum et
al.1986). The females were treated 2 weeks prior to pregnancy and then throughout gestation. No deaths were
observed in rats treated by gavage with 2,4,6-TCP in corn oil at 720 mg/kg/day for 90 days (Bercz et al. 1990).
In a 7-week dietary study, 1 of 5 rats died at 1,075 mg/kg/day and 4 of 10 mice died at 4,095 mg/kg/day, with no
deaths observed at 735 mg/kg/day among rats or at 2,795 mg/kg/day among mice (NCI 1979). In a chronic
study, no increased mortality trend was observed in rats or mice treated with 2,4,6-TCP in the diet at
concentrations up to 500 mg/kg/day for 106-107 weeks for rats and 1,356 mg/kg/day for 105 weeks for mice
(NCI 1979).
No deaths were observed in rats treated by gavage with 200 mg 2,3,4,6-TeCP/kg/day during gestation (RTI
1987) or among male and female rats treated at 200 mg/kg/day for 90 days (American Biogenics 1988). In both
studies the 2,3,4,6-TeCP was given in olive oil.
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The LD50 values and all reliable LOAEL values for death in each species and duration category are recorded in
Table 2-2 and plotted in Figure 2-2.
2.2.2.2 Systemic Effects
The highest NOAEL values and all reliable LOAEL values for systemic effects in each species and duration
category for oral exposures to chlorophenols are recorded in Table 2-2 and plotted in Figure 2-2.
Respiratory Effects. No studies were located regarding respiratory effects in humans after oral exposure to any
of the eight chlorophenols discussed in this profile.
Lung hemorrhaging occurred in rats treated with a single lethal gavage dose of 2,4-DCP (Wil Research
Laboratories 1982). Nasal lesions were noted in male but not female rats exposed to 210 mg/kg/day for
103 weeks. Nasal lesions were not observed in mice fed as much as 1,300 mg/kg/day for the same exposure
period (NTP 1989). This effect may, therefore, be specific to the male rat or may have been a result of aspiration
while eating. Histopathological changes have not been observed in the lungs of rats or mice orally exposed to
2,4-DCP (Borzelleca et al. 1985a; NTP 1989), 2,4,5-TCP (McCollister et al. 1961), 2,4,6-TCP (Bercz et al.
1990; Blackburn et al. 1986; NCI 1979), or 2,3,4,6-TeCP (American Biogenics 1988).
Cardiovascular Effects. No studies were located regarding cardiovascular effects in humans after oral
exposure to any of the eight chlorophenols discussed in this profile.
No change in heart weight was noted in mice fed 2,4-DCP at doses up to 230 mg/kg/day for 6 months
(Kobayashi et al. 1972). Histopathological examinations of the heart have not revealed any effects in rats fed
2,4-DCP at 2,000 mg/kg/day or in mice fed 2,4-DCP at 2,600 mg/kg/day for 13 weeks (NTP 1989). Studies on
rats exposed to 2,4-DCP at doses as high as 440 mg/kg/day and mice exposed to as much as 1,300 mg/kg/day
for 103 weeks also showed no histological changes in the heart (NTP 1989).
Heart weight changes were not observed in rats treated with 18 gavage doses of 1,000 mg 2,4,5-TCP/kg, nor
were.histological changes observed in the hearts of rats treated with 2,4,5-TCP in the diet at doses up to1,000
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Heart weight did not increase in rats exposed orally to 2,4,6-TCP over an intermediate (10 or 13 weeks)
exposure period to doses as high as 1,000 mg/kg/day (Bercz et al. 1990; Blackburn et al. 1986). No treatment-
related lesions were evident upon histopathologic examination of the hearts of rats and mice exposed to doses as
high as 720 and 1,356 mg/kg/day of 2,4,6-TCP, respectively for 90 days (Bercz et al.1990) or 105 weeks (NCI
1979).
No changes in heart weight or histology were observed in rats treated with 2,3,4,6-TeCP for 90 days
(American Biogenics 1988).
Gastrointestinal Effects. No studies were located regarding gastrointestinal effects in humans after oral
exposure to any of the eight chlorophenols discussed in this profile.
Mild catarrhal enteritis was observed in female Sprague-Dawley albino rats given a single gavage dose of 316-
5,000 mg/kg/day 2,4-DCP in corn oil and sacrificed 24 hours later (Henke and Lockwood 1978). No pathology
reports were provided for rats that were sacrificed on day 7 or day 14. In another study, gross necropsy revealed
reddened hind, stomach and intestines in Fischer-344 rats given a single gavage dose of 2,400 mg/kg/day 2,4-
DCP in corn oil. Both studies demonstrated that this compound can be irritating to the gastrointestinal tract (Wil
Research Laboratories 1982). The observation of gastrointestinal effects at lower doses in Sprague-Dawley
compared to Fischer-344 rats suggests that Sprague-Dawley rats may be more sensitive to the acute
gastrointestinal effects of 2,4-DCP. No significant histopathological changes were observed in the
gastrointestinal tracts of Fischer-344 rats fed 2,000 mg/kg/day 2,4-DCP or mice fed 2,600 mg/kg/day 2,4-DCP
for 13 weeks, or in rats fed 440 mg/kg/day 2,4-DCP or mice fed 1,300 mg/kg/day 2,4-DCP for 103 weeks (NTP
1989).
In a 90-day study, no significant histopathological changes were observed in the gastrointestinal tracts of rats
treated by gavage with 2,4,6-TCP at 720 mg/kg/day (Bercz et al. 1990). Histopathologic examination of the
stomach and intestines of rats and mice exposed to 2,4,6-TCP for 2 years at doses as high as 500 and 1,356
mg/kg/day, respectively, revealed no treatment-related lesions (NCI 1979).
Wistar rats administered a single gavage dose of 632 mg/kg  2,3,4,6-TeCP had mucosal hyperemia of the
stomach and severe necrosis of the intestine (Hattula et al. 1981). At a dose of 432 mg/kg, mild necrosis was
observed in the intestines of 1/10 rats, with no effects observed at 410 mg/kg. Focal necrosis of the small
intestines was observed in Wistar rats treated by gavage for 55 days with 100 mg/kg/day 2,3,4,6- TeCP. No
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effects were observed at 10 mg/kg/day (Hattula et al. 1981). In contrast, no histopathological changes were
observed in the gastrointestinal tracts of Sprague-Dawley rats treated with 2,3,4,6-TeCP at 200 mg/kg/day for 90
days (American Biogenics 1988). 2,3,4,6-TeCP was administered in olive oil in both the Hattula et al. (1981)
(concentrations not reported) and American Biogenics (1988) studies (maximum concentration of 20 mg/mL).
Because olive oil was used as a vehicle for both studies, the differences in effects to the gastrointestinal tract
may likely be due to the dissimilar dosing solution concentrations and rodent strains.
Hematological Effects. No studies were located regarding hematological effects in humans after oral
exposure to any of the eight chlorophenols discussed in this profile.
Groups of 12 male and 12 female mice, administered once daily by gavage with up to 69 mg/kg/day 2-CP or up
to 638 mg/kg/day 2,4-DCP for 14 days, showed no adverse effects on standard hematological parameters,
including total and differential white blood cells, red blood cells, platelets, hematocrit, hemoglobin, and
coagulation measures relative to unexposed controls (Borzelleca et al. 1985a). However, when groups of 20
male and 20 female mice were dosed with up to 383 mg/kg/day of 2,4-DCP (male), and 49 mg/kg/day (female)
in drinking water for 90 days, the number of white blood cells was increased in the high-dose males (Borzelleca
et al. 1985c). No changes in red or white blood cell counts were noted in mice exposed to 2,4-DCP at doses up
to 230 mg/kg/day for 6 months (Kobayashi et al. 1972). After 13 weeks of prenatal exposure and up to 15 weeks
of postnatal exposure to 2-CP in drinking water, rat weanlings showed no adverse effects on red cell count,
hematocrit, mean corpuscular volume, white cell count, or hemoglobin concentration; the highest exposure dose
was 50 mg/kg/day (Exon and Koller 1982). Chronic prenatal/postnatal exposure to either 50 mg/kg/day 2-CP or
30 mg/kg/day 2,4-DCP resulted in increased erythrocyte count, packed cell volume, and hemoglobin
concentration. The increases for erythrocyte count and hemoglobin (>10%) were statistically significant (p≤
0.05) (Exon and Koller 1985). However, the investigators suggested that the increase may be secondary to
effects on liver enzymes or on hematopoietic stem cells and did not consider these effects biologically
significant,
In an NTP study (NTP 1989), bone marrow atrophy was observed in male rats treated with 2,4-DCP in the diet
at 1,000 mg 2,4-DCP/kg/day for 13 weeks and in female rats at 500 mg/kg/day. The atrophy resulted in
depletion of both erythroid and myeloid elements, with no effects observed at 250 mg/kg/day. No hematological
effects were noted in mice treated with 2,4-DCP in the diet for 13 weeks at doses up to 2,600 mg/kg/day or in
rats or mice treated with 2,4-DCP for 103 weeks (rats, 440 mg/kg/day; mice, 1,300 mg/kg/day) (NTP 1989).
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Treatment of rats with 2,4,5-TCP in the diet at doses up to 1,000 mg/kg/day for 98 days resulted in no
changes in hematocrit, hemoglobin, or white blood cell counts(McCollister et al. 1961). Administration of up to
720 mg/kg/day 2,4,6-TCP to rats for 90 days resulted in no adverse effects on erythrocyte count, leukocyte
count, corrected leukocyte count, hemoglobin, hematocrit, platelet count, or a differential analysis of leukocytes
(Bercz et al. 1990). Rats exposed orally for 7 weeks to 2,4,6-TCP exhibited a “moderate to marked increase” in
splenic hematopoiesis (NCI 1979). A high incidence of bone marrow hyperplasia and leukocytosis occurred in
rats chronically exposed to 2,4,6-TCP in their diet at 250 mg/kg/day (NCI 1979). Further discussion of these
hematological effects in rats can be found in Section 2.2.2.8. No hematological effects were evident in mice
exposed chronically to 2,4,6-TCP in their diet at doses up to 1,300 mg/kg/day (NCI 1979).
Treatment of rats by gavage with doses of 200 mg/kg/day 2,3,4,6-TeCP for 90 days significantly (p<0.05)
reduced hemoglobin and hematocrit in both sexes (American Biogenics 1988). Although the effects were
statistically significant, the investigators did not consider the effects to be toxicologically significant because the
group mean data were within the normal range of reference control data for the laboratory where the study was
conducted. In addition, no gross or histopathologic evidence was found to support the decreases in hemoglobin
and hematocrit.
Musculoskeletal Effects. No studies were located regarding musculoskeletal effects in humans after oral
exposure to any of the eight chlorophenols discussed in this profile.
Ninety-day (up to 2,600 mg/kg/day) and 2-year (up to 1,300 mg/kg/day) exposure of rats and mice to
2,4-DCP did not result in any histopathological changes in the muscle or ribs (NTP 1989). Single dose and 55-
day exposure to 2,3,4,6-TeCP produced no adverse histopathological effects on muscle in Wistar rats (Hattula et
al. 1981). The highest single and intermediate-duration exposure levels were 632 mg/kg and 100 mg/kg/day,
respectively (Hattula et al. 1981).
Hepatic Effects. No studies were located regarding hepatic effects in humans after oral exposure to any of the
eight chlorophenols discussed in this profile.
Treatment of mice by gavage with 2-CP in corn oil at doses up to 69 mg/kg/day for 14 days resulted in a
significant decrease in liver weights in females with no effects on serum glutamic-oxaloacetic transaminase
(SGOT); serum glutamic-pyruvic transaminase (SGPT); liver microsomal proteins; cytochrome P-450;
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cytochrome b5; or activities of liver aminopyrine demethylase, aniline hydroxylase, or arylhydrocarbon
hydroxylase (Borzelleca et al. 1985a). The study authors did not consider the change in liver weight to be
adverse because biologically or statistically significant compound-related adverse effects were not observed.
In Sprague-Dawley rats, twice daily administration of as little as 0.32 mg/kg 4-CP for 2 weeks
(0.64 mg/kg/day) resulted in significant activation of hepatic enzymes including cytochrome P-450
(Phomchirasilp et al. 1989b). Microsomal protein and cytochrome P-450 levels were also elevated in the
treated rats. The magnitude of increases over 2 weeks in liver microsomal protein and cytochrome P-450
content declined at doses above 0.64 mg/kg/day. Following additional experiments in which treatment was
given two times per day, both a 2-week exposure to 2.58 mg/kg/day and an 8-week exposure to 0.64
mg/kg/day resulted in a foamy cytoplasm and the clustering of mitochondria and endoplasmic reticulum.
The electron microscopic changes were not observed in the livers of rats treated at 1.28 mg/kg/day for 2
weeks. In separate studies, similar treatment doses of 4-CP had no effect on relative liver weights,
microsomal zoxazolamine 6-hydroxylase activity, or measures of serum lipid and lipidlipoprotein
concentrations, but did increase fasting glucose levels (Phomchirasilp et al. 1989a). Light microscopy was
not reported in this study. Based on the electron microscopic changes following 2 weeks of exposure, 2.58
mg/kg/day is considered a LOAEL and 1.28 mg/kg/day is considered a NOAEL. As described in footnote
“b” of Table 2-2, an acute duration oral MRL of 0.01 mg/kg/day was calculated for the chlorophenols
based on 4-CP. The LOAEL for 4-CP was the lowest LOAEL among all the acute-duration LOAELs for
all the chlorophenols discussed in this profile.
Sprague-Dawley rats dosed at 20 mg/kg/day of 2,4-DCP in the drinking water had increased liver weights
(Exon et al. 1984), an effect that could indicate hyperplasia or enzyme induction. No histopathological
changes were observed in the livers of Fischer-344 rats fed 2,4-DCP in the diet at doses up to 2,000
mg/kg/day for 13 weeks or 400 mg/kg/day for 103 weeks (NTP 1989). Liver weights or liver enzymes
released to the serum were not measured in the NTP (1989) study. Mice fed 325 mg/kg/day of 2,4-DCP for
13 weeks had dose-related increases in hepatocellular necrosis (not further described) (NTP 1989). When
mice were fed 383 or 230 mg/kg/day for 90 days or 6 months, respectively, no effects were noted on
SGOT or SGPT activity (these enzymes are released into the bloodstream as a result of liver injury)
(Borzelleca et al. 1985a; Kobayashi et al. 1972). One of 10 mice exposed to 230 mg/kg/day 2,4-DCP for 6
months had hepatocellular hyperplasia. No liver effects were observed at 100 mg/kg/day (Kobayashi et al.
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1972). Diffuse syncytial alterations occurred in male mice given 800 mg/kg/day 2,4-DCP in the diet for 103
weeks (NTP 1989). The number of cells affected was small, and the affected cells were scattered within the
histologic sections.
When guinea pigs were administered 40 mg/kg 2,4-DCP perorally 3 times a week for 2 weeks, lipid
peroxidation was increased in the liver (Clerhata et al. 1996). A high intake of ascorbic acid
(50 mg/animal/day) significantly decreased lipid peroxidation in the liver in comparison to guinea pigs with low
ascorbic acid intake (2 mg/kg/day). 2,4-DCP accumulation was also decreased in the liver of animals with high
ascorbic acid intake.
The pretreatment of rats with 2,4,5- or 2,4,6-TCP by gavage at doses up to 400 mg/kg/day for 14 days had no
effect on ethylp-nitrophenylphosphonothionate detoxification (Carlson 1978). 2,4,5-TCP but not 2,4,6-TCP at
400 mg/kg/day decreased microsomal NADPH-reductase activity and cytochrome P-450 activity.
Histologic changes in the liver were not observed when rats were treated by gavage with 2,4,5-TCP in corn oil
at doses up to 1,000 mg/kg/day for 18 or 24 days (McCollister et al. 1961). Slight pathologic changes, which
were not further described, were noted in the livers of rabbits treated by gavage with 2,4,5-TCP in 5% gum
acacia solution for 20 or 28 days (McCollister et al. 1961). Over a 98-day period, a dose of 300 mg/kg/day given
to rats in the diet resulted in mild centrilobular degeneration and focal necrosis, with no effects observed at 100
mg/kg/day (McCollister et al. 1961).
Increased liver weight and midzonal vacuolation of hepatocytes were evident in rats exposed orally for
7 weeks to 2,300 mg/kg/day 2,4,6-TCP (NCI 1979). Increased relative liver weights were found in groups of
male rats exposed to 240 and 720 mg/kg/day of 2,4,6-TCP for 90 days and groups of female rats exposed to 720
mg/kg/day of 2,4,6-TCP for 90 days (Bercz et al. 1990). No treatment-related histopathological evidence of
tissue damage was noted. Clinical chemistry results included increased serum albumin and total protein
concentrations, which the investigators attributed to either an altered hydration status or dysfunctional hepatic
activity (Bercz et al. 1990). The investigators considered 240 mg/kg/day as a LOAEL for hepatic effects and the
next lower dose, 80 mg/kg/day, as a NOAEL for acute duration exposure. In contrast, increased liver weight and
histopathologic lesions were not evident in rats exposed to 2,4,6-TCP over intermediate or chronic periods at
doses up to 1,000 and 500 mg/kg/day, respectively (Blackburn et al. 1986; NCI 1979).
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Microscopic examination revealed hepatic hyperplasia and other signs of hepatocellular damage (e.g., liver cell
abnormalities, focal areas of cellular alteration) in mice exposed chronically to 2,4,6-TCP in the diet at doses as
low as 650 mg/kg/day (NCI 1979). It is possible these lesions were precursors of the hepatocellular adenomas
and carcinomas also observed in this study. More information relating to these hepatic neoplasms can be found
in Section 2.2.2.8.
Concentration-related increases in absolute liver weight occurred in rats exposed perinatally to 3 or
30 mg/kg/day 2,4,6-TCP for 15 weeks (Exon and Koller 1985). The investigators did not examine functional or
anatomical hepatic parameters.
The different effects of 2,4,6-TCP in rats and mice may, in part, be a result of the different methodologies used
for exposure, variations in experimental design, and/or possible differences in gastrointestinal absorption
because of the nature of the vehicle. In the intermediate oral studies by Bercz et al. (1990) and Blackburn et al.
(1986), 2,4,6-TCP was administered in corn oil by gavage. Interpretation of the Blackburn et al. (1986) data is
further complicated by the investigators’ failure to report sample sizes used in the statistical analysis. The NCI
(1979) studies used administration of 2,4,6-TCP in the diet, while 2,4,6-TCP was administered in drinking water
in the Exon and Koller (1985) study, therefore, a direct comparison is not very meaningful.
For both acute- (one dose) and intermediate-duration (55 days) administration of 2,3,4,6-TeCP in Wistar rats,
the most severe effects occurred in the liver (Hattula et al. 1981). In the single dose study, various adverse
histopathological effects occurred at unspecified dose levels up to a maximum dose of 632 mg/kg. Intermediate-
duration (55 days) administration of 100 mg/kg/day resulted in both Level III (large confluative necroses with
dilated and thrombosed veins) and Level II (bile duct proliferation, focal necrosis, and polymorphonuclear
leukocyte infiltration) hepatic damage. At 50 mg/kg/day, 1 out of 10 rats showed Level III damage. The
NOAEL for hepatic effects following 55 days of exposure was 10 mg/kg/day (Hattula et al. 1981). The number
of animals used in the 55-day study was not stated.
In a study sponsored by the EPA (American Biogenics 1988), increased liver weights and centrilobular
hypertrophy were observed in rats treated by gavage with 2,3,4,6-TeCP at 100 or 200 mg/kg/day for 90 days. No
effects were observed at 25 mg/kg/day.
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Renal Effects. No studies were located regarding renal effects in humans after oral exposure to any of the eight
chlorophenols discussed in this profile.
In mice, daily administration of 35 or 69 mg/kg/day 2-CP for 14 days had no adverse effects on measures of
renal function, including blood urea nitrogen (BUN), total protein, albumin/globulin ratio, or electrolyte
balance (Borzelleca et al. 1985a). No significant compound-related adverse effects were noted at necropsy.
In the same study, a dose of 175 mg/kg/day was lethal to all exposed mice.
Except for renal tubular necrosis in mice that died following treatment with 2,4-DCP in the diet for 3 weeks
at 5,200 mg/kg/day (NTP 1989), kidney effects have not been observed in animals treated with 2,4-DCP.
Based on histological examinations, the reported NOAELs for kidney effects are 2,000 and 440 mg/kg/day
for rats fed 2,4-DCP in the diet for 13 and 103 weeks, respectively (NTP 1989), and 230,2,600, and 1,300
for mice fed 2,4-DCP in the diet for 90 days, 13 weeks, and 103 weeks, respectively (Kobayashi et al. 1972;
NTP 1989). Treatment of mice with 2,4-DCP in drinking water at doses up to 491 mg/kg/day had no effect
on kidney weights or clinical chemistry values including urine protein, phosphorus, calcium, sodium,
chloride, potassium, or creatinine levels (Borzelleca et al. 1985a). Histopathological examinations were not
completed because the clinical chemistry was negative.
Treatment of rats with 2,4,5-TCP at 1,000 mg/kg/day by gavage for 18 days resulted in a significant
increase in kidney weight, with no histopathologic changes or changes in BUN (McCollister et al. 1961).
Slight pathologic changes (not further described) were observed in rabbits given 20 gavage doses of 100 or
500 mg/kg/day, with no effects noted at 10 mg/kg/day (McCollister et al. 1961). In a go-day study, 2,4,5-
TCP administered in the diet at 300 mg/kg/day resulted in mild degenerative changes in the renal
epithelium of the convoluted tubules and in proliferation of the interstitial tissue (McCollister et al. 1961).
No kidney effects were observed at 100 mg/kg/day.
Administration of 720 mg/kg/day 2,4,6-TCP in corn oil by gavage for 90 days resulted in increased absolute
and relative kidney weights in male, but not female, Sprague-Dawley rats and decreased urinary pH in both
sexes. No other effects on clinical parameters of renal function were observed (Bercz et al. 1990). Renal
weight did not increase in Long-Evans rats administered 2,4,6-TCP in corn oil by gavage at doses as high as
1,000 mg/kg/day for 11 weeks, 5 days per week (Blackburn et al. 1986). Strain differences and daily
treatment as opposed to treatment five times per week may account for the differences in renal effects in the
Bercz et al. (1990) and Blackburn et al. (1986) studies. No treatment-related lesions were evident upon
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histopathologic examination of the kidney in rats and mice exposed to dietary 2,4,6-TCP for 2 years at doses as
high as 500 and 1,356 mg/kg/day, respectively (NCI 1979).
A single dose or 55day exposure to 2,3,4,6-TeCP, at doses up to 632 mg/kg or 100 mg/kg/day, respectively, had
no adverse effect on the histological appearance of the kidneys of rats (Hattula et al. 1981). Increased kidney
weights without any histopathologic changes were observed in rats treated by gavage with 2,3,4,6-TeCP at 100
mg/kg/day for 90 days (American Biogenics 1988). No renal effects were observed at 25 mg/kg/day.
Endocrine Effects. No studies were located regarding endocrine effects in humans after oral exposure to any of
the eight chlorophenols discussed in this profile.
Histopathologic examinations did not reveal any changes in the endocrine glands (adrenals, pituitary, thyroid,
pancreas) of rats or mice treated with 2,4-DCP in the diets at doses up to 2,000 (rats) or
2,600 (mice) mg/kg/day for 13 weeks, or at doses up to 440 (rats) or 1,300 (mice) mg/kg/day for 103 weeks
(NTP 1989). Histopathologic changes of the adrenals were not observed in rats treated with 2,4,5-TCP in the
diet at 1,000 mg/kg/day for 98 days (McCollister et al. 1961).
Female rats treated by gavage with 720 mg/kg/day of 2,4,6-TCP for 90 days had slightly, but statistically
significant, elevated adrenal weights compared to untreated controls (Bercz et al. 1990). Because no
histopathological changes were noted, this dose is considered a NOAEL. Adrenal gland weights were not
increased in male rats treated by gavage with 2,4,6-TCP at 1,000 mg/kg/day for 11 weeks (Blackburn et al.
1986), providing further support that the adrenal glands are not a target of 2,4,6-TCP toxicity. However,
differences between male and female rats could be due to endocrine differences between males and females.
Histopathologic changes were not observed in the adrenal glands, thyroid, pancreas, or parathyroid glands in rats
or mice treated with 2,4,6-TCP in the diet at doses of 500 (rats) or 1,356 (mice) mg/kg/day for 105 weeks (NCI
1979). Treatment of rats by gavage with 2,3,4,6-TeCP for 90 days at doses up to 200 mg/kg/day had no effect on
the histologic appearance of the adrenal glands, pituitary, pancreas, or thymus (American Biogenics 1988).
Dermal Effects. No studies were located regarding dermal effects in humans after oral exposure to any of the
eight chlorophenols discussed in this profile.
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Pregnant rats given 750 mg/kg 2,4-DCP by gavage experienced hair loss (Rodwell et al. 1989). No
histological changes in the skin were found in rats or mice given as much as 2,000 or 2,600 mg/kg/day,
respectively, for up to 13 weeks, nor for these same species fed up to 440 or 1,300 mg/kg/day for up to
103 weeks (NTP 1989). Upon histopathologic examination of the skin, no treatment-related effects were
observed in rats or mice exposed chronically to oral doses of 2,4,6-TCP as high as 500 or 1,356 mg/kg/day,
respectively (NCI 1979).
Ocular Effects. No studies were located regarding ocular effects in humans after oral exposure to any of the
eight chlorophenols discussed in this profile.
Histopathologic examination of the eyes did not reveal any adverse effect in rats or mice either treated with 2,4-
DCP (NTP 1989) in the diet or treated by gavage with 2,3,4,6-TeCP (American Biogenics 1988) for
intermediate or chronic durations. Ophthalmoscopic examinations did not reveal any treatment-related effects in
rats treated by gavage with 2,4,6-TCP at doses up to 720 mg/kg/day for 90 days (Bercz et al. 1990).
Body Weight Effects. No studies were located regarding body weight effects in humans after oral
exposure to any of the eight chlorophenols discussed in this profile.
In a 14-day study, both sexes of mice receiving 69 mg/kg/day 2-CP had unspecified body weight decrements
(Borzelleca et al. 1985a); the NOAEL was 35 mg/kg/day. No effects on body weight were observed in rats
treated with 2-CP in drinking water at doses of 50 mg/kg/day during gestation and lactation as well as 15-weeks
postweaning (Exon and Koller 1981,1982). Single-day gestational exposure of gravid Sprague-Dawley rats to
1,000 mg/kg 4-CP resulted in a significant body weight loss (Kavlock 1990). By 72 hours after dosing, the body
weight difference was no longer statistically significant, and lower levels did not produce any body weight gain
inhibition in gravid Sprague-Dawley rats. The NOAEL for the body weight effect for 4-CP was 667 mg/kg/day.
Additional results from this study are discussed in Section 2.2.2.6.
Studies with rats and mice fed 2,4-DCP for acute, intermediate, and chronic durations revealed dose-related
decreases in food intake and body weight (NTP 1989). These effects are believed to be due to the bad taste of
2,4-DCP. Body weights were not affected in mice treated with 2,4-DCP in the diet at doses up to 230 mg/kg/day
(Kobayshi et al. 1972) or in drinking water at doses up to 491 mg/kg/day (Borzelleca et al.1985a). To improve
palatability in drinking water, Borzelleca et al. (1985a) used a 1:9 emulphor:water
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solution which is a modified vegetable oil. Body weights of pregnant animals treated on gestation days
6-l5 were reduced at 375 but not 200 mg/kg/day (Rodwell et al. 1989).
Treatment of rats by gavage with 2,4,5-TCP for 18 or 24 days at 1,000 mg/kg/day had no effect on body weight
(McCollister et al. 1961). In contrast, treatment with 2,4,5-TCP in the diet at 1,000 mg/kg/day for 90 days
resulted in a 24% decrease in body weight gain in female but not in male rats (McCollister et al. 1961). No
effects on food intake were measured.
Treatment of rats with 2,4,6-TCP by gavage at 1,000 mg/kg/day for 2 weeks before mating and throughout
gestation resulted in reduced body weights through gestation day 14 (Blackburn et al. 1986). Body weights on
gestation day 21 were not significantly different from those of the controls. No effect on body weight was
observed in rats treated by gavage with 2,4,6-TCP at 1,000 mg/kg/day for 90 days (Bercz et al. 1990) or 11
weeks (Blackburn et al. 1986), suggesting that pregnant animals may be more sensitive to effects on body
weight following treatment with 2,4,6-TCP. No effect on body weight was observed in mice treated with 2,4,6-
TCP in drinking water at 30 mg/kg/day for 24-25 weeks (Exon and Koller 1985). Body weights were
significantly reduced in rats treated with 2,4,6-TCP in the diet for 7 weeks at 735 but not at 500 mg/kg/day and
250 mg/kg/day for 105 weeks (NCI 1979). Body weights were also significantly decreased in mice fed 2,600
mg/kg/day 2,4,6-TCP in the diet for 7 weeks and at 658 mg/kg/day for 105 weeks (NCI 1979). No effects on
body weight were observed in mice fed 1,300 mg/kg/day 2,4,6-TCP for 7 weeks (NCI 1979). Food intake data
were not provided in the NCI (1979) study. The fact that 2,4,6-TCP affected body weight following dietary
intake but had little effect at similar doses following gavage treatment suggests that 2,4,6-TCP may have caused
the food to be less palatable and reduced food intake in mice at the concentrations used in the NCI (1979) study.
Therefore, decreased body weight may be an effect of decreased food intake rather than an effect of 2,4,6-TCP
treatment.
Body weight was significantly decreased in rats treated by gavage with 2,3,4,6-TeCP at 100 mg/kg/day
(American Biogenics 1988) for 90 days, but not 100 mg/kg/day for 55 days (Hattula et al. 1981).
2.2.2.3    Immunological and Lymphoreticular Effects
No studies were located regarding immunological and lymphoreticular effects in humans after oral exposure to
any of the eight chlorophenol isomers discussed in this profile.
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Rats fed 50 mg/kg/day 2-CP for up to 16 weeks and mice fed 69 mg/kg/day 2-CP for 14 days showed no
changes in humoral or cell-mediated immunological assays (Borzelleca et al. 1985a; Exon and Koller
1983,1985). Indices assessed in the Exon and Koller (1983, 1985) studies include antibody production, delayed
type hypersensitivity, and phagocytic activity of peritoneal exudate cells. Female mice exposed to 69 mg/kg/day
for 14 days had statistically significant decreases in spleen weight but no gross abnormalities in spleen
morphology (Borzelleca et al. 1985a). Spleen and thymus weights were not significantly affected in rats that
received 50 mg 2,4-DCP kg/day in drinking water for 16 weeks (Exon and Koller 1983, 1985). Perinatal
exposure of young rats to 2-CP at doses up to 50 mg/kg/day produced no treatment-related effects on humoral or
cell-mediated immunity, thymus weights, or spleen weights (Exon and Koller 1983, 1985).
Histopathological examination of lymph nodes, spleen, and thymus did not reveal any effects in rats or
mice treated with 2,4-DCP in the diet at doses up to 2,000 (rats) and 2,600 mg/kg/day (mice) for 13 weeks, or
440 (rats) and 1,300 mg/kg/day (mice) for 103 weeks (NTP 1989). Bone marrow atrophy was observed in rats
treated at 500 but not 250 mg/kg/day for 13 weeks (NTP 1989). Because both erythroid and myeloid elements
were affected, this study is also discussed in Section 2.2.2.2 under Hematological Effects. No changes in spleen
weight were observed in mice treated with 2,4-DCP in the diet at 230 mg/kg/day for 6 months (Kobayashi et al.
1972), and no changes in spleen or thymus weight were noted in mice treated with 2,4-DCP in the drinking
water at doses up to 491 mg/kg/day for 90 days.
As shown in Table 2-2 and Figure 2-2, immune system effects have been reported in animals at low doses of
2,4-DCP. Decreased delayed-type hypersensitivity occurred in rats during 15-week-duration exposure to 3
mg/kg/day of 2,4-DCP in drinking water, and increased serum antibodies to key hole limpert nemocyanin were
found in the blood of rats during similar exposures to 30 mg/kg/day (Exon and Koller 1985; Exon et al. 1984).
Macrophage function, measured by the in vitro phagocytosis of sheep red blood cells, showed no effect from
2,4-DCP treatment. These results suggest that the immune system is quite sensitive to 2,4-DCP. No immune
system effects occurred with exposure to 0.3 mg/kg/day (Exon et al. 1984). Based on the NOAEL of 0.3
mg/kg/day, an intermediate-duration oral MRL of 0.003 mg/kg/day was calculated for the chlorophenols as
described in the footnote in Table 2-2. The LOAEL for 2,4-DCP was the lowest among all the intermediate-
duration LOAELs for all the chlorophenols discussed in this profile.
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No changes in spleen weight or histological appearance were observed in rats treated with 2,4,5-TCP in the diet
at doses of 1,000 mg/kg/day for 98 days (McCollister et al. 1961) or in rats treated by gavage with 720
mg/kg/day 2,4,6-TCP for 90 days (Bercz et al. 1990). Spleen weights were significantly increased in rats
exposed to 2,4,6-TCP in the drinking water both pre- and postnatally at doses of 30 mg/kg/day, while no
significant effects on immune function (antibody levels, delayed-type hypersensitivity, macrophage numbers)
were observed (Exon and Koller 1985). Treatment of rats and mice with 2,4,6-TCP in the diet for 2 years at
doses up to 500 mg/kg/day for rats and 1,356 mg/kg/day for mice did not reveal any significant gross or
histopathological changes in the spleen, lymph nodes, or thymus (NCI 1979).
Administration of a single gavage dose 632 mg/kg of 2,3,4,6-TeCP in Wistar rats resulted in “slight stasis” in
the spleens of rats (Hattula et al. 1981); the toxicological significance of this finding is unknown. No
histological changes were observed in the spleen, lymph nodes, or thymus of rats treated with 2,3,4,6-TeCP by
gavage at doses up to 200 mg/kg/day for 90 days (American Biogenics 1988).
The highest NOAEL values and all reliable LOAEL values for immunological and lymphoreticular effects in
rats and mice for each exposure duration are recorded in Table 2-2 and plotted in Figure 2-2.
2.2.2.4 Neurological Effects
No studies were located regarding neurological effects in humans after oral exposure to any of the eight
chlorophenol isomers discussed in this profile.
In most acute animal studies involving 2-, 4-CP and 2,4-DCP exposure, a common syndrome of effects
precedes death (Borzelleca et al. 1985a, 1985b; Kobayashi et al. 1972; Spencer and Williams 1950; Wil
Research Laboratories 1982). This syndrome includes restlessness, tremors, convulsions, dyspnea and/or
tachypnea, and collapse or coma. In many of these studies, the major effects associated with exposure to high
doses of many phenolic compounds are myoclonic convulsions, or spasmodic twitching of a group of muscles.
The relationship between chlorophenol exposure and the onset of convulsions is discussed further in Sections
2.4 and 2.5. In general, the sensitivity of these clinical signs (particularly convulsions) decreases with increasing
chlorination.
In an LD50 study, single oral doses (unspecified) of 2-CP or 4-CP caused restlessness, motor weakness,
tremors, convulsion, or central nervous system depression in rats and mice (Borzelleca et al. 1985a, 1985b).
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The actual doses used in the study (Borzelleca et al. 1985b) were not stated. A single oral dose of 514 mg/kg 4-
CP produced seizures immediately followed by death in male ICR mice (Phornchirasilp et al. 1989b). Single
doses of 2-CP >300 mg/kg resulted in distress and twitching in rabbits (Spencer and Williams 1950).
Administration of 4-CP produced similar effects at higher, unspecified doses. In male and female ICR mice,
repeated administration of 35 and 69 mg/kg/day 2-CP for 44 days resulted in hyperactivity and decreased brain
weight, respectively (Borzelleca et al. 1985a); although, the brain tissue appeared grossly normal (Borzelleca et
al. 1985a).
Mice treated with 2,4-DCP in the diet at 5,200 mg/kg/day for 14 days were lethargic and 1 out of 5 males died
(NTP 1989). Hunched posture was observed in rats treated with 2,4-DCP in the diet at 2,000 mg/kg/day for 13
weeks (NTP 1989) with no histopathological changes in the brain, sciatic nerve, or spinal cord. In mice treated
with 2,4-DCP in the diet at doses up to 2,600 mg/kg/day for 13 weeks, no histopathological changes were
observed in the brain, sciatic nerve, or spinal cord (NTP 1989). No effect on brain weight was observed in mice
treated with 2,4-DCP in the drinking water at doses up to 491 mg/kg/day (Borzelleca et al.1985a). No clinical
signs of neurological effects were reported in rats or mice fed doses up to 440 mg/kg/day for rats and 1,300
mg/kg/day for mice, and histopathologic examination of the brains of these animals did not reveal any effects
(NTP 1989).
No changes in brain weight or histological appearance of the brain were observed in rats treated with
2,4,5-TCP in the diet at doses up to 1,000 mg/kg/day for 98 days (McCollister et al. 1961).
Histopathologic examination of the brain (cerebrum and cerebellum) of rats and mice exposed repeatedly to oral
2,4,6-TCP at doses as high as 720 and 1,356 mg/kg/day, respectively, revealed no treatment-related effects
(Bercz et al. 1990; NCI 1979). Similarly, in Wistar rats exposed acutely to up to 632 mg/kg 2,3,4,6-TeCP, or
repeatedly to 200 mg/kg/day 2,3,4,6-TeCP for 90 days, no histopathological effects in the brain were observed
(American Biogenics 1988).
The highest NOAEL and all LOAEL values for neurological effects in each species and duration category are
recorded in Table 2-2 and plotted in Figure 2-2.
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2.2.2.5 Reproductive Effects
No studies were located regarding reproductive effects in humans after oral exposure to any of the eight
chlorophenol isomers discussed in this profile.
A teratogenicity study in which pregnant rats were treated with 2,4-DCP by gavage on gestation days 6-15 at
doses that caused maternal deaths and decreased body weight gain showed neither postimplantation loss nor
changes in the numbers of resorptions and viable fetuses (Rodwell et al. 1989). No reproductive organ pathology
was observed in rats or mice of either sex fed up to 2,000 or 2,600 mg/kg/day 2,4-DCP, respectively, for 13
weeks (NTP 1989). Reproductive organ pathology was also not observed in male rats fed 440 and female rats
fed 250 mg/kg/day 2,4-DCP and male mice fed 1,300 and female mice fed 8,210 mg/kg/day 2,4-DCP for 2 years
(NTP 1989). Sperm from male mice fed 500 mg/kg/day 2,4-DCP for 90 days in drinking water were not
impaired in their ability to fertilize ova (Seyler et al. 1984).
Using identical experimental protocols, investigators have studied the reproductive effects of 2-CP, 2,4-DCP,
and 2,4,6-TCP in Sprague-Dawley female rats (Exon and Koller 1985). Groups of rats received uncontaminated
drinking water or one of three concentrations of a chlorophenol in drinking water, beginning at weaning and
extending through mating and parturition. The total exposure duration for each group was approximately 13
weeks. The only consistent concentration-related effect observed in all three experiments was a marginal
decrease (p<0.10) in litter size. In all cases, the individual conceptus, rather than the litter, was the unit of
statistical analysis. For 2-CP, 2,4-DCP, and 2,4,6-TCP, the highest concentration in water corresponded to
50,30, and 30 mg/kg/day, respectively; these doses are considered LOAELs for reproductive effects. No
significant reproductive effects were observed at 5 mg/kg/day 2-CP and 3 mg/kg/day for 2,5-DCP and 2,4,6-
TCP.
In a study designed to look at reproductive function, Blackburn et al. (1986) treated female rats with
2,4,6-TCP by gavage at doses up to 1,000 mg/kg/day for 2 weeks before mating and throughout gestation and
treated male rats with 2,4,6-TCP at doses up to 1,000 mg/kg/day for 10 weeks. The treated females were mated
with untreated males, and the treated males were mated with untreated females. 2,4,6-TCP had no effects on
breeding success, litter size, or litter survival when either sex was treated. Treatment of males had no effect on
sperm count, motility, or morphology, nor were there any changes in weights of the testes, prostate, or seminal
vesicles. Although treatment-related deaths occurred in both sexes at 1,000 mg/kg/day, this dose can be
considered a NOAEL for 2,4,6-TCP reproductive effects in rats.
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In 90-day studies, gavage treatment of rats with either 2,4,5-TCP at doses up to 1,000 mg/kg/day
(McCollister et al. 1961) or with 2,4,6-TCP up to 720 mg/kg/day (Bercz et al. 1990) had no effect on the weight
of the testes or ovaries. Treatment of rats with 2,4,6-TCP in the diet for 2 years had no effects on the histologic
appearance of the testis and prostate or of the uterus or ovaries (NCI 1979).
In a study designed to examine developmental effects, pregnant rats were treated by gavage with
2,3,4,6-TeCP at doses up to 200 mg/kg/day on gestation days 6-l 5 (RTI 1987). An increased trend in
percent preimplantation loss with dose suggested an effect on the process of implantation or early
postimplantation viability. Because this study was not designed to examine the preimplantation/ implantation
phase of reproduction, the investigators suggested that the effect requires confirmation. Therefore, a LOAEL or
NOAEL for reproductive effects in female rats exposed to 2,3,4,6-TeCP is not clearly defined by this study. No
histopathological changes were observed in the testes, ovaries, or uterus and cervix of rats treated by gavage
with 2,3,4,6-TeCP at doses up to 200 mg/kg/day for 90 days (American Biogenics 1988).
The highest NOAEL values and all reliable LOAEL values are listed in Table 2-2 and plotted in Figure 2-2.
2.2.2.6 Developmental Effects
No studies were located regarding developmental effects in humans after oral exposure to any of the eight
chlorophenol isomers discussed in this profile.
No significant changes in offspring body or liver weights were observed in rats treated with 2-CP in drinking
water at doses up to 50 mg/kg/day throughout gestation and up to 91 days post partum (Exon and Keller 1981,
1983, 1985). Groups of 6-13 female Sprague-Dawley rats receiving a single dose of 333,667, or 1,000 mg/kg 4-
CP on gestational day 11 showed no adverse changes in litter sizes, perinatal loss, pup weight, or litter biomass
(Kavlock 1990). The only treatment-related effect was a transient decrease in maternal body weight at 1,000
mg/kg.
Oral exposure of pregnant rats to 750 mg/kg/day 2,4-DCP for 10 gestational days induced a slight decrease in
fetal weight and a statistically significant delayed ossification of sternal and vertebral arches and led to a slight
insignificant increase in early embryonic deaths (0.8/average litter controls; 1.2/litter 750 mg/kg/day) (Rodwell
et al. 1989). Maternal death occurred at this dose level, indicating that 2,4-DCP was not selectively toxic to
embryos or fetuses. The authors indicated that, although the number of deaths and fetal weights
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differed from that of the concurrent controls, values were not different from the historical control data from their
laboratory. No evidence of malformations in the offspring was found in this study. At 375 mg/kg/day, maternal
body weight was reduced, with no effects observed at 200 mg/kg/day.
No effect on immune function parameters (antibody production, delayed type hypersensitivity response,
phagocytic activity) was noted in 6-week-old rats treated with 2,4-DCP in the drinking water at doses up to 30
mg/kg/day throughout gestation (Exon and Koller 1985; Exon et al. 1984). Spleen weights were significantly
increased at 30 mg/kg/day, although no histological changes in the spleen were observed.
Gavage administration of 650 mg/kg/day 2,4,5-TCP during organogenesis (days 6-15 of gestation) produced no
fetotoxicity, malformations, or structural terata in the offspring of Sprague-Dawley rats (Chernoff et al. 1990).
Treatment resulted in statistically insignificant increases in maternal lethality and decrements in maternal weight
gain (Chernoff et al. 1990). In another developmental study, groups of mice received either a single gavage dose
of 800-900 mg/kg 2,4,5-TCP on 1 day of gestation (any of gestation days S-15), or 250-300 mg/kg/day on any 3
days of gestation (gestation days 7-9, 10-12, or 13-15) (Hood et al. 1979). With the exception of a significant
increase in the incidence of prenatal mortalities and resorptions in dams dosed on day fourteen, 2,4,5-TCP had
no effect on resorption incidence or pup survival. 2,4,5-TCP administration did not affect mean fetal weight or
the incidence of gross malformations, skeletal malformations, or cleft palates (Hood et al. 1979).
In a study designed to examine reproductive effects, a 10-11% decrease in litter weights was observed in litters
of female rats treated by gavage with 2,4,6-TCP at 500 mg/kg/day for 2 weeks before mating and throughout
gestation (Blackburn et al. 1986). No effects on litter weights were observed at 100 mg/kg/day, and no effects
on survival to postnatal day 42 were observed. No effects on body weight were observed among offspring of
male rats treated by gavage with 2,4,6-TCP at 1,000 mg/kg/day for 10 weeks before mating (Blackburn et al.
1986). Because comprehensive examinations of offspring were not completed, this study is not sufficient to
conclude that developmental effects do not occur following exposure to 2,4,6-TCP.
Maternal exposure of rats to 500 mg/kg/day 2,4,6-TCP produced a transient reduction in the body weight of
offspring (Blackbum et al. 1986). No developmental effects were noted in the offspring of female rats exposed
to 2,4,6-TCP throughout gestation (Blackbum et al. 1986; Exon and Koller 1985). In addition, no developmental
effects were noted in the offspring of male rats treated with 2,4,6-TCP and untreated females (Blackbum et al.
1986). These studies were limited by the lack of reporting on the number of animals from
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which group means were calculated (Blackburn et al. 1986) and by a lack of reporting on maternal toxicity
(Exon and Koller 1985).
In a developmental study in which female Sprague-Dawley rats orally received purified 2,3,4,6-TeCP
throughout organogenesis, the only effect on the fetus was delayed ossification of the skull bones (Schwetz et al.
1974). The reported incidences were 14/173 (8%) and 18/104 (17%) at 0 and 30 mg/kg/day, respectively. When
analyzed by litter, no statistical difference for delayed ossification was observed. Therefore, 30 mg/kg/day
2,3,4,6-TeCP is considered a NOAEL for developmental effects in rats. In a follow-up study, pregnant CD rats
received 0,25, 100, or 200 mg/kg/day, in olive oil, every day during organogenesis (RTI 1987). Administration
of the two highest doses resulted in corrected maternal body weight gain (dam body weight-gravid uterus
weight) inhibitions of 13% and 26%, respectively, with no effects at 25 mg/kg/day. Measurement of food intake
indicated that these effects were not related to decreased food consumption, Minor variations between dose
groups in fetal malformation and aberrations were not dose related. The investigators also noted a dose-related
trend for 2,3,4,6-TeCP-mediated effects on implantation or postimplantation viability. No further evidence of
maternal or fetotoxic effects were observed (RTI 1987). Based on maternal toxicity, this study identifies 100
mg/kg/day as a LOAEL and 25 mg/kg/day as a NOAEL for developmental effects.
The highest NOAEL value and all LOAEL values from each reliable study for developmental effects for each
exposure duration category are recorded in Table 2-2 and plotted in Figure 2-2.
2.2.2.7 Genotoxic Effects
No studies were located regarding genotoxic effects in humans after oral exposure to any of the eight
chlorophenols discussed in this profile.
In ICR mice, daily gavage administration of 69 mg/kg/day 2-CP or 638 mg/kg/day 2,4-DCP in corn oil for 14
days did not increase sister chromatid exchange (SCE) rates in testicular or bone marrow cells (Borzelleca et al.
1985a). Further details were not provided. Ninety-day exposure,of mice to 2,4DCP in drinking water at doses up
to 500 mg/kg/day also had no effect on SCE in bone marrow and testicular cells (Borzelleca et al. 1985a). A
single gavage dose of 2,4,5-TCP (164 mg/kg), 2,4,6-TCP (164 mg/kg), or 2,3,4,6-TeCP (28 or 193 mg/kg) given
to rats did not damage deoxyribonucleic acid (DNA) as measured by the fraction of DNA eluted from white
blood cells or livers (Kitchin and Brown 1988).
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Other genotoxicity studies are discussed in Section 2.5.
2.2.2.8 Cancer
No studies were located regarding cancer in humans after oral exposure to any of the eight chlorophenol isomers
discussed in this profile.
In the one oral carcinogenicity study located, groups of Sprague-Dawley rats received prenatal, postnatal, or
both pre- and postnatal exposure to 2-CP (Exon and Koller 1985). The exposure concentrations were 0,5, 50,
and 500 ppm in drinking water (0, 0.5, 5, 50 mg/kg/day). Under all exposure conditions, 2-CP administration
had no effect on the incidence, latency, or types of tumors relative to the untreated controls. Additional groups
of gravid dams received ethylurea and nitrite, precursors of the carcinogenic initiator ethylnitrosourea (ENU), on
gestation days 14 and 21. No consistent effects on either tumor incidence or latency occurred in rats treated with
ENU and then treated either prenatally or postnatally with 2-CP. The groups of males receiving ENU and both
prenatal and postnatal 2-CP had increased tumor incidence and decreased tumor latency relative to a control
group receiving ENU only. The investigators indicate that the combined changes were marginally statistically
significant (p< 0.10) in comparison to a group receiving the initiator ENU only. ENU-exposed female rats also
exposed pre- and postnatally to 2-CP showed no consistent, concentration-related effects on either tumor
incidence or latency (Exon and Koller 1985). Findings in the combined-exposure male treatment groups indicate
that 2-CP may be either a cocarcinogen or a tumor promotor. However, an analysis of incidence and latency data
suggests that the effects may not be concentration related. No effects on tumorigenicity were found in similar
studies with 2,4-DCP given in drinking water at 0.3,3, or 30 mg/kg/day. It is not clear whether a maximum
tolerated dose was achieved in these studies (Exon and Koller 1985).
Chronic carcinogenicity bioassays in rats and mice treated with 2,4-DCP in the diet at doses up to
440 mg/kg/day for rats and 1,300 mg/kg/day for mice did not provide any evidence that 2,4-DCP is
carcinogenic (NTP 1989). In contrast, carcinogenicity bioassays with rats and mice provide evidence that
chronic oral exposure to 2,4,6-TCP is associated with leukemia and liver cancer (NCI 1979). In male rats,
chronic oral exposure to 2,4,6-TCP in the diet produced a significant dose-related increase in the incidence of
monocytic leukemia (NCI 1979). An increased incidence of leukemia also occurred in female rats; however, the
increase was not significant compared to the controls. In addition, leukocytosis and monocytosis as well as
hyperplasia of the bone marrow were induced in treated male and female rats that did not develop
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leukemia. In rats with leukemia, there were large numbers of circulating monocytes in the blood that ranged
from well-differentiated monocytes to immature and blast forms. Monocytes were often observed in the liver,
spleen, lymph tissue, and bone marrow and occasionally in the lungs, adrenals, and other organs.
In both male and female B6C3Fl mice treated chronically with 2,4,6-TCP in the diet, a significant
doserelated increase in the incidence of hepatocellular adenomas and carcinomas (not further described) was
noted (NCI 1979). Liver damage, including individual liver cell abnormalities, focal areas of cellular
alteration and focal and nodular areas of hyperplasia were commonly present in the treated mice. Significant
limitations of this study included the failure to report the dioxin content of the 2,4,6-TCP formulation,
changes in the dosing regimen of mice, and no testing of organ function. Another limitation was the failure
to compare the incidence of liver tumors to historical controls as well as concurrent controls. Hepatocellular
carcinoma has a high natural incidence in this strain of mouse which tends to vary from one study to the
next.
A single oral dose of 2,4,6-TCP (200 mg/kg) did not significantly increase skin tumors in mice treated
dermally with a tumor promoter (12-O-tetradecanoylphorbol-13-acetate [TPA]) relative to TPA alone,
suggesting that 2,4,6-TCP does not act systemically as an initiator (Bull et al. 1986). Other studies also
examined the possible carcinogenic effects of 2,4,6-TCP, but contained limitations that preclude a
conclusion (Bionetics Research Labs 1968; Innes et al. 1969; Stoner et al. 1986). The limitations included
early termination of the experiment (24 weeks) (Stoner et al. 1986), only one treatment group (Bionetics
Research Labs 1968; Innes et al. 1969), a small number of treated animals (Bionetics Research Labs 1968;
Innes et al. 1969), and a change in dosing regimen and method of exposure (Bionetics Research Labs 1968;
Innes et al. 1969).
The Cancer Effect Levels (CELs) are recorded in Table 2-2 and plotted in Figure 2-2.
2.2.3 Dermal Exposure
2.2.3.1 Death
A worker who splattered pure 2,4-DCP on portions of his right arm and leg while disposing of industrial
waste collapsed and experienced a seizure within 20 minutes of the accident and died shortly thereafter.
Postmortem examination revealed blood and urine 2,4-DCP concentrations of 24.3 and 5.3 mg/L,
respectively. The identity of 2,4-DCP was confirmed by mass spectrometry. The investigators did not
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estimate an absorbed dose (Kintz et al. 1992), but assuming a blood volume of 5 liters and a body weight of 70
kg, the dose would be approximately 2 mg/kg as a minimum. A screen for other drugs including ethanol,
organic solvents, tranquilizers, and drugs of abuse was negative.
Limited data were located on the lethal effects of dermally applied chlorophenols in experimental animals.
Results of a contract laboratory study indicate that the dermal LD50 of 2-CP in rabbits is between 1,000 and
1,580 mg/kg (Younger Lab 1975). Antemortem observations included increasing weakness, tremors, collapse,
and coma. Gross necropsy in the rabbit studies indicated hemorrhage in the lungs, Liver discoloration,
gastrointestinal inflammation, darkened spleens and kidneys, and enlarged gall bladders. The study data do not
clearly indicate whether mortality resulted from any of these effects. Conclusions from this study are limited by
small test groups and/or the lack of information regarding experimental methodology.
A dermal LD50 of 1,415 mg/kg has been reported for male rabbits exposed to 2,4-DCP for 24 hours (Carreon et
al. 1980b). Because there were only two rabbits per dose group, the 95% confidence interval on this value is
very large (236-8,455 mg/kg). Unoccluded dermal application of 2,000 mg/kg 2,3,4,5-TeCP or 2,3,5,6-TeCP
resulted in 1 out of 20 and 2 out of 20 deaths, respectively, in Sprague-Dawley rats (Shen et al. 1983). The
purity of each test compound was >99%. Because these preliminary studies indicated that the dermal LD50
values for 2,3,4,5-TeCP and 2,3,5,6-TeCP were greater than 2,000 mg/kg, further testing of these compounds
was not completed. The LD50 for commercial tetrachlorophenol, consisting primarily of the 2,3,4,6-isomer (at
least 90%), was 485 mg/kg in males and 565 mg/kg in females. Clinical signs preceding death for all
tetrachlorophenol isomers included initial hyperactivity followed by hypoactivity, neuromuscular weakness, and
convulsions (Shen et al. 1983).
The LD50 values and dermal doses of chlorophenols associated with death are recorded in Table 2-3.
2.2.3.2 Systemic Effects
No studies were located regarding respiratory, cardiovascular, hematological, musculoskeletal, hepatic, or renal
effects in humans or animals after dermal exposure to any of the eight chlorophenols discussed in this profile.
The systemic effects that were observed after dermal exposure to chlorophenols are discussed below.
Gastrointestinal Effects. No studies were located regarding gastrointestinal effects in humans after
dermal exposure to any of the eight chlorophenols discussed in this profile.
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Diarrhea was observed in one of two female rabbits the day after a dermal exposure to a single dose of
398 mg/kg/day 2,4-DCP (Hencke and Lockwood 1978). This limited study suggests that either dermally applied
2,4-DCP, or the stress of being exposed to a skin irritant, can result in gastrointestinal effects in rabbits.
Dermal Effects. Chloracne and evidence of acquired porphyria, hyperpigmentation, and hirsutism have been
observed in workers employed in the manufacture of 2,4-DCP- and 2,4,5-TCP-based herbicides (Bleiberg et al.
1964; Bond et al. 1989). The chloracne incidence was greatest in young employees exposed in trichlorophenol
production and in chlorophenol production and finishing procedures (Bond et al. 1989). In this study, workers
exposed to the highest concentration of the contaminant TCDD were at the greatest risk of developing
chloracne.
The results of animal studies indicate that monochlorophenols are corrosive to epithelial tissue (Bioassay
Systems 1981; Rhodia 1978). Severe effects have been reported at exposure levels of 242-2,000 mg/kg of 2-CP
or 4-CP applied directly to rabbit skin. Corrosion (not further described) is typically accompanied by other signs
of severe skin injury, including erythema, edema, and discoloration. A single dermal application of a lower dose
(100 mg/kg) of 4-CP to one ear of a mouse did not increase ear weight relative to the untreated ear (Dohi et al.
1989). Because of the inadequacies of the test methodologies used, few conclusions regarding dose-response
relationships or comparative isomeric potency can be made.
Dermal lesions were caused by a single direct application of as little as 200 mg/kg 2,4-DCP to bare
abdominal skin of New Zealand White rabbits (Carreon et al. 1980a, 1980b; Hencke and Lockwood 1978;
Younger Labs 1976). The dose-related dermal damage observed was described as mild-to-moderate erythema
and mild-to-marked edema, followed by necrosis and scabbing. No NOAEL values were identified in these
studies.
Dermal application of 20 mL/kg (32 g/kg) 2,3,4,5-TeCP on the shaved skin of female rats resulted in
dermatosis associated with scar formation. Rats treated with the sodium hydroxide extracted fraction of
2,3,4,5-TeCP had no dermatological lesion, indicating that the adverse effects were attributable to the
chlorophenol rather than contaminants, such as dioxins (Shen et al. 1983).
Ocular Effects. Lumber mill workers exposed to a mixture of tetrachlorophenols (specific isomers not
stated) and pentachlorophenol reported eye irritation more frequently than unexposed workers (Kleinman et
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al. 1986). The eye irritation was likely a direct effect of the tetrachlorophenols, resulting from contact with the
airborne chemicals or contact with contaminated surfaces (e.g., hands, clothing).
Monochlorophenols produce effects ranging from slight hyperemia to severe corrosion when applied to the
corneas of rabbits. Rabbits administered 0.6 mg/kg 4-CP (a 1% solution) showed slight hyperemia (Harrison and
Madonia 1971). At 1.2 mg/kg, rabbits had more severe hyperemia with edematous swelling, corneal cloudiness,
and exudation. The maximum response occurred 5 hours after application. Inflammation was no longer apparent
at 96 hours. Severe discomfort and corrosion was reported to occur 1 minute after the application of 33 mg/kg
undiluted 2-CP to rabbit eyes (Younger Labs 1975). Although the results are inadequate for an assessment of
comparative potencies across isomers, the available data indicate that 2-CP and 4-CP produce rapid and severe
cornea1 destruction at relatively low concentrations.
Severe cornea1 damage occurred in the eyes of rabbits after a single direct application of 0.1 mL 2,4-DCP
(Hencke and Lockwood 1978). Careful washing of the eye 30 seconds after application did not prevent this
damage.
2.2.3.3 Immunological and Lymphoreticular Effects
No studies were located regarding immunological and lymphoreticular effects in humans following dermal
exposure to any of the eight chlorophenols discussed in this profile.
The murine local lymph node assay, which is predictive of skin sensitization potential, was completed in mice
treated with 2,4,5-TCP (Kimber and Weisberger 1991). A single dermal exposure of 50 mL of 2,4,5-TCP was
applied on one shaved flank; 5 days later the mice were given 3 daily doses (140-560 mg/kg/day) applied to the
ear. A positive response was observed at all doses, suggesting that 2,4,5-TCP can be a skin sensitizer. This study
is limited since only three mice were used in each group and a statistical analysis of the data was not completed.
2.2.3.4 Neurological Effects.
An industrial waste worker who accidentally splashed pure 2,4-DCP on portions of his right arm and leg,
experienced a seizure within 20 minutes of the exposure, and died shortly thereafter (Kintz et al. 1992). Lumber
mill workers exposed to a mixture of tetrachlorophenols (specific isomers not stated) and
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pentachlorophenol reported headaches more frequently than unexposed workers (Kleinman et al. 1986).
Industrial hygiene observations of inadequate use of protective equipment to prevent skin exposure led the
investigators to suggest that exposure was principally through the skin, with some possibility of oral ingestion.
Rabbits given single applications of 250 mg/kg 2,4-DCP or more became lethargic (Carreon et al. 1980a, 1980b;
Younger Labs 1976), and two rabbits in the 2,000-mg/kg group and one in the 4,000-mg/kg group became
anorexic (Carreon et al. 1980b). Small sample sizes weaken the validity of these data, but the lethargy observed
in this study is in keeping with the signs of central nervous system depression seen in rats and mice orally
exposed to 2,4-DCP. In a single-dose dermal study of the tetrachlorophenols in rats, clinical signs observed
before death were hyperactivity, neuromuscular weakness, convulsions, and death (Shen et al. 1983). Both
2,3,5,6-TeCP and 2,3,4,5-TeCP that had dermal LD50 values >than 2,000 mg/kg were less toxic than 2,3,4,5-
TeCP that had a dermal LD50 of 468 mg/kg in males and 565 mg/kg in females.
No NOAEL values were identified for neurological effects. The lowest LOAEL values for neurological effects
in rabbits are recorded in Table 2-2.
2.2.3.5 Reproductive Effects
No studies were located regarding reproductive effects in humans or animals after dermal exposure to any of the
eight chlorophenol isomers discussed in this profile.
2.2.3.6 Developmental Effects
No studies were located regarding developmental effects in humans or animals after dermal exposure to any of
the eight chlorophenol isomers discussed in this profile.
2.2.3.7 Genotoxic Effects
Genotoxicity studies are discussed in Section 2.5.
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2.2.3.8 Cancer
Numerous authors have studied the possible relationship between occupational chlorophenol exposure and the
expression of oncogenicity. For all of these studies, the workers were exposed by both the inhalation and dermal
routes. The description and results of these studies were provided in Section 2.2.1.8.
Results of case-control studies have suggested increased risks for soft tissue sarcoma, malignant lymphoma, and
acute myeloid leukemia in slaughterhouse workers exposed occupationally to a number of chemicals, including
2,4,6-TCP, by dermal exposure during the treatment of animal pelts (Pearce et al. 1988; Smith et al. 1984).
Workers in these studies were also exposed to potentially oncogenic viruses (including bovine leukemia virus).
Because of the confounding exposures to various agents, no conclusions can be made from these studies as to
the causal agent for these cancers.
In 15-week mouse initiation-promotion studies, 2-CP and 2,4-DCP, but not 2,4,6-TCP, showed tumor
promoting activity (Boutwell and Bosch 1959). One application of the known tumor initiator 9,10-dimethyl-1,2-
benzanthracene (DMBA) to the middorsal region of mice was followed by twice weekly dermal applications of
25 µL of a 20% solution of either 2-CP, 2,4-DCP, or 2,4,6-TCP. Compared to DMBA treatment alone, 2-CP and
2,4-DCP increased the number of skin tumors, with no effect from 2,4,6-TCP exposure (Boutwell and Bosch
1959). In a study in which no initiator was used, 2-CP applied to the backs of mice twice per week for 12 weeks
resulted in papillomas in 46% of the mice (Boutwell and Bosch 1959). No carcinomas were observed. The
significance of these results is limited by the lack of appropriate vehicle control groups, irritation, and the
reporting of only gross pathological effects (EPA 1980a).
2,4,6-TCP did not have initiating activity in an initiation-promotion study in mice (Bull et al. 1986). Mice were
treated with a dermal dose of 200 mg/kg/day 2,4,6-TCP followed 2 weeks later by 20 weeks (3 times per week)
of dermal 12-0-tetradecanoylphorbol-13-acetate (TPA) treatment.
2.3    TOXICOKINETICS
Tri- and tetrachlorophenol are rapidly absorbed and excreted following occupational exposure, which
involves both the inhalation and dermal routes. Studies using human cadaver tissue also suggest rapid
absorption after dermal application. Data on the absorption of chlorophenols by the oral route are limited
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to animal studies. Based on the results of these studies and the physical properties of chlorophenols, the
gastrointestinal absorption of chlorophenols should be rapid and virtually complete. Data are insufficient to
quantitatively estimate the absorption rate or to compare absorption following administration in food versus
administration in water.
Limited evidence from animal studies suggests rapid clearance of chlorophenols from all body tissues.
Intravenous administration of 2,4-DCP to rats resulted in short-lived deposition in the kidney, liver, brain, and
fat. The extent of plasma protein binding, which is a major determinant of both the body burden and elimination
kinetics, increases with increasing chlorination. Increased plasma protein binding decreases the clearance rate of
higher chlorinated phenols (Pekari et al. 1991).
Few systematic metabolic studies were located for chlorophenols. In general, rapid Phase II metabolism to
glucuronide and sulfate conjugates seems to be the predominant route of metabolism. The relative proportion of
these conjugates may be species-, dose-, and route-related. The most important Phase I metabolites are
apparently quinone and semiquinone reactive intermediates. Prominent urinary metabolites after 2,4,6-TCP
administration in rats are other trichlorophenols. In at least one in vitro study, no evidence of dioxin precursors
was found.
After occupational exposure to chlorophenols in a lumber treatment facility, elimination rates were inversely
proportional to the degree of chlorination probably because of increased plasma protein binding with increased
chlorination. Elimination half-lives of 18 hours and 4.2 days were recorded for 2,4,6-TCP and 2,3,4,6-TeCP,
respectively. Elimination occurred according to a two-compartment open model. In rats orally administered
radiolabelled 2,4,6-TCP, 92.5% of the administered radioactivity appeared in the urine and 6.4% appeared in the
feces within 3 days after exposure cessation.
2.3.1 Absorption
Absorption of chlorophenols has not been studied in children.
2.3.1.l Inhalation Exposure
The identification of 2,4,6-TCP and 2,3,4,6-TeCP in the serum and urine of workers exposed while treating
lumber indicates that 2,4,6-TCP and 2,3,4,6-TeCP are absorbed through inhalation (Pekari et al. 1991). No
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airborne chlorophenol concentrations were provided. Although inhalation exposure was possible, a study of
pullers at a timber mill (Fenske et al. 1987) suggests that 95% of the estimated exposure is by the dermal route.
No studies were located regarding the absorption of chlorophenols in animals after inhalation exposure to any of
the eight chlorophenol isomers discussed in this profile.
2.3.1.2 Oral Exposure
No studies were located regarding oral absorption in humans of any of the eight chlorophenol isomers
discussed in this profile. These isomers have moderately high lipophilicity and pKas >5.0; consequently,
intestinal ahsorption should be favored (Ambre 1990). Based on chemical properties and on limited animal data,
absorption through the gastrointestinal tract after oral intake in humans is expected to be both rapid and virtually
complete.
The animal data indicating rapid and complete absorption are based solely on studies reporting recovery of all or
most of the orally administered chlorophenols in the urine. Spencer and Williams (1950) recovered ≥100% of a
single oral dose of 2- or 4-CP (emulsified in water) given to rabbits. Five days after three daily gavage
treatments of rats with radiolabelled 2,4,6-TCP (vehicle not reported), 82.3% of the administered radioactivity
was recovered in the urine (Korte et al. 1978). In a 15-day study of 25 µg/day radiolabelled 2,4,6-TCP, 92% of
the administered radioactivity was recovered in the urine of the treated rats (Bahig et al. 1981).
2.3.1.3 Dermal Exposure
In vivo and in vitro data indicate that the chlorophenols are readily absorbed following dermal exposure. In an
industrial accident, 20 minutes after a worker was splashed with a pure solution of 2,4-DCP on less than 10% of
his body (arm and leg), he collapsed and shortly thereafter died (Kintz et al. 1992). Postmortem blood and urine
concentrations of 2,4-DCP were 24.3 and 5.3 mg/L, respectively. Using a fluorescent tracer, and measures of
urinary excretion of TeCP in lumber mill workers exposed to a wood preservative (20% TeCP, 3%
pentachlorophenol, <0.4% other CPs), Fenske et al. (1987) estimated that 30-100% of the 2,3,4,6-TeCP
deposited on the skin is absorbed. Absorption occurred through the hands and forearms despite the use of
chemical-resistant gloves. Fenske et al. (1987) also indicate that the skin regions with
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greatest exposure, the hands and forearms, were in frequent contact with wood so that abrasion may have
reduced the barrier properties of the stratum corneum.
The results of diffusion experiments using hydrated human cadaver epidermis also indicate that the
chlorophenols readily cross the skin at low concentrations. The permeability coefficients determined in
excised human abdominal epidermis were 5 .5, 6.1, 10.0, and 9.9 cm miN- 1x104 for 2-CP, 4-CP, 2,4-DCP, and
2,4,6-TCP (Roberts et al. 1977). 2-CP and 4-CP were reported to damage the skin, determined by an increase in
the permeability coefficient at aqueous concentrations of 0.8 and 0.75% (w/v), respectively, while no damage
was observed with 2,4-DCP and 2,4,6-TCP at concentrations up to saturation. In a study using abdominal skin
exposed to air, absorption of 2,3,4,6-TeCP over 24 hours was 33% from an aqueous medium (1.54% 2,3,4,6-
TeCP) and 63% from a diesel-oil-based medium (0.96 2,3,4,6-TeCP) (Horstman et al. 1989). These values were
determined by assuming that the amount of the applied dose that was not recovered from the skin’s surface was
the amount absorbed. The actual amounts recovered in the skin and receiving solutions were 9.5 and 3.9% for
the aqueous- and oil-based medium, respectively. The authors attribute low recovery to difficulties in extracting
2,3,4,6-TeCP from the skin.
Dermal absorption can be inferred from in vivo animal studies resulting in death and/or adverse systemic effects
following dermal exposure to 2-CP (Younger Labs 1975) and 2,4-DCP (Carreon et al. 1980a, 1980b; Hencke
and Lockwood 1978; Younger Labs 1976).
Chlorophenols are also readily permeable in rodent skin in vitro preparations. At solution pHs between 5.0 and
5.74, the apparent 2-CP, 2,4-DCP, and 2,4,6-TCP permeability constants for a hairless mouse skin preparation
over a concentration range of 0.05-0.5% varied from 0.14 to 0.36 cm/hour in whole skin and from 0.136 to
0.276 cm/hour in skin stripped of the stratum corneum (Huq et al. 1986). The investigators proposed that
permeability is probably greater in the more highly vascularized human tissue because the extensive network of
surface capillaries in humans reduces the thickness of the diffusional barrier. They further stated that dermally
absorbed phenolic compounds are potentially more toxic than orally absorbed compounds because Phase II
detoxification reactions are more rapid after oral exposure. In another in vitro diffusion study of 4-CP, 87.4 to
90.5% of the applied dose crossed rat epidermal preparations in 72 hours, indicating extensive absorption
(Hughes et al. 1993). Those phenols (both chlorophenols and other substituted phenols) with log Kow, values
between 1.4 and 3.5 showed the greatest amount of permeability through the dermal membrane. Although
specific data were not identified, dermal absorption of
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chlorophenols should also be greater for the neutral acid form than for the phenolate anion as ions do not readily
cross cell membranes.
2.3.1.4 Other Routes of Exposure
No studies were located regarding absorption in humans exposed to any of the eight chlorophenol isomers by
other routes.
An experiment with rabbits indicated that 2,4,6-TCP is absorbed through the cornea to a minor degree
following ocular application (Ismail et al. 1977).
2.3.2 Distribution
Distribution of chlorophenols has not been studied in children.
2.3.2.1 Inhalation Exposure
No studies were located regarding the tissue distribution in humans or animals exposed by inhalation to any of
the eight chlorophenol isomers discussed in this profile.
2.3.2.2 Oral Exposure
No studies were located regarding the tissue distribution in humans exposed orally to any of the eight
chlorophenol isomers discussed in this profile.
Chlorophenols do not appear to accumulate in animals following oral exposure. For example, liver 2-CP
concentrations were 2.2,3.2, and 0.8 ppm, and kidney 2-CP concentrations were 2.6,2.4, and 2.2 ppm in female
rats exposed to 2-CP in the drinking water for 16 weeks at 5,50, and 500 ppm, respectively (Exon and Koller
1982). The investigators did not provide an explanation for the low value (0.8 ppm) found in the livers of rats
receiving the high dose and did not indicate whether these values were wet or dry weight concentrations.
Radioactivity was not recovered in the liver, lung, and subcutaneous fat of rats given three daily gavage doses of
radiolabelled 2,4,6-TCP (Korte et al. 1978) or in unspecified tissues of rats given radiolabelled 2,4,6-TCP by
gavage for 15 days (Bahig et al. 1981).
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The highest concentrations of 2,3,4,6-TeCP were found in the spleen followed by the kidneys and liver
24 hours after a single oral dose was given to rats (Hattula et al. 1981). In a 55day study in which rats were
treated by gavage with 2,3,4,6-TeCP at 10,50, or 100 mg/kg/day, tissue levels, measured 24 hours after the last
dose, were dose related. For all doses, the concentrations of 2,3,4,6-TeCP in the brain and muscle were lower
than those found in the kidney, liver, and spleen. At the 100 mg/kg/day dose, the kidney had the highest 2,3,4,6-
TeCP concentrations (5.1 ppm) followed by the spleen (3.2 ppm), liver (2.2 ppm), brain (1.2 ppm), and muscle
(0.46 ppm) (Hattula et al. 1981). At the 10 mg/kg/day dose, 2,3,4,6-TeCP was not detected in the brain or
muscle (detection limit not stated), while low levels were found in the spleen (0.04 ppm), kidney (0.03 ppm),
and liver (0.01 ppm).
2.3.2.3 Dermal Exposure
Concentrations of 2,4-DCP were 24.3, 5.3, 18.7, and 1.2 mg/L in the blood, urine, bile, and stomach contents of
a worker who collapsed (within 20 minutes) and died shortly after being splashed with pure 2,4-DCP on his
right arm and leg (Kintz et al. 1992).
No studies were located regarding the tissue distribution in animals dermally exposed to any of the eight
chlorophenol isomers discussed in this profile.
2.3.2.4 Other Routes of Exposure
A study in which laboratory animals were given intravenous 2,4-DCP provides some insight regarding
distribution patterns anticipated in humans (Somani and Khalique 1982). Intravenously administered
2,4-DCP rapidly distributes to the kidney, liver, fat, and brain in rats, with the highest concentrations in the
kidney and liver. Elimination from these tissues is also rapid; the elimination half-time for plasma is
approximately 10 minutes (Somani and Khalique 1982). The results of in vitro binding studies using human
serum proteins indicate that both 2,4-DCP and 2,4,6-TCP strongly bind to serum proteins, including albumin
and globulin (Judis 1982). The percentage of the compound bound to albumin was slightly greater for 2,4,6-TCP
(94.1%) than for 2,6-DCP (87.7%).
In rabbits, following ocular exposure, radiolabelled 2,4,6-TCP was distributed to various compartments of the
eye (Ismail et al. 1977). At 30 minutes post exposure, the applied radioactivity was detected in the cornea (4%),
aqueous humor (0.37%), lens (0.037%), iris (0.18%), choroid (0.04%), vitreous (0.01%), conjunctiva
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(2.14%), limbus (0.96%), and sclera (0.35%). At 60 minutes post exposure the respective percentages were 2.4,
0.17, 0.03, 0.10, 0.13, 0.01, 2.49, 0.88, and 0.53%.
Peak concentrations of 2,4,6-TCP were observed in all tissues assayed (blood, liver, kidney, muscle, fat, and
brain) 30 minutes after rats were given a single intraperitoneal injection of 25 mg/kg 2,4,6-TCP (Pekari et al.
1986). The highest concentration observed was in the kidneys, 329 ± 117 nmol/g tissue, a concentration
approximately 2, 7, 10, 13, and 26 times the concentrations found in the blood, liver, fat, muscle, and brain,
respectively.
2.3.3 Metabolism
Both human and animal studies indicate that sulfation and glucuronidation are the main metabolic pathways of
chlorophenols. Among sawmill workers, virtually all the absorbed tri- and tetrachlorophenols were excreted in
the urine as conjugated metabolites (Pekari et al. 1991). Sulfate conjugation was predominant.
A number of rabbit studies (Azouz et al. 1953; Bray et al. 1952a, 1952b; Spencer and Williams 1950) have
shown that metabolism of the monochlorophenols is principally via conjugation. In the latter study, groups of 6
rabbits were treated by gavage with 171.3 mg/kg of 2-CP or 4-CP emulsified in water as a single dose. For both
isomers, the 24-hour urine analysis indicated that between 78.1 and 88.3% of the administered dose was
excreted as the glucuronide, and between 12.8 and 20.6% of the administered dose was excreted as the ethereal
sulfate. A total of 101.7 and 101.1% of the administered 2-CP or 4-CP doses, respectively, was accounted for as
urinary glucuronide and sulfate conjugates. Metabolism was further investigated in 4 rabbits, each treated by
gavage with an average dose of 395 mg/kg/day of 4-CP. After 36 hours, 54.1% of the administered dose
appeared in the urine as the glucuronide conjugate, and 10.4% of the administered dose appeared in the ethereal
sulfate fraction. Only 0.1% of the administered dose was excreted as 4-chlorocatechol. The low total recovery
(64.5%) in the latter experiment limits conclusions. Other rabbit studies indicated that chlorocatechols
constituted only 1.5-4.5% of the administered doses of 300 mg/kg 2-CP or 500 mg/kg 4-CP (Azouz et al. 1953).
In a limited study in dogs (Coombs and Hele 1926) about half of an oral dose of 2- or 4-CP was excreted in the
urine as the ethereal sulphate. No evidence for metabolism to mercapturic acid was found.
In contrast to the study in dogs, Phornchirasilp et al. (1989a) has proposed that in mice 4-CP is metabolized by
P-450 enzymes to intermediates that react with glutathione to form glutathionyl adducts.    This pathway
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was proposed based on the observation that 4-CP treatment of mice depleted liver thiol stores. The depletion of
liver thiol stores was prevented by a P-450 inhibitor (SKP 525-A) suggesting that P-450 activity is required for this
effect.
A study in rats found that glucuronides and other unspecified conjugates were formed following a single
intravenous dose of 2,4-DCP (10 mg/kg) (Somani and Khalique 1982). One hour after dosing, only small
amounts of 2,4-DCP were found in the tissues studied (plasma, liver, kidneys, fat, brain). Although other
unspecified conjugates were found in the fat, glucuronide conjugates were not found in the fat at any time
interval. Two minor metabolites of 2,4-DCP, both dichloromethoxy phenols, have been identified in studies
using isolated perfused rat livers (Somani et al. 1984). The extent to which the dichloromethoxy phenols are
formed in vivo has not been determined (Somani et al. 1984).
2,4-DCP has been shown to be metabolized into two major metabolites identified as 2-chloro-1,4-
hydroxyquinone and 2-chloro- 1,4-benzoquinone by microsomal fractions and whole cells of yeast
Saccharomyces cerevisiae expressing human cytochrome P-450 3A4 (Mehmood et al. 1997). Another
metabolite, 1,2,4-hydroxybenzene, was also detected during biotransformation by whole cells but was not
observed in microsomal fractions. Thus, human CYP3A4 can remove either or both chlorine atoms from the
aromatic ring of 2,4-DCP molecule, forming 2-chloro-1,4-hydroxyquinone and 1,2,4-hydroxybenzene,
respectively. 2-chloro-1,4-hydroxyquinone was probably acted on by dehydrogenase from yeast microsomes,
forming 2-chloro-1,4-benzoquinone (Mehmood et al. 1997).
Little information was located on the metabolism of trichlorophenols. In general, 2,4,6-TCP undergoes
biotic isomerization to other trichlorophenol isomers and conjugation with glucuronic acid (Bahig et al.
1981). Male rats eliminated 63% of a gavage dose of 2,4,6-TCP in the urine as 4 trichlorophenol isomers
and 28% as conjugates. Three of the trichlorophenol isomers were identified as 2,4,6-TCP (parent
compound), 2,3,6-TCP, and 2,4,5-TCP; the fourth isomer was not identified. Glucuronic acid accounts
for approximately 80% of the conjugates detected in urine (Bahig et al. 1981).
In vitro studies using rat liver microsomes have shown that 2,4,5-TCP can be metabolized to 3,4,6-trichlorocatechol,
2,5-dichlorohydroquinone, and a dihydroxydichlorobenzene (not further characterized) (Butte et al. 1988; Juhl et al.
1991). Metabolites were also dimerized to a dihydroxyhexachlorobiphenyl, a dihydroxypentachlorodiphenyl ether,
two hydroxypentachlorodiphenyl ethers, a hydoxyhexachlorodiphenyl ether, and a Hydroxyhexachlorodioxin or
hydroxyhexachlorodiphenoquinone (Butte et al. 1988). Metabolites generated following incubation
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of 2,4,6-TCP with rat liver S-9 fraction were 2,6-dichloro-1,4-hydroquinone and two isomers of
hydroxypentachlorodiphenyl ether (Juhl et al. 1989). The 2,6-dichloro-1,4-semiquinone free
radical was also identified. Although in vivo these metabolites may be minor, in vitro they were responsible for
DNA damage (Juhl et al. 1989, 199l).
Metabolism of 2,4,6-TCP by the skin has not been detected (Huq et al. 1986). Therefore, Huq et al. (1986) have
suggested that 2,4,6-TCP absorbed through the skin could be more toxic than a similar ingested dose because the
ingested compound is partially converted to glucuronide conjugates.
In a study in rats, a majority (70%) of intraperitoneally administered 2,4,6-TCP detected in the blood was in
conjugated form 30 minutes after dosing. The authors speculated that the chemical was conjugated with glucuronic
acid (Pekari et al. 1986). The average percentage of the metabolites of 2,4,6-TCP conjugated in the blood over the
course of the study was 83±11%.
A study of the metabolism of the TeCP isomers following intraperitoneal injection in rats, indicates that much of
the dose is excreted in the urine unchanged (Ahlborg and Larrson 1978). Following treatment with 2,3,4,5- and
2,3,4,6-TeCP, a trichlorohydroquinone was identified in the urine as a minor metabolite. Following treatment with
2,3,5,6-TeCP, about 35% of the recovered dose (total recovery 98.7%) was tetrachloro-p-hydroquinone, while the
remaining was the unchanged parent compound (Ahlborg and Larrson 1978).
Metabolism of chlorophenols has not been studied in children. In humans, activity of UDP-glucuronosyltransferase
(responsible for glucuronide conjugates) does not reach adult levels until about 6-8 months of age, although the
development of this activity is isoform specific. Activity of sulfotransferases (responsible for sulfate conjugates)
seems to develop earlier, although again, it is isoform specific. The activity of some sulfotransferase isoforms may
be greater than that of adults during infancy and early childhood (Leeder and Kearns 1997). Since chlorophenols
are detoxified in the liver by conjugation with glucuronic acid and sulfate, the toxicity of chlorophenols may be
different in children.
2.3.4 Excretion
Excretion of chlorophenols has not been studied in children.
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2.3.4.1    Inhalation Exposure
After occupational exposure by combined dermal and inhalation routes to a chlorophenol dipping solution,
maximal urinary concentrations were 1-11.8 µmol/L 3.4-17.3 µmol/L, and 0.2-0.9 µmol/L for tri-, tetra-, and
pentachlorophenol, respectively (Pekari et al. 1991). Elimination half-lives were 18 hours, 4.2 days, and 16
days, respectively. The renal clearance rate of 2,3,4,6-TeCP was approximately five times faster than the
clearance rate of pentachlorophenol; this finding reflects the increased plasma protein binding of the higher
chlorinated compound (Pekari et al. 1991). The clearance rate of 2,4,6-TCP could not be calculated because of
highly variable serum concentrations (Pekari et al. 1991).
No animal studies were located regarding the excretion of any of the eight chlorophenol isomers after
inhalation exposure.
2.3.4.2   Oral Exposure
The limited available data indicate that orally administered monochlorophenols are rapidly absorbed and
excreted in the urine, primarily as glucuronide and sulfate conjugates, in rats, rabbits, and dogs (Bray et al.
1952a, 1952b; Coombs and Hele 1926; Spencer and Williams 1950). Most of the administered dose is excreted
in the urine within 24 hours. More comprehensive data, including the kinetics of tissue uptake and distribution,
are limited to 4-CP (discussed below). Data are insufficient to identify differences in the excretion of
monochlorophenol isomers between animal species.
At oral doses of 150-450 mg/kg, excretion of the glucuronide conjugate of orally administered 4-CP in
rabbits followed first-order kinetics (Bray et al. 1952a). The velocity constant kg, or the rate of glucuronide
excretion relative to remaining body burden, was 0.41 hour-1. The investigators noted that the value of kg for 4-
CP is apparently not related to the electron withdrawing influence of the substituent group (Bray et al.1952a).
Male rats administered radiolabelled 2,4,6-TCP by gavage for 3 days and observed for 5 days after dosing
eliminated a total of 82.3% of the total dose in the urine and 22.2% in the feces (Korte et al. 1978). In a second
study using male rats, radiolabelled 2,4,6-TCP was administered by gavage for 15 days, with sacrifice 3 days
after administration ended. A total of 92.5% of the administered dose was excreted in the urine, and 6.4% was
excreted unchanged in the feces (Bahig et al. 1981). Four trichlorophenol isomers
CHLOROPHENOLS          84
2. HEALTH EFFECTS
were detected in the urine and comprised 63% of the total urinary radioactivity. These isomers were the
unchanged parent compounds, 2,3,6-TCP, 2,4,5-TCP, and an unidentified compound. The metabolites identified
in the polar fraction were trichlorophenol conjugates with glucuronic acid; these products accounted for 28% of
the radioactivity eliminated in the urine (Bahig et al. 1981). Free trichlorophenol was identified in the feces. The
excretion of radioactivity declined rapidly after dosing ended. By the third day postexposure, only 4.3% of the
radioactivity in a daily dose was detected in the urine and 1.9% was detected in the feces (Bahig et al.1981).
2.3.4.3 Dermal Exposure
As discussed in Section 2.3.4.1, combined dermal and inhalation exposure to a chlorophenol-containing wood
treatment solution resulted in the urinary excretion of tri-, tetra-, and pentachlorophenol. Rate constants of
elimination were inversely proportional to the extent of chlorination (Pekari et al. 1991).
No animal studies were located regarding the excretion of any of the eight chlorophenol isomers after dermal
exposure.
2.3.4.4 Other Routes of Exposure
A study in rats showed rapid clearance from the kidney, liver, fat, brain, and plasma of both the parent
compound and metabolites after intravenous administration of 10 mg/kg/day 2,4-DCP in an aqueous solution
(Somani and Khalique 1982). Half-lives for 2,4-DCP and its conjugates ranged from 4 to 30 minutes in these
tissues, with the highest values in kidney, followed by the liver, fat, plasma, and brain (Somani and Khalique
1982). No detectable amounts were found in the brain at 60 minutes. These data suggest that 2,4-DCP does not
accumulate in body tissues and is quickly excreted.
In rats administered 2,4,6-TCP by intraperitoneal injection, the majority (70%) of 2,4,6-TCP associated
radioactivity detected in the blood 30 minutes after dosing was in a conjugated form (Pekari et al. 1986). The
authors speculated that it was conjugated with glucuronic acid. The biological half-life of conjugated 2,4,6-TCP
was 1.4 hours in blood and ranged from 1.4 to 1.8 hours in other tissues. Elimination of approximately 90% of
the administered dose in the urine occurred within 4-6 hours. Only trace amounts of trichlorophenol were
detected in tissues 10 hours after dosing (Pekari et al. 1986).
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Ahlborg and Larrson (1978) studied the urinary excretion of TeCPs in rats following intraperitoneal injection of a
single dose. The slowest rate of excretion was observed following treatment with 2,3,4,5-TeCP. During the 72
hours after administration, about 60% of the dose was recovered in the urine; the majority of it was excreted
unchanged. In contrast, following treatment with 2,3,4,6-TeCP, 95.9% of the dose was excreted in the urine in 72
hours, and 98.7% of the administered 2,3,5,6-TeCP was excreted in the urine within 24 hours after dosing. The
investigators (Ahlborg and Larsson 1978) did not provide an explanation regarding the slower excretion of 2,3,4,5-
TeCP compared to the excretion of 2,3,4,6-TeCP and 2,3,5,6-TeCP.
2.3.5 Physiologically based Pharmacokinetic (PBPK)/Pharmacodynamic (PD) Models
Physiologically based pharmacokinetic (PBPK) models use mathematical descriptions of the uptake and
disposition of chemical substances to quantitatively describe the relationships among critical biological processes
(Krishnan et al. 1994). PBPK models are also called biologically based tissue dosimetry models. PBPK models are
increasingly used in risk assessments, primarily to predict the concentration of potentially toxic moieties of a
chemical that will be delivered to any given target tissue following various combinations of route, dose level, and
test species (Clewell and Andersen 1985). Physiologically based pharmacodynamic (PBPD) models use
mathematical descriptions of the dose-response function to quantitatively describe the relationship between target
tissue dose and toxic end points.
PBPK/PD models refine our understanding of complex quantitative dose behaviors by helping to delineate
and characterize the relationships between: (1) the external/exposure concentration and target tissue dose of
the toxic moiety, and (2) the target tissue dose and observed responses (Andersen et al. 1987; Andersen and
Krishnan 1994). These models are biologically and mechanistically based and can be used to extrapolate the
pharmacokinetic behavior of chemical substances from high to low dose, from route to route, between
species, and between subpopulations within a species. The biological basis of PBPK models results in more
meaningful extrapolations than those generated with the more conventional use of uncertainty factors.
The PBPK model for a chemical substance is developed in four interconnected steps: (1) model
representation, (2) model parametrization, (3) model simulation, and (4) model validation (Krishnan and
Andersen 1994). In the early 1990s, validated PBPK models were developed for a number of
toxicologically important chemical substances, both volatile and nonvolatile (Krishnan and Andersen 1994;
Leung 1993). PBPK models for a particular substance require estimates of the chemical substance-specific
physicochemical parameters, and species-specific physiological and biological parameters. The numerical
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estimates of these model parameters are incorporated within a set of differential and algebraic equations that
describe the pharmacokinetic processes. Solving these differential and algebraic equations provides the predictions
of tissue dose. Computers then provide process simulations based on these solutions.
The structure and mathematical expressions used in PBPK models significantly simplify the true complexities of
biological systems. If the uptake and disposition of the chemical substance(s) is adequately described, however,
this simplification is desirable because data are often unavailable for many biological processes. A simplified
scheme reduces the magnitude of cumulative uncertainty. The adequacy of the model is, therefore, of great
importance, and model validation is essential to the use of PBPK models in risk assessment.
PBPK models improve the pharmacokinetic extrapolations used in risk assessments that identify the maximal (i.e.,
the safe) levels for human exposure to chemical substances (Andersen and Krishnan 1994). PBPK models provide
a scientifically-sound means to predict the target tissue dose of chemicals in humans who are exposed to
environmental levels (for example, levels that might occur at hazardous waste sites) based on the results of studies
where doses were higher or were administered in different species. Figure 2-3 shows a conceptualized
representation of a PBPK model.
If PBPK models for chlorophenols exist, the overall results and individual models are discussed in this
section in terms of their use in risk assessment, tissue dosimetry, and dose, route, and species extrapolations.
There are no PBPK models for chlorophenols.
2.4 MECHANISMS OF ACTION
2.4.1 Pharmacokinetic Mechanisms
Chlorophenols have moderately high lipophilicity. They are weak organic acids with pKa values that range from
5.4 to 8.9 (Shiu et al. 1994); consequently, absorption should be favored in the stomach and the intestine.
Absorption through the gastrointestinal tract is by simple diffusion and is expected to be both rapid and virtually
complete. The chlorophenols are also readily absorbed after dermal exposure. Dermal absorption should also be
greater for the neutral acid form than for the phenolate anion as ions do not readily cross cell membranes. Dermally
absorbed doses of chlorophenols are potentially more toxic than orally absorbed doses (Huq et al. 1986). The
chlorophenols were not metabolized or conjugated during
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their diffusive transport through the skin (Huq et al. 1986); however, they are partially converted to more easily
eliminated, less toxic glucuronide conjugates after oral ingestions.
After a single oral dose of 2,3,4,6-TeCP to rats, the kidney had the highest tissue concentration, followed by the
spleen, liver, brain, and muscle (Hattula et al. 1981). When administered intravenously to rats, 2,4-DCP rapidly
distributes to the kidney, liver, fat, and brain, with the highest concentrations in the kidney and liver (Somani
and Khalique 1982). 2,4-DCP and 2,4,6-TCP strongly bind to serum proteins, including albumin and globulin
(Judis 1982).
2.4.2   Mechanisms of Toxicity
Chlorophenols uncouple mitochondrial oxidative phosphorylation and produce convulsions. Within
20 minutes of being accidentally splashed with 2,4-DCP on his right arm and leg, a worker experienced seizures,
collapsed, and died shortly thereafter (Kintz et al. 1992). Lethargy, tremors, convulsions, and/or central nervous
system depression have been reported in chlorophenol-exposed animals (Borzelleca et al. 1985a; Deichmann
and Mergard 1948). Within the series including phenols and chlorinated phenols, convulsive effects decreased
with increasing chlorination. Limited data were located on the mechanism of phenol- or chlorophenol-induced
convulsions. Phenol administration in cats facilitated effects on central synaptic transmission at both excitatory
and inhibitory synapses (Banna and Jabbur 1970). The authors proposed that certain phenols increase the
amount of neurotransmitter released during synaptic transmission, resulting in convulsions. After intraperitoneal
injection of several chlorophenols, convulsions predominated in those mice receiving the 2- and 4-CP
compounds (Farquh&son et al. 1958). Because these compounds have pK values of 8.65 or higher and would
not be in the ionic form at physiologic pH, the investigators attributed the observed effect to the chlorophenol
rather than to the ion.
Particularly for the higher chlorophenols, the primary toxic mechanism associated with exposure is the
uncoupling of mitochondrial oxidative phosphorylation (Farquharson et al. 1958; Weinbach and Garbus 1965).
Although the kinetics of chlorophenol-induced uncoupling have primarily been studied in in vitro mitochondrial
preparations, the associated metabolic effects (such as increased body temperature and dyspnea) have been
verified in vivo (Farquharson et al. 1958). The ability of chlorophenols to uncouple oxidative phosphorylation
increases with increasing chlorination. Toxic manifestations include central nervous system depression followed
by increased respiration, hyperthermia, a blood pressure rise, progressive euromuscular weakness, and cyanosis.
The results of a number of in vitro studies (Cascorbi and Ahlers
CHLOROPHENOLS           89
2. HEALTH EFFECTS
1989; Izushi et al. 1988; Mitsuda et al. 1963; Narasimhan et al. 1992; Shannon et al. 1991; Stockdale and
Selwyn 1971) indicate a concentration-dependent triphasic effect of chlorophenols on phosphorylation and
cellular respiration. At low concentrations, uncoupling produces stimulation of state 4 (resting state) respiration
as a result of increased adenosine triphosphatase (ATPase) activity in the absence of a phosphate acceptor.
Inhibition of state 3 (active) respiration is also observed. At moderate concentrations, resting respiration is
neither stimulated nor inhibited. Significant inhibition of respiration, associated with a breakdown of the
electron transport process and decreased ATPase activity, occurs at very high concentrations. These
concentrations are also associated with mitochondrial swelling and disruption of the mitochondrial matrix
structure. Investigators have cited two independent mechanisms to explain these effects on cellular metabolism.
Uncoupling activity has been attributed to a protonophoric effect (a disruption of the energy gradient across the
mitochondrial membrane resulting from distribution of chlorophenols in the phospholipid bilayer of the
membrane), whereas inhibition of cellular respiration has been attributed to a direct action on intracellular
proteins.
The results of these and other studies also illustrate that higher order chlorophenols have the greatest effects on
cellular metabolism. In general, investigators have found that 2-CP and 4-CP are less than 7% as potent as
tetrachlorophenol in uncoupling oxidative phosphorylation and inhibiting cellular respiration (Cascorbi and
Ahlers 1989; Janik and Wolf 1992; Narasimhan et al. 1992; Weinbach and Garbus 1965). Within the
chlorophenol series, two physicochemical parameters, the a-Hammett constant, a measure of electron
withdrawing ability, and the octanol-water partition coefficient (log Kow), accounted for 98% of the variability in
the inhibition of ATPase activity (Cascorbi and Ahlers 1989).
Corrosive skin damage resulting from high concentration phenol exposure has been attributed to protein
denaturation by protein-solute complexes (Roberts et al. 1977). In this study, various concentrations of 2-CP and
4-CP were applied to samples of human abdominal skin maintained in a diffusion chamber. The estimated
threshold concentrations for damage (the aqueous concentration at which the transmembrane permeability
coefficient began to increase) were 0.8% and 0.75%, respectively, for these two isomers. The investigators
proposed that the extent of damage was related to the concentration of the solute partitioned into the stratum
corneum, the diffusivity of the solute, and the pK of the applied phenolic compound.
In a study in rats, Kitchin and Brown (1988) examined the effects of single gavage doses of 2,4,5-TCP, 2,4,6-
TCP, and 2,3,4,6-TeCP on markers of carcinogenic initiation (alkaline elution for DNA damage in liver and
blood), promotion of carcinogenesis (ornithine decarboxylase activity in the liver), and hepatic cell damage
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(serum alanine aminotransferase [SGPT] activity). At a dose one-fifth the LD50 (164 mg/kg for 2,4,5 and 2,4,6-
TCP; 28 mg/kg for 2,3,4,6-TeCP), no effects were observed. 2,4,6-TCP and 2,3,4,6-TeCP were also tested at
higher equimolar concentrations (2,4,6-TCP, 500 mg/kg; 2,3,4,6-TeCP, 193 mg/kg). At the high dose, both
compounds resulted in a significant increase in liver ornithine decarboxylase activity. No effects on alkaline
elution of DNA or on SGPT activity were observed, suggesting that 2,4,6-TCP and 2,3,4,6-TeCP were weak
promoters.
2.4.3   Animal-to-Human Extrapolations
Extrapolating animal toxicity data to predict human risk from chlorophenol exposure appears to be
reasonable because of the similarity in metabolic pathways and effects. However, the one case of human death
following dermal exposure indicates that animals may be more resistant to the toxic effects of 2,4-
dichlorophonol than humans.
2.5 RELEVANCE TO PUBLIC HEALTH
Issues relevant to children are explicitly discussed in 2.6 Children’s Susceptibility and 5.6 Exposures of
Children.
Overview.
Chlorophenols are used as intermediates in the production of dyes and chlorinated pesticides. Because of its
biocidal properties, 4-CP is also used as a dental antiseptic. Runoff from pesticide degradation, contaminated
food intake, and the chlorination of both drinking water and waste water are the environmental sources of
human exposure to chlorophenols. A chlorophenol-containing waste site may result in groundwater
contamination with subsequent introduction into the drinking water supplies. Dermal exposure can occur in
occupational settings. Much lower levels of dermal exposure can occur through showering and bathing with
water containing chlorophenols. In addition, the environmental dechlorination of the higher chlorophenols can
result in exposure to the lower chlorophenols.
Exposed pesticide production workers may be at increased risk for soft tissue sarcoma, Hodgkin’s disease, and
non-Hodgkin’s lymphoma. Although these results have been found in several occupational studies, the majority
of studies find no, or only slightly, increased cancer risk associated with exposure. Possible
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confounding variables in the positive studies included recall and selection bias. Another major health
concern in workers is the development of chloracne, which is probably attributable to the presence of other
chlorinated dioxins as contaminants in CP-containing pesticides.
The results of animal studies partially support the human data. 2,4,6-TCP was a carcinogen in 2-year rat and
mouse studies. Other studies suggest that chlorophenols, rather than being initiators, may be tumor promoters.
This is supported by genotoxicity data that suggest that the chlorophenols are not directly mutagenic. The EPA
has classified 2,4,6-TCP as a class B2 carcinogen. Hepatic effects, ranging from enzyme induction to
generalized necrosis, are also found in animals. Although 2,4-DCP has been shown to effect cell-mediated
immunity in laboratory studies, the toxicological relevance of this finding to individuals exposed near hazardous
waste sites is unknown. The higher chlorinated phenols have shown equivocal reproductive and developmental
effects only at doses producing maternal toxicity. These findings indicate a possible concern for pregnant
women exposed in the workplace or through contaminated environmental media. Observations of corrosion and
death after skin application of high doses of chlorophenols reinforces the dermal health hazard concern for
workers.
Minimal Risk Levels for Chlorophenols
Exposures to chlorophenols at hazardous waste sites are most likely to be to a mixture of chlorophenols rather
than to a single compound. Unfortunately, no information regarding effects following exposure to a mixture of
chlorophenols was identified. As a conservative approach, duration-specific MRLs for the chlorophenols as a
class were developed based on the single compound with the lowest LOAEL and, therefore, should protect
against effects following exposure to all chlorophenols as well as exposure to mixtures of chlorophenols if
effects of multiple chlorophenols are additive.
Inhalation
The inhalation data for chlorophenols is limited to a single acute study of 2-CP in which rats were exposed
(nose-only) to 17, 104, or 908 ppm for 4 hours (Duchosal and Biederman 1991). Restlessness and hunched
posture were observed at the high concentration. Dark red foci were observed at the two lower concentrations.
CHLOROPHENOLS           92
2. HEALTH EFFECTS
but not at the high concentration. No controls were used in this study. Because of the lack of a clear
doseresponse relationship and the absence of controls, this study was not considered appropriate for the
derivation of an inhalation MRL.
Oral
• An MRL of 0.01 mg/kg/day has been derived for acute-duration oral exposure to chlorophenols. This MRL
is based on electron microscopic changes (foamy cytoplasm and clustering of rnitochondria and
endoplasmic reticulum) observed in the hepatocytes of rats treated with 4-CP at 2.58 mg/kg/day but not at
1.28 mg/kg/day (Phornchirasilp et al. 1989b). The rats were treated by gavage two times per day with the 4-
CP in corn oil. There are no additional studies that examine liver effect following oral exposure to 4-CP.
• An MRL of 0.003 mg/kg/day has been derived for intermediate-duration oral exposure to chlorophenols.
This MRL is based on a decrease in delayed type hypersensitivity observed in rats treated with 2,4-DCP in
the drinking water throughout gestation and 10 weeks after weaning at 3 mg/kg/day but not at 0.3
mg/kg/day (Exon and Keller 1985; Exon et al. 1984).
Chronic
No chronic duration oral MRLs were derived for any of the chlorophenols because the NOAELs identified in
the chronic studies were greater than LOAELs identified in the intermediate duration studies.
Death. No data were found on death following inhalation or ingestion of chlorophenols. The only report of
death in humans following exposure to chlorophenols is a single case in which a man died shortly after being
splashed on less than 10% of his body with 2,4-DCP (Kintz et al. 1992). Postmortem blood and urine
concentrations were 24.3 and 5.3 mg/L, respectively. Most data from acute inhalation, oral, and dermal lethality
animal studies suggest that chlorophenols are lethal only at high exposure levels. Acute lethality generally
occurs at oral doses greater than 100 mg/kg (Ahlborg and Larsson 1978; Bercz et al. 1990; Blackburn et al.
1986; Borzelleca et al. 1985a, 1985b; Carreon et al. 1980a; Kobayashi et al. 1972; NTP 1989; Rodwell et al.
1989). The range of oral LD50 values, 89 mg/kg for male mice treated with 2,3,5,6- TeCP in ethanol (Ahlborg
and Larsson 1978) to 2,960 mg/kg for male rats treated with 2,4,5-TCP in corn oil (McCollister et al. 1961),
indicates that the chlorophenols are slightly or moderately toxic according to the
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classification scheme of Hodge and Sterner (1949). The use of different vehicles in oral studies makes it difficult
to draw any conclusions about which of the chlorophenols are the most toxic. For example, in studies of the
TeCPs, oral LD50s in rats were lower when the compounds were given in 40% ethanol rather than propylene
glycol (Ahlborg and Larssen 1978).
More limited dermal LD50 data indicate a range of 485 mg/kg for 2,3,4,6-TeCP in rats (Shen et al. 1983) to
1,414 mg/kg/day for 2,4-DCP in rabbits (Carreon et al. 1980b). The range of LD50s following intraperitoneal
injection exposure was 48 mg/kg for 2,3,5,6-TeCP given to mice in 40% ethanol (Ahlborg and Larsson 1978) to
430 mg/kg for 2,4-DCP given to rats in olive oil (Farquharson et al. 1958).
Typical signs of severe acute intoxication include ataxia, fatigue, disorientation, tachycardia, and increased
respiratory rate followed by dyspnea, myoclonic convulsions, and coma (Borzelleca et al. 1985a, 1985b;
Farquharson et al. 1958; Kobayashi et al. 1972). Convulsions are a diagnostic feature of intoxication with
certain phenolic compounds, including the lower chlorinated phenols. The mechanism of action of this effect is
poorly understood. Furthermore, an adequate dose-response relationship for this end point has not been
established. Convulsions have been reported after both oral and dermal administration, indicating that the effect
is not route specific.
Given the high doses of chlorophenols required to produce death in laboratory animals, death in humans
exposed through contaminated drinking water is unlikely. The taste and odor thresholds of the chlorophenols,
which are in the ppb range (Burttschell et al. 1959), would make the likelihood of intoxication via drinking
water quite remote because of the unpleasant taste and odor of the contaminated water. In the occupational
setting, exposure to more highly concentrated chlorophenols could result in death following inhalation, oral, or
dermal exposure as suggested by the case report by Kintz et al. (1992).
Systemic Effects. No data regarding the systemic toxicological effects of exposure to chlorophenols in
humans, in isolation from other contaminants, were located in the literature. The discussion provided below will
describe systemic effects in humans occupationally exposed to a variety of airborne contaminants (including
chlorophenols), laboratory animal studies, and supporting data.
Respiratory Effects. In a small cross-sectional study on workers involved in 2,4,5,-TCP production, no
adverse effects on pulmonary function or the incidence of pulmonary lesions were observed (Calvert et al.
1991). Lumber mill workers exposed to a mixture of tetrachlorophenols (specific isomers not stated) and
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pentachlorophenol reported upper respiratory tract irritation more frequently than unexposed workers
(Kleinman et al. 1986). Acute inhalation exposure of laboratory animals to monochlorophenols has resulted in
hemorrhage in the lungs and tachypnea (Duchosal and Biedermann 1991). Rats and mice exposed to high oral
doses of 2,4-DCP or 2,4,6-TCP had no adverse effects on lung weight or histopathology (Bercz et al. 1990;
Blackburn et al. 1986; NCI 1979; NTP 1989).
The limited data are insufficient to predict the respiratory response of humans exposed either acutely or chronically
to chlorophenols.
Cardiovascular Effects. No studies were located regarding cardiovascular effects in humans after exposure by any
route to any of the eight chlorophenols discussed in this profile. Animal studies have not reported histological
changes in the heart following exposure to 2,4-DCP, 2,4,5-TCP, or 2,4,6-TCP (Bercz et al 1990; Blackburn et al.
1986; NCI 1979; NTP 1989), providing limited evidence that these compounds are not cardiovascular toxicants.
Gastrointestinal Effects. Symptomology of gastrointestinal effects has not been reported in production
workers exposed to trichlorophenols and other chlorinated organics (Calvert et al. 1992). Single gavage doses of
432 mg/kg or more 2,3,4,6-TeCP has produced intestinal cell necrosis in rats (Hattula et al. 1981). The results of
other animal studies, however, did not indicate damage to the intestinal tract after exposure to large oral doses of
chlorophenols (NCI 1979; NTP 1989).
Hematological Effects. Adequate data for the assessment of hematological effects in chlorophenol-exposed
humans were not located. Results from oral acute- to chronic-duration animal studies indicate that 2-CP has no
adverse effects on standard hematological end points at doses up to 50 mg/kg/day (Borzelleca et al. 1985a; Exon
and Koller 1985). Consequently, under the conditions of these studies, the hematological system does not appear to
be a target organ at moderately high exposure concentrations.
Results of chronic oral studies in rats indicate that various hematopoietic effects, such as bone marrow
atrophy, hyperplasia, and leukocytosis, occur in rats exposed chronically to 500 mg/kg/day or more 2,4-DCP or
2,4,6-TCP (NCI 1979; NTP 1989). Furthermore, the results of the NCI (1979) studies indicate that 2,4,6- TCP is
associated with an increased incidence of leukemia in rats.
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Musculoskeletal Effects. No studies were located regarding musculoskeletal effects in humans.
Intermediate and chronic oral exposure of animals to 2,4-DCP (NTP 1989) or 2,3,4,6-TeCP (Hattula et al. 1981)
did not result in any histopathologic changes in muscle.
Hepatic Effects. Chlorophenol-exposed manufacturing workers have been diagnosed with porphyria,
elevated serum transaminase levels, regenerative hepatocellular activity, and hemofuscin deposition (Bleiberg et al.
1964). In another group of production workers, elevated GGT activity has been associated with an interaction
between 2,4,5-TCP exposure and alcohol consumption (Calvert et al. 1992). These data indicate a concern for
hepatic effects in individuals exposed to chlorophenols.
Acute exposure concentrations of up to 69 mg/kg/day 2-CP for 14 days in mice produced no changes in hepatic
microsomal P-450 enzyme levels (Borzelleca et al. 1985a). In contrast, 2-week administration of 0.64 mg/kg/day 4-
CP in Sprague-Dawley rats increased microsomal demethylase activities, microsomal protein, and cytochrome P-
450 content (Phornchirasilp et al. 1989a). Electron microscopic changes in hepatocytes (foamy cytoplasm,
clustering of mitochondria and endoplasmic reticulum) occurred at ≥ 2.58 mg/kg/day, and 1.28 mg/kg/day was
considered a NOAEL. The discrepancies in results between these two studies may be related to species differences
but is most likely due to a 10-fold difference in test material volume measured on a body weight basis.
Animal data regarding the hepatic effects of the higher chlorinated phenols are conflicting. Mouse studies
indicate that chronic exposure to 2,4-DCP is associated with liver necrosis (NTP 1989). There is
inconclusive evidence that 2,4-DCP causes hepatocellular hyperplasia in rats and mice and diffuse
syncytial alterations in mice exposed for long periods. A possible mechanism for the observed diffuse
syncytial alterations was demonstrated in an in vitro study (Onfelt 1987) in which 2,4-DCP interfered with
normal cell division by disrupting spindle formation. Interference of 2,4-DCP with oxidative
phosphorylation, as demonstrated in an in vitro study with isolated mitochondria (Stockdale and Selwyn
1971), may be a mechanism for any or all of these liver effects since it can deplete the energy stores
available to affected cells.
Hepatic effects observed in rats and mice following intermediate and chronic oral exposure to 2,4,6-TCP
include alterations in hepatocytes, increased liver weight, and hepatic hyperplasia (Exon and Koller 1985;
NCI 1979). The latter effect may possibly be a precursor to hepatic adenomas and carcinomas also
observed in mice chronically exposed to 2,4,6-TCP (NCI 1979). Exposure to mid- to high-oral doses of
2,4,6-TCP has resulted in increased relative liver weights (Bercz et al. 1990; NCI 1979) and midzonal
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vacuolation of hepatocytes (NCI 1979). In intermediate-duration oral studies, administration of as low as 50
mg/kg/day was associated with massive hepatocellular necrosis and venous thrombosis in l/10 rats (Hattula et al.
1981).
The mechanism for the observed hepatic alterations is difficult to determine. Various hepatic microsomal drug-
metabolizing enzymes were not induced in an acute study in which rats were given several intraperitoneal
injections of 2,4,6-TCP (Denomme et al. 1983). Acute oral dosing with as much as 400 mg/kg had no effect on
enzyme activities and protein levels that are indicative of either increased metabolic activity or hepatotoxicity
(Carlson 1978). Hepatic ornithine decarboxylase activity, a potential marker of tumor promoting capabilities, was
elevated over control levels only after administration of lethal doses of 2,4,6-TCP or 2,3,4,6-TeCP (Kitchin and
Brown 1988). Despite the inability to specifically ascertain the mechanistic basis of observed hepatotoxic effects,
the available in vivo data are adequate to indicate that individuals exposed to sufficient levels of chlorophenols near
hazardous waste sites are potentially at risk for liver effects ranging from increased enzyme activity to generalized
necrosis.
Renal Effects. No data on the renal effects of chlorophenols in humans were located. In animal studies, either no or
mild renal effects are evident at oral exposure levels of 720-2,600 mg/kg/day (Bercz et al. 1990; Blackburn et al.
1986; NCI 1979; NTP 1989). Renal tubular necrosis occurred only at lethal exposure concentrations (NTP 1989).
The current data suggest that renal toxicity may only occur at doses unlikely in occupational or environmental
settings.
Endocrine Effects. There are no reports of endocrine effects in humans occupationally exposed to chlorophenols.
Histopathological changes have not been observed in endocrine glands (adrenal gland, pituitary, thyroid,
parathyroids, pancreas) in animals exposed to chlorophenols for intermediate and chronic durations, providing
limited evidence that endocrine glands are not a target of chlorophenol toxicity (American Biogenics 1988; Bercz
et al. 1990; Blackburn et al. 1986; McCollister et al. 1961; NCI 1979; NTP 1989). An in vitro study examining the
binding of chlorophenols to human transthyretin (a carrier of thyroid hormone) found that increasing chlorination
resulted in greater affinity for the thyroxine (T4) binding site of the carrier (van den Berg 1990). The affinities of 2-
CP, 2,4,5-TCP, and 2,4,6-TCP compared to T4 were 0.004, 0.15, and 0.33, respectively. Tetrachlorophenols were
not tested. Based on the results of this in vitro study, van den Berg (1990) suggests that chlorophenols may reduce
plasma T4 levels through competition with T4 binding on transthyretin and other T4 carriers (e.g., thyroid binding
globulin, albumin).
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Dermal Effects. Chloracne and evidence of acquired porphyria cutanea tarda, hyperpigmentation, and
hirsutism have been observed in factory workers who were concurrently exposed to chlorophenols in
phenoxy-based herbicides and, potentially, to dioxins (TCDD) (Bleiberg et al. 1964; Bond et al. 1989). In at
least one study, chloracne incidence was positively correlated with TCDD exposure (Bond et al. 1989). The
results of dermal studies with rats and rabbits indicate that chlorophenols can produce various effects, ranging
from mild erythema to severe corrosion of the skin (Bioassay Systems 1981; Carreon et al. 1980a, 1980b;
Hencke and Lockwood 1978; Rhodia 1978; Shen et al. 1983). The reports describing dermal effects are very
limited and do not provide details of the effects observed; additionally, dose-response relationships are not
clearly defined. The lowest dose resulting in direct dermal effects was 242 mg/kg/day 2-CP applied to the skin
of rabbits (Bioassay Systems 1981).
Dermal exposure may be a special concern because wood treatment workers had measurable tetrachlorophenol
levels on the hands and volar surface of the forearm, despite the use of gloves when handling timber (Fenske et
al. 1987).
Ocular Effects. Eye irritation was reported among lumber mill workers exposed to a mixture of
tetrachlorophenols (specific isomers not stated) and pentachlorophenol (Kleinman et al. 1986). The eye irritation
was likely a direct effect of the tetrachlorophenols. The results of ocular toxicity studies in rabbits indicate that
2-CP concentrations as low as 1% can result in mild hyperemia (Rhodia 1978). The extent of tissue damage is
concentration-related. Application of a 2% solution resulted in severe hyperemia with edema and cloudy
swelling (Rhodia 1978), while administration of undiluted 2-CP produced edema with severe tissue erythema
and corrosion (Younger Labs 1975). Severe cornea1 damage in rabbits occurred after the direct application of
0.1 mL 2,4-DCP in the eye (Hencke and Lockwood 1978). Consequently, moderately high vapor concentrations
of 2-CP, 2,4-DCP, and possibly other chlorophenols in industry or at hazardous waste sites have the potential to
produce ocular irritation and/or damage in unprotected individuals.
Body Weight Effects. Effects on body weight have not been reported in humans occupationally exposed to
chlorophenols. Body weight loss has been observed in animals exposed to chlorophenols following acute,
intermediate, and chronic duration exposure (American Biogenics 1988; Borzelleca et al. 1985a; Kavlock 1990;
McCollister et al. 1961; NCI 1979; NTP 1989; Rodwell et al. 1989). When chlorophenols are administered in
the diet, changes in body weight may be in part a result of decreased food intake because of reduced palatability
(NTP 1989), although body weight decreases have also been observed following gavage administration
(American Biogenics 1988). The lowest dose associated with body weight decrease was
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20 mg 2,3,4,6-TeCP given to rats by gavage for 90 days (American Biogenics 1988). The observation that a TeCP
has the greatest effect on body weight is consistent with the observation that TeCPs are more potent in uncoupling
oxidative phosphorylation than the monochlorophenols (Cascorbi and Ahlers 1989; Narasimhan et al. 1992).
Immunological and Lymphoreticular Effects. No human data were located regarding immunological or
lymphoreticular effects of chlorophenols. The results of one animal study indicate that neither humoral nor cell-
mediated immunity is affected by oral exposure to 2-CP at doses up to 50 mg/kg/day (Exon and Koller 1985). In
contrast, combined pre- and postnatal exposure to 2,4-DCP at 3 mg/kg/day both stimulated antibody production
and inhibited a delayed type hypersensitivity response (Exon and Koller 1985). Combined pre- and postnatal
exposure to 2,4,6-TCP in drinking water at doses up to 30 mg/kg/day did not significantly affect humoral or cell-
mediated immunity in rats (Exon and Koller 1985). As discussed under hematological effects, bone marrow
atrophy affecting both erythroid and myeloid elements has been observed in rats treated with 2,4-DCP in the diet at
500 mg/kg/day for 13 weeks (NTP 1989). Histological examination of lymph nodes, spleen, and thymus in
chlorophenol-exposed animals has not revealed any effects in intermediate and chronic duration studies
(McCollister et al. 1961; NCI 1979; NTP 1989).
Because of limited animal data and knowledge regarding the toxicological significance of many immunological
findings, the relevance to public health of immunological effects following exposure to the chlorophenols cannot
be determined specifically. However, animal evidence indicates that 2,4-DCP may have an effect on the immune
system.
Neurological Effects. Lumber mill workers exposed to a mixture of tetrachlorophenols (specific isomers not
stated) and pentachlorophenol reported headaches more frequently than unexposed workers (Kleinman et al. 1986).
In animals exposed to chlorophenols by the inhalation, oral, or dermal routes, convulsions (a sign of exposure to
high doses of some phenolic compounds) decrease with increasing chlorination. In oral and dermal acute lethality
studies, convulsions were noted only as antecedents of death (Borzelleca et al. 1985a, 1985b; Deichmann and
Mergard 1948). Consequently, adequate information about dose-response relationships or isomeric potencies were
not determined. The mechanisms for these effects are not known, although interference with oxidative energy
metabolism in the central nervous system has been suggested, based on in vitro studies with rat brain and nerve
tissues (Farquharson et al. 1958). After intraperitoneal injection in mice, the median doses producing convulsions
were 99 and 116 mg/kg, respectively, for 2-CP and 4-CP (Angel and Rogers 1972). Although this administration
route has limited relevance for human exposure, the
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data do suggest that humans exposed at hazardous waste sites via drinking water are likely to be at minimal risk
of developing convulsions.
Reproductive Effects. No data were located regarding the reproductive effects of chlorophenols in
humans. Studies on the reproductive toxicity of chlorophenols in rats suggest that 2-CP, 2,4-DCP, and
2,4,6-TCP, administered on days 6 through 15 of gestation, may reduce liter size (Exon and Koller 1985).
However, at the highest dose tested (about 30 mg/kg/day 2,4-DCP and 2,4,6-TCP, and 50 mg/kg/day 2-CP) litter
sizes were reduced compared to controls only at the p≤0.1 level. A study designed to assess the reproductive
toxicity of 2,4,6-TCP found no effect on male or female reproductive functions at doses that caused death and
reduced body weight (Blackburn et al. 1986). An increasing trend for preimplantation loss was observed in
pregnant rats treated with 2,3,4,6-TeCP on gestation days 6-15 (RTI 1987). Because this study was not designed
to examine the preimplantation/ implantation phase of reproduction, the issue of whether 2,3,4,6-TeCP affects
implantation still needs to be resolved. Histological changes in the testes or ovaries have not been observed in
rats or mice exposed to 2,4-DCP, 2,4,5- or 2,4,6-TCP, or 2,3,4,6-TeCP in intermediate- and chronic-duration
studies (American Biogenics 1988; Bercz et al. 1990; McCollister et al. 1961; NCI 1979; NTP 1989).
Developmental Effects. No data were located regarding developmental effects in humans following
exposure to chlorophenols. The results of developmental studies in animals do not clearly show a selective
effect on development at doses lower than those causing maternal toxicity. At maternally toxic doses (750
mg/kg/day) reduced fetal body weight and delayed ossification were observed in the offspring of rats treated
with 2,4-DCP on gestation days 6-15 (Rodwell et al. 1989). No developmental effects were noted in rats treated
with 2,3,4,6-TeCP even at a dose that caused a 26% reduction in maternal body weight gain. The lack of a
specific developmental effect for 2-CP, 2,4,6-TCP (Fu et al. 1990), 4-CP, and 2,3,4,5-TeCP (Mayura et al. 1991)
is supported by studies using the in vitro hydra assay which showed that the compounds were equally toxic to
adult and developing organisms.
In vitro exposure of rat embryos indicates that the chlorophenols can directly affect development. Exposure of
rat embryos to 6 mM 4-CP or 2,3,4,5-TeCP resulted in a significant decrease in crown-rump length, somite
number, and DNA and protein content (Mayura et al. 1991). The effects of 2,3,4,5-TeCP on development were
much greater than 4-CP. 2,3,4,5-TeCP but not 4-CP also resulted in a significant reduction in yolk sac diameter.
4-CP exposure (195-781 nM) of rat embryos reduced measures of growth (somite number, crown rump length,
DNA content) and increased structural defects (hind limb bud absence,
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hypoplasia of first arch, tail defects) (Oglesby et al. 1992). The effects of 4-CP were ameliorated by coculture
with hepatocytes, suggesting that 4CP, rather than a metabolite, was responsible for the effects on development.
In summary, the in vivo data suggest marginal effects of chlorophenol exposure on maternal and fetal toxicity
and no evidence of teratogenicity. The more highly chlorinated compounds may present the greatest health risk
to pregnant women exposed occupationally or through contaminated drinking water.
Genotoxic Effects. Studies regarding genotoxic effects in humans were not available. 2-CP and 4-CP
have been tested in one in vivo and several in vitro genotoxicity assays. Acute administration of up to
69 mg/kg/day 2-CP in mice was not associated with any changes in bone marrow or testicular sister
chromatid exchange (SCE) frequency (Table 2-4). Similarly, oral administration of up to 638 mg/kg/day (14
days) or 500 mg/kg/day (90 days) had no effect on SCEs in the testes or bone marrow (Borzelleca et al. 1985a).
No further details were provided.
In mammalian in vitro systems, 2-CP induced slight-to-moderate increases in c-mitosis (indicating disturbances
of the spindle function) and aneuploidy in cultured Chinese hamster lung cells (Onfelt 1987; see Table 2-5). The
increase in aneuploidy, compared to controls, was statistically significant (p<0.025) by the chisquare test. The
results of prokaryotic genotoxicity assays for 2-CP and 4-CP were primarily negative for mutagenicity. In
standard Salmonella typhimurium reverse mutation assays with strains TA98, TA100, TA1535, TA1537, and
TA1538, treatment generally did not produce an increased number of revertants (DeMarini et al. 1990; Haworth
et al. 1983; Rapson et al. 1980). Negative findings occurred both in the presence and absence of metabolic
activation. In one study, 4-CP had a marginally positive response in strain TA1537 (Seuferer et al. 1979).
Neither 2-CP nor 4-CP, either with or without the S9 protein fraction, showed positive gene expression in a umu
test system (Ono et al. 1992; Sakagami et al. 1988). 2-CP and 4-CP were negative in a prophage induction assay
with Escherichia coli (DeMarini et al. 1990). 4-CP induced an increased number of revertants in S. typhimurium
strains TA97 TA98, TAlOO, and TA104 (Strobe1 and Grummt 1987). The effects were most pronounced in
strain TA97, in the presence of metabolic activation. Interpretation of these data is confounded by the absence of
concentration-effect relationships.
2,4-DCP was negative for SCE induction in the testes and bone marrow after drinking water administration in
rats (Borzelleca et al. 1985a; see Table 2-4). As shown in Table 2-5, the compound was mostly negative for
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Rasanen et al. 1977; Simmon et al. 1977) but was positive with activation in a prophage induction assay (DeMarini
et al. 1990) and positive without activation in a umu test system (Ono et al. 1992). In mammalian cells (Table 2-5),
2,4-DCP was negative for gene mutation in Chinese hamster V79 cells (Hattula and Knuutinen 1985) but produced
chromosomal aberrations in Chinese hamster V79 cells (Onfelt 1987) and induced unscheduled DNA synthesis in
rat hepatocytes (Probst et al. 1981).
2,4,5-TCP did not increase DNA damage in mice given a single oral dose (164 mg/kg) as indicated by
alkaline elution of DNA from white blood cells and the liver (Kitchin and Brown 1988). 2,4,5-TCP was
predominantly negative in standard S. typhimurium reversion bioassays (George et al. 1992; Rasanen et al. 1977)
but was positive both with and without activation in a umu test system (Ono et al. 1992) and with (DeMarini et al.
1990) and without activation (George et al. 1992) in prophage induction assays (Table 2-5). 2,4,5-TCP did induce
chromosome aberrations in Chinese hamster ovary cells both with and without metabolic activation (Armstrong et
al. 1993).
2,4,6-TCP has been evaluated for genotoxicity in a variety of in vitro and in viva assays. As summarized in Tables
2-4 and 2-5, the results of these various assays have been both positive and negative, with the majority of studies
reporting negative results. According to Kitchin and Brown (1988), short-term in vitro tests with chlorinated
phenols often show weakly positive or no effects. Five different assays have reported positive results. In vitro,
2,4,6-TCP has demonstrated genotoxic activity without metabolic activation in bacteria (Bacillus subtilis), yeast
(Saccharomyces cervisiae), and mammalian cells (Chinese hamster V79 cells, mouse lymphoma L5178Y TK +/-
cells) (Fahrig et al. 1978; Hattula and Knuutinen 1985; Kinae et al. 1981; McGregor et al. 1988). In vivo, 2,4,6-
TCP has demonstrated genotoxic activity in somatic cells of mice in the spot test (Fahrig et al. 1978). 2,4,6-TCP
has tested positive for chromosomal aberrations in Chinese hamster ovary cells both with and without metabolic
activation (Armstrong et al. 1993). Positive results for mutations in Chinese hamster V-79 cells reported by Hattula
and Knuutinen (1985) were in contrast to the negative results reported by Jansson and Jansson (1992). Additional
negative results occurred in bacteria (S. typhimurium without activation), yeast (S. cervisie), and mammalian ovary
cells (Fahrig et al. 1978; Galloway et al. 1987; Haworth et al. 1983; Kinae et al. 1981; Lawlor et al. 1979; Rasanen
et al. 1977). In vivo tests using insect systems (Drosophila melanogaster) were also negative (Valencia et al. 1985).
An increase in DNA damage was not observed in the white blood cells or livers of mice given a single oral dose of
2,3,4,6-TeCP (193 mg/kg) (Kitchin and Brown 1988). 2,3,4,6-TeCP did test positive for mutation in Chinese
hamster V79 cells (Hattula and Knuutinen 1985). All three tetrachlorophenol isomers have
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tested negative for mutation in standard S. typhimurium strains (Rasanen et al. 1977; Zeiger et al. 1988). 2,3,4,5-
and 2,3,4,6-TeCP, but not 2,3,5,6-TeCP, tested positive in a prophage induction assay (DeMarini et al. 1990), and
2,3,4,6-TeCP was positive both with and without activation in a umu test system (Ono et al. 1992).
The preponderance of the evidence from in vivo (Borzelleca et al. 1985a; Kitchen and Brown 1988; Valencia et al.
1985) and in vitro studies with prokaryotes (DeMarini et al. 1990; George et al. 1992; Haworth et al. 1983; Kinae
et al. 1979; Ono et al. 1992; Probst et al. 1981; Rapson et al. 1980; Rasanen et al. 1977; Sakagami et al. 1988;
Simmon et al. 1977; Zeiger et al. 1988) suggests that as a class the chlorophenols are not directly mutagenic. In
contrast, a more limited number of in vitro studies with eukaryotic cells have generally been positive for
chromosomal aberrations (Armstrong et al. 1993; Jansson and Jansson 1992; Onfelt 1987; Probst et al. 1981)
suggesting that chromosome malsegregation may be the mechanism of genotoxicity for the chlorophenols. The
lack of effect in the in vivo studies may be a result of the rapid urinary excretion of chlorophenols in these single-
dose studies (Borzelleca et al. 1985a; Kitchin and Brown 1988).
Cancer. Numerous cohort and case-control studies of wood finishing and chlorophenoxy herbicide workers
exposed to higher chlorophenols are available (Coggon et al. 1991; Eriksson et al. 1981, 1990; Hardell et al.
1987; Hoar et al. 1986; Honchar and Halperin 1981; Kogevinas et al. 1992; Lynge 1985; Ott et al. 1980;
Pearce et al. 1988; Smith et al. 1984; Woods et al. 1987). The results of these studies vary, but some suggest
a relationship between chlorophenol exposure and increased incidence of soft-tissue sarcomas, lung
cancers, malignant lymphomas, non-Hodgkin’s lymphomas, and nasal/nasopharyngeal cancers. The
conclusions from these studies are limited by small cohort sizes, coexposure to other contaminants
(including TCDD), and the lack of adequate control groups.
Chronic oral studies of 2,4-DCP in rats and mice (Exon and Koller 1985; NTP 1989) have not resulted in
any significant carcinogenic effect, even following both pre- and postnatal exposure (Exon and Koller
1985). A positive result in a dermal initiation promotion study suggests that 2,4-DCP can act as a promoter
(Boutwell and Bosch 1959).
The data available are inadequate regarding cancer in humans following exposure to 2,4,6-TCP. Animal
data suggest that humans may be at risk of cancer following exposure to 2,4,6-TCP (NCI 1979). A
significant dose-related increase in the incidence of leukemia occurred in male rats chronically exposed to
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2,4,6-TCP in the diet (NCI 1979). Both female and male mice treated chronically with 2,4,6-TCP in the diet had
significantly increased incidences of hepatocellular carcinomas and adenomas when compared to the controls (NCI
1979).
The carcinogenicity of 2,4,6-TCP following both intraperitoneal and subcutaneous exposure has been
evaluated in studies with mice. No significant increase in the incidence of pulmonary tumors was noted in mice
given repeated intraperitoneal injections of 2,4,6-TCP over an intermediate exposure period and followed over a
24-week observation period (Stoner et al. 1986). No significant increase in the incidence of injection-site tumors or
systemic tumors was observed in mice 18 months after a single subcutaneous injection of 2,4,6-TCP (Bionetics
Research Labs 1968). These intraperitoneal and subcutaneous studies are limited because the duration of exposures
was less than lifetime. In addition, although the intraperitoneal and subcutaneous routes of administration are
valuable research methods, their relevance to human exposure pathways is limited.
IARC (1987) considers chlorophenols as a group to have limited evidence for human carcinogenicity (group 2B).
The Department of Health and Human Services (NTP 1994) considers that 2,4,6-TCP may reasonably be
anticipated to be a carcinogen. Based on the positive NCI (1979) cancer bioassays with rats and mice, EPA (IRIS
1994) has classified 2,4,6-TCP as a B2 agent (probable human carcinogen). This category applies to those chemical
agents for which there is sufficient evidence of carcinogenicity in animals and inadequate evidence of
carcinogenicity in humans. EPA (IRIS 1994) has calculated a cancer potency factor (q1* or slope factor) for 2,4,6-
TCP of 0.02 (mg/kg/day) for both oral and inhalation exposure. This cancer potency factor is equivalent to a
drinking water unit risk value and an inhalation unit risk value of 3.1x10-7 (µg/L)-1 and 3.1x10-6 (µg/m3)-1,
respectively (IRIS 1994). The drinking water concentration of 2,4,6-TCP associated with an excess lifetime cancer
risk of 10-4, 10-5, and 10-6 is 300 µg/L, 30 µg/L , and 3 µg/L, respectively. The air concentration of 2,4,6-TCP
associated with an excess lifetime cancer risk of 10-4, 10-5, and 10-6 is 30 µg/m3, 3 µg/m3, and 0.3 µg/m3,
respectively (IRIS 1994).
The mechanism(s) by which 2,4,6-TCP induces cancer in animals are not known. However, it has recently been
suggested that 2,4,6-TCP causes cancer either by suppressing the immune system, by acting as a weak clastogen,
and/or by acting as a weak initiator or promoter of carcinogenesis (Kitchin and Brown 1988). According to Kitchin
and Brown (1988), two positive results (direct V-79, Bacillus subtilus) support the idea that 2,4,6-TCP may be an
initiator. However, three negative results in the Ames test, hepatocyte mediated V-79, and alkaline elution in vivo
fail to support the idea that 2,4,6-TCP is an initiator. 2,4,6-TCP was also
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not an initiator following a single oral, dermal, or subcutaneous dose given to mice followed by 20 weeks of
three times per week skin applications of the promotor 12-O-tetradecanoylphorbol-13-acetate (Bull et al. 1986).
Supporting evidence for 2,4,6-TCP as a promotor includes the observation that ornithine decarboxylase and
cytochrome P-450 induction occurs at high doses.
2.6 CHILDREN’S SUSCEPTIBILITY
This section discusses potential health effects from exposures during the period from conception to maturity at
18 years of age in humans, when all biological systems will have fully developed. Potential effects on offspring
resulting from exposures of parental germ cells are considered, as well as any indirect effects on the fetus and
neonate due to maternal exposure during gestation and lactation. Relevant animal and in vitro models are also
discussed.
Children are not small adults. They differ from adults in their exposures and may differ in their susceptibility to
hazardous chemicals. Children’s unique physiology and behavior can influence the extent of their exposure.
Exposures of children are discussed in section 5.6 Exposures of Children.
Children sometimes differ from adults in their susceptibility to hazardous chemicals, but whether there is a
difference depends on the chemical (Guzelian et al. 1992; NRC 1993). Children may be more or less susceptible
than adults to health effects and the relationship may change with developmental age (Guzelian et al. 1992;
NRC 1993). Vulnerability often depends on developmental stage. There are critical periods of structural and
functional development during both pre-natal and post-natal life and a particular structure or function will be
most sensitive to disruption during its critical period(s). Damage may not be evident until a later stage of
development. There are often differences in pharmacokinetics and metabolism between children and adults. For
example, absorption may be different in neonates because of the immaturity of their gastrointestinal tract and
their larger skin surface area in proportion to body weight (Morselli et al. 1980; NRC 1993); the gastrointestinal
absorption of lead is greatest in infants and young children (Ziegler et al. 1978). Distribution of xenobiotics may
be different; for example, infants have a larger proportion of their bodies as extracellular water and their brains
and livers are proportionately larger (Widdowson and Dickerson 1964; Foman et al. 1982; Owen and Brozek
1966; Altman and Dittmer 1974; Foman 1966). The infant also has an immature blood-brain barrier (Adinolfi
1985; Johanson 1980) and probably an immature blood-testis barrier (Setchell and Waites 1975). Many
xenobiotic metabolizing enzymes have distinctive developmental patterns and at various stages of growth and
development, levels of particular enzymes may be higher or
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lower than those of adults and sometimes unique enzymes may exist at particular developmental stages (feeder
and Kearns 1997; Komori 1990; Vieira et al. 1996; NRC 1993). Whether differences in xenobiotic metabolism
make the child more or less susceptible also depend on whether the relevant enzymes are involved in activation
of the parent compound to its toxic form or in detoxification. There may also be differences in excretion,
particularly in the newborn who has a low glomerular filtration rate and has not developed efficient tubular
secretion and resorption capacities (Altman and Dittmer 1974; West et al. 1948; NRC 1993). Children and
adults may differ in their capacity to repair damage from chemical insults. Children also have a longer lifetime
in which to express damage from chemicals; this potential is particularly relevant to cancer.
Certain characteristics of the developing human may increase exposure or susceptibility while others may
decrease susceptibility to the same chemical. For example, the fact that infants breathe more air per kilogram of
body weight than adults may be somewhat counterbalanced by their alveoli being less developed, so there is a
disproportionately smaller surface area for absorption (NRC 1993).
No direct information is available regarding the health effects of chlorophenols observed in children.
However, health effects observed in adults are also expected to be of potential concern in children. Although no
direct information is available on the effects of chlorophenols on the developmental process in humans, studies
in animals indicate few developmental effects. No significant changes in offspring body or liver weights were
observed in rats treated with 2-CP in drinking water at doses up to 50 mg/kg/day throughout gestation and up to
91 days post par-turn (Exon and Koller 1981, 1985). No adverse changes in litter sizes, perinatal loss, pup
weight, or litter biomass were observed when female rats received a single dose of 4-CP as high as 1,000 mg/kg
on gestational day 11 (Kavlock 1990). Oral exposure of pregnant rats to a maternal toxic dose of 750 mg/kg/day
2,4-DCP for 10 gestational days induced a slight decrease in fetal weight and a statistically significant delayed
ossification of sternal and vertebral arches and led to a slight insignificant increase in early embryonic deaths
(Rodwell et al. 1989). No effects on immune function parameters were observed in 6-week old rats treated with
2,4-DCP in the drinking water at doses up to 30 mg/kg/day throughout gestation (Exon and Koller 1985; Exon
et al. 1984). Gavage administration of 650 mg/kg/day 2,4,5-TCP during organogenesis (days 6-15 of gestation)
produced no fetotoxicity, malformations, or structural terata in the offspring of rats (Chemoff et al. 1990).
Administration of 800-900 mg/kg 2,4,5-TCP in mice on 1 day of gestation or 250-300 mg/kg/day on any 3 days
of gestation had no effect on resorption incidence, pup survival, mean fetal weight, gross malformations,
skeletal malformation, or cleft palates (Hood et al. 1979). Similarly, maternal exposure of rats to 500 mg/kg/day
2,4,6-TCP only produced a
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transient reduction in the body weight of offspring (Blackburn et al. 1986). When female Sprague-Dawley rats
orally received purified 2,3,4,6-TeCP throughout organogenesis, the only effect on the fetus was delayed
ossification of the skull bones (Schwetz et al. 1974). However, this effect was not statistically significant when
analyzed by litters. In a follow-up study in pregnant rats receiving 0,25, 100, or 200 mg/kg/day every day during
organogenesis, the two highest doses resulted in inhibition of maternal body weight gain. There was also a dose-
related trend for 2,3,4,6-TeCP-mediated effects on implantation or postimplantation viability. Chlorophenols do
not appear to be teratogenic in animals (Rodwell et al. 1989; Exon and Koller 1981; Schwetz et al. 1974).
Prior maternal exposure to chlorophenols is unlikely to affect the fetus or a nursing neonate. The relative
rapid metabolism and excretion of chlorophenols (Keith et al. 1980) should limit their potential to accumulate
in maternal tissue; chlorophenols do not appear to accumulate in animals after oral exposure (Korte et al.
1978; Bahig et al. 1981). The accumulation of 2-CP in tissues of dams was found to be minimal (Exon and
Koller 1982). However, 2,3,4,6-TeCP was detected in adipose tissues from people not occupationally exposed
to chlorophenols (Mussalo-Rauhamaa et al. 1989), probably due to the relatively higher octanolwater partition
coefficient of TeCP. Chlorophenols and/or their metabolites might cross the placenta as it has been shown in a
reproductive study in rats that transplacental exposure to 2-CP can be feto- or embryotoxic at a high dose,
resulting in a significant increase in the number of still births (Exon and Koller 1982), although it is possible
that these could be indirect effects of  the fetus. In another study, an increase in delayed ossification of the
fetal skull bones was observed when pregnant Sprague-Dawley rats were treated with TeCP, supporting that
chlorophenols might cross the placenta. No studies are available that measured chlorophenols in breast milk.
As a class, the chlorophenols are not directly genotoxic although a limited number of in vitro studies with
eukaryotic cells have been positive for chromosomal aberrations. There is no information to indicate that
parental exposure may affect children via damage to germ cells.
Metabolism of chlorophenols has not been studied in children. However, sulfation and glucuronidation are the
main metabolic pathways for chlorophenols in both human and animal studies. The conjugated metabolites
are then eliminated in urine. In humans, activity of UDP-glucuronosyltransferase (responsible for glucuronide
conjugates) does not reach adult levels until about 6-8 months of age, although the development of this
activity is isoform specific. Activity of sulfotransferases (responsible for sulfate conjugates) seems to develop
earlier, although again it is isoform specific. The activity of some sulfotransferase isoforms may be
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greater than that of adults during infancy and early childhood (Leeder and Kearns 1997). In rats, while
sulfation is almost at adult levels at birth, UDP-glucuronosyltransferase activity towards different xenobiotics
varies with maturation (Weiss 1960; Young and Lietman 1978). It is possible that chlorophenols might be
eliminated at a slower rate in children, resulting in increased susceptibility of children to their toxicity.
2.7 BIOMARKERS OF EXPOSURE AND EFFECT
Biomarkers are broadly defined as indicators signaling events in biologic systems or samples. They have been
classified as markers of exposure, markers of effect, and markers of susceptibility (NAS/NRC 1989).
Due to a nascent understanding of the use and interpretation of biomarkers, implementation of biomarkers as
tools of exposure in the general population is very limited. A biomarker of exposure is a xenobiotic substance or
its metabolite(s), or the product of an interaction between a xenobiotic agent and some target molecule(s) or
cell(s) that is measured within a compartment of an organism (NAS/NRC 1989). The preferred biomarkers of
exposure are generally the substance itself or substance-specific metabolites in readily obtainable body fluid(s)
or excreta. However, several factors can confound the use and interpretation of biomarkers of exposure. The
body burden of a substance may be the result of exposures from more than one source. The substance being
measured may be a metabolite of another xenobiotic substance (e.g., high urinary levels of phenol can result
from exposure to several different aromatic compounds). Depending on the properties of the substance (e.g.,
biologic half-life) and environmental conditions (e.g., duration and route of exposure), the substance and all of
its metabolites may have left the body by the time samples can be taken. It may be difficult to identify
individuals exposed to hazardous substances that are commonly found in body tissues and fluids (e.g., essential
mineral nutrients such as copper, zinc, and selenium). Biomarkers of exposure to chlorophenols are discussed in
Section 2.7.1.
Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration within an
organism that, depending on magnitude, can be recognized as an established or potential health impairment or
disease (NAS/NRC 1989). This definition encompasses biochemical or cellular signals of tissue dysfunction
(e.g., increased liver enzyme activity or pathologic changes in female genital epithelial cells), as well as
physiologic signs of dysfunction such as increased blood pressure or decreased lung capacity. Note that these
markers are not often substance specific. They also may not be directly adverse, but can indicate potential health
impairment (e.g., DNA adducts). Biomarkers of effects caused by chlorophenols are discussed in Section 2.7.2.
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A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism’s ability to
respond to the challenge of exposure to a specific xenobiotic substance. It can be an intrinsic genetic or other
characteristic or a preexisting disease that results in an increase in absorbed dose, a decrease in the biologically
effective dose, or a target tissue response. If biomarkers of susceptibility exist, they are discussed in Section 2.9,
“Populations That Are Unusually Susceptible.”
2.7.1    Biomarkers Used to Identify or Quantify Exposure to Chlorophenols
There are no biomarkers of exposure or effect that have been validated in children or adults exposed as
children. The only known biomarkers of chlorophenol exposure are the hydrolyzed urinary extracts of the parent
compounds and dechlorinated derivatives. However, these extracts are not unique to chlorophenol exposure. For
example, conjugated forms of higher chlorophenols have been observed after laboratory administration of
hexachlorocyclohexanes (Engst et al. 1976; Koransky et al. 1975), indicating that urinary chlorophenol levels are
not specific to chlorophenol exposure. Similarly, the presence of chlorophenols or their metabolites in urine is not
necessarily diagnostic for chlorophenol exposure because these compounds are also detectable in urine after
exposure to certain other pesticides, such as lindane (Karapally et al. 1973), VC-13 (Shafik et al. 1973), 2,4-
dichloro-phenoxyacetic acid, and 2,4,5-trichlorophenoxyacetic acid (Hill et al. 1989). Finally, metabolic
dechlorination of higher chlorophenols to lower chlorophenols occurs under some conditions (Renner and Mucke
1986). Studies to determine the importance of these processes on urinary chlorophenol formation, as either
conjugated or unconjugated metabolites, have not been conducted.  Consequently, the value of assessing urinary
chlorophenol concentrations as measures of potential exposure in workers or residents near hazardous waste sites
cannot currently be determined.
2.7.2    Biomarkers Used to Characterize Effects Caused by Chlorophenols
No unique biomarkers of effects are available for chlorophenols. As discussed in Section 2.2, the clinical
signs associated with high acute levels of monochlorophenol administration include myoclonic convulsions
(Angel and Rogers 1972; Borzelleca et al. 1985a, 1985b; Farquharson et al. 1958) and dermal and ocular
lesions (Bioassay Systems 1981; Rhodia 1978; Younger Labs 1975). Both myoclonic convulsions and
epithelial tissue corrosion are commonly observed after exposure to numerous phenolic compounds and are
therefore not necessarily diagnostic of monochlorophenol exposure. Increasing chlorination results in clinical
signs of metabolic derangement, such as hyperthermia and blood pressure decrements (Angel and Rogers
1972; Farquharson et al. 1958). These clinical signs are not specific to chlorophenols; they occur
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following exposure to any agent that uncouples mitochondrial oxidative phosphorylation such as nitrophenol
(Ahlborg and Thunburg 1980). Other effects of chlorophenols, including effects on the immune system (Exon et al.
1984) and on reproduction (Exon and Koller 1985), are also not specific to chlorophenols.
For more information on biomarkers for renal and hepatic effects of chemicals see ATSDR/CDC Subcommittee
Report on Biological Indicators of Organ Damage (1990) and for information on biomarkers for neurological
effects see OTA (1990).
2.8 INTERACTIONS WITH OTHER SUBSTANCES
Data regarding the interaction of chlorophenols with other chemical substances in humans or animals were not
located. Substances that result in effects similar to those for the chlorophenols have the potential to interact with
these compounds. For example, chlorophenols may interact with other carcinogens, promoters, neurotoxic agents,
and liver, renal, dermatologic, and ocular toxins.
Factors interfering with Phase II conjugation reactions would inhibit the detoxification of chlorophenols. The
results of recent experimentation indicate that the polycyclic aromatic hydrocarbon (PAH), 3-methylcholanthrene
(3-MC), stimulates the glucuronidation of phenolic substrates through the induction of glucuronylsyltransferase
(Jansen et al. 1992; Wishart 1978a, 1978b). The enzymes induced have a spectrophotometric peak of 448
nanometers (cytochrome P-448) and are characteristically distinct from the phenobarbital-type induced enzymes
that have an absorbance maximum at 450 nanometers. These findings suggest that other toxic and/or carcinogenic
PAHs, such as benzo(a)pyrene, can significantly enhance the metabolism of phenols. The relationship between
PAH particulate and solid material, commonly associated with incinerators and hazardous waste sites, and
chlorophenol metabolism has not been studied. In general, the ability of another chemical to affect the toxicity of
chlorophenols may depend on its affinity for the cytochrome P-448 substrate binding site.
Chlorophenols are toxic to the liver. Exposure to hepatotoxic drugs such as acetaminaphen (Tylenol) and
chlorophenols may result in additive effect. However, there are no studies that indicate such interaction.
Using an in vitro rat liver microsomal preparation, Arrhenius et al. (1977) noted that 2,4-DCP, 2,4,6-TCP, and
2,3,4,6-TeCP in the concentration range of 0.03-3 mM shifted the metabolism of aromatic amines from C-
oxygenation to n-oxygenation. The carcinogenic metabolites of aromatic amines can be formed by M-
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oxygenation. Therefore, Arrhenius et al. (1977) suggested that the chlorophenols should be considered as possible
synergists for the carcinogenicity of aromatic amines.
2.9    POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
A susceptible population will exhibit a different or enhanced response to chlorophenols than will most
persons exposed to the same level of chlorophenols in the environment. Reasons include genetic make-up,
developmental stage, age, health and nutritional status (including dietary habits that may increase
susceptibility, such as inconsistent diets or nutritional deficiencies), and substance exposure history
(including smoking). These parameters may result in decreased function of the detoxification and excretory
processes (mainly hepatic, renal, and respiratory) or the preexisting compromised function of target organs
(including effects or clearance rates and any resulting end-product metabolites). For these reasons we expect the
elderly, with declining organ function, and the youngest of the population, with immature and developing organs,
will generally be more vulnerable to toxic substances than healthy adults. Populations who are at greater risk due to
their unusually high exposure are discussed in Section 5.7, Populations With Potentially High Exposure.
No specific population that would be particularly susceptible to chlorophenol intoxication has been identified.
Because of the extensive hepatic conjugation and renal clearance of these compounds, individuals with liver or
kidney dysfunction may be the most sensitive population. The results of recent studies indicate that individuals
with cirrhosis of the liver (Macdonald et al. 1992; Ohta 1991) or hepatitis (Ohta 1991) show impaired Phase II
conjugation. Chronic renal failure is associated with the inability to clear conjugated metabolites, resulting in
elevated, steady-state whole body concentrations of glucuronide and sulfate metabolites (Martin et al. 1991).
Patients with acute tubular necrosis, with or without cirrhosis, show markedly elevated urinary β-glucuronidase
concentrations (Solis-Herruzo et al. 1986) and, theoretically, a high body burden of unconjugated metabolites.
These data suggest that chlorophenol-exposed individuals with preexisting liver or kidney disease may be at
increased risk from exposure.
Individuals with Gilbert’s disease or Crigler-Najjar syndrome, inherited deficiencies of bilirubin UDPglucuronyl
transferase (UGT), may have increased sensitivity to the effects of chlorophenol exposure (de Morais and Wells
1988; de Morais et al. 1992). Considerable progress in understanding the genetic control of these abnormalities has
recently been made (Jansen et al. 1992). Patients with Type I Crigler-Najjar syndrome may be at the greatest risk
following exposure to phenolic compounds. This form of the syndrome
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is characterized by unconjugated hyperbilirubinemia and apparently results from a deficiency in the 3-
Mcinducible form of the phenolic UGT. Defects in cytochrome P-450 induction occur in Type II (partial
hyperbilirubinemia) Crigler-Najjar syndrome and Gilbert disease; consequently, these patients may not be as
sensitive to increased plasma concentrations of chlorophenol.
Cigarette smokers are at potentially increased risk from chlorophenol exposure (Alvares 1978; Bock et al.
1987). The incomplete combustion products of smoking, such as PAHs, induce P-448 metabolism, resulting in
the potential formation of reactive metabolites and an increased conjugation rate (see Sections 2.3.3 and 2.7).
Alternatively, PAHs may accelerate the detoxification of chlorophenol. Consequently, definitive statements
about the relationship between cigarette smoking and chlorophenol metabolism cannot be made at the present
time.
Evidence from rat studies (Exon et al. 1985) suggests that at least one part of the immune system (delayed
hypersensitivity) is sensitive to 2,4-DCP. Persons with immune system deficiencies, therefore, may be more
susceptible to the adverse effects of 2,4-DCP exposure.
Fetuses or neonates may also be at increased risk. In humans, activity of UDP-glucuronosyltransferase
(responsible for glucuronide conjugates) does not reach adult levels until about 6-8 months of age, although the
development of this activity is isoform specific. Activity of sulfotransferases (responsible for sulfate conjugates)
seems to develop earlier, although again, it is isoform specific. The activity of some sulfotransferase isoforms
may be greater than that of adults during infancy and early childhood (Leeder and Kearns 1997). This
conclusion is also supported by data from rat hepatic bioassays in which UGT activities toward phenolic
substrates reached adult levels between days 16 and 20 of gestation (Wishart 1978a). Enzymatic activity toward
bilirubin is negligible during this gestational period (the “late foetal” group), but surges between gestation day
20 and postnatal day 2 (the “postnatal” group). The differences in fetal and neonatal detoxification systems,
compared to the mature organism, may result in a slower elimination of the chlorophenols, which may serve to
increase the toxicity of these compounds.
Further discussion of the susceptibility of children is in Section 2.6 Children’s Susceptibility.
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2.10    METHODS FOR REDUCING TOXIC EFFECTS
This section will describe clinical practice and research concerning methods for reducing toxic effects of
exposure to chlorophenols. However, because some of the treatments discussed may be experimental and
unproven, this section should not be used as a guide for treatment of exposures to chlorophenols. When specific
exposures have occurred, poison control centers and medical toxicologists should be consulted for medical
advice.
2.10.1    Reducing Peak Absorption Following Exposure
Following high-dose oral exposure to chlorophenols, administration of water for dilution may be warranted
(Bronstein and Currance 1988). Although Ellenhorn and Barceloux (1988) recommend the use of ipecac/lavage,
activated charcoal, and cathartics for gastric contamination from chlorophenols, Bronstein and Currance (1988)
recommend against emesis because of possible aspiration into the lungs. This is more important for the liquid
chlorophenols than for the solid species.
Specific decontamination procedures for chlorophenols after skin or eye contact are not available. However,
general approaches for minimizing absorption can be extrapolated from literature on phenol or
pentachlorophenol. After dermal contact, rinsing with water (Gosselin et al. 1984) or washing with soap
(Bronstein and Currance 1988) may be the procedures of choice. The case reported by Kintz et al. (1992) in
which death occurred in a worker dermally exposed to 2,4-DCP on less than 10% of his body indicated that
washing with water may not be sufficient, especially if contaminated clothing is not removed. Attempts to
decontaminate phenols with alcohol, vegetable oils, glycerin, or polyethylene glycol, with or without methanol,
have met with variable success (Gosselin et al. 1984). After flushing a contaminated eye with water, irrigation is
sometimes used. This technique is suggested for adults with an intact lid who have no evidence of edema
(Bronstein and Currance 1988). For children, irrigation of each eye with normal saline, using large bore
intravenous tubing, is sometimes recommended (Bronstein and Currance 1988). In more advanced cases, the use
of proparacaine hydrochloride may follow eye irrigation (Bronstein and Currance 1988).
2.10.2 Reducing Body Burden
The limited experimental data suggest that orally administered chlorophenols are rapidly conjugated and
excreted in the urine (see Sections 2.3.3 and 2.3.4). The efficacy of drug therapy to accelerate Phase II
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detoxification reactions is not known. For example, supplying substrates for glucuronidation and sulfur
conjugation may increase the excretion of the chlorophenols. Based on studies involving pentachlorophenol
exposure, the utility of either exchange transfusions or forced diuresis is equivocal (Robson et al. 1969; Young
and Haley 1978).
A high intake of ascorbic acid has been shown to reduce accumulation of 2,4-DCP and decrease liquid
peroxidation in the liver of guinea pigs compared to animals with low ascorbic acid intake (Derhata et al. 1996).
2.10.3 Interfering with the Mechanism of Action for Toxic Effects
The mechanism of toxic action for 2-CP or 4-CP is not known. Although these chemicals may be weak
uncouplers of oxidative phosphorylation, inconsistent findings of increased metabolic rate after exposure
suggest that this mechanism may not be the mechanism of greatest consequence (Angel and Rogers 1972;
Farquharson et al. 1958; Weinbach and Garbus 1965). Convulsive seizures, of unknown origin, are the most
characteristic clinical signs of acute overdose (Angel and Rogers 1972; Borzelleca et al. 1985a). Treatment for
the prevention of seizures includes the common anticonvulsant sequence of diazepam, phenytoin, and
phenobarbital (Bronstein and Currance 1988; Ellenhorn and Barceloux 1988). The use of anticonvulsants on
infants and children must be closely monitored to prevent overdosage and toxic effects of drugs.
No methods to directly reduce the adverse effects of chlorophenol-induced stimulation of mitochondrial
respiration were located.
2.11 ADEQUACY OF THE DATABASE
Section 104(I)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether adequate
information on the health effects of chlorophenols is available. Where adequate information is not available,
ATSDR, in conjunction with the National Toxicology Program (NTP), is required to assure the initiation of a
program of research designed to determine the health effects (and techniques for developing methods to
determine such health effects) of chlorophenols.
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The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if met would
reduce the uncertainties of human health assessment. This definition should not be interpreted to mean that all
data needs discussed in this section must be filled. In the future, the identified data needs will be evaluated and
prioritized, and a substance-specific research agenda will be proposed.
2.11.1    Existing Information on Health Effects of Chlorophenols
The existing data on health effects of inhalation, oral, and dermal exposure of humans and animals to
chlorophenols are summarized in Figure 2-4. The purpose of this figure is to illustrate the existing information
concerning the health effects of chlorophenols. Each dot in the figure indicates that one or more studies provide
information associated with that particular effect. The dot does not necessarily imply anything about the quality
of the study or studies, nor should missing information in this figure be interpreted as a “data need.” A data
need, as defined in ATSDR’s Decision Guide for Identifying Substance-Specific Data Needs Related to
Toxicological Profiles (ATSDR 1989), is substance-specific information necessary to conduct comprehensive
public health assessments. Generally, ATSDR defines a data gap more broadly as any substance-specific
information missing from the scientific literature.
Humans are potentially exposed to chlorophenols occupationally, through municipal solid waste combustion,
and as a result of the disinfection of drinking water. The chlorophenol by-products of manufacturing activities
may be the greatest single source of concern at NPL hazardous waste sites. Workers in phenoxy pesticide
production, wood preservation, dye manufacturing, and alcohol denaturation may be at some risk from
chlorophenol exposure. Exposure potential in most of these industries is greater for the higher chlorinated
phenols, which, based on the results of animal studies, are more toxic than the dichlorophenols and the
monochlorophenols (Borzelleca et al. 1985a). Results of human studies involving exposure to higher
chlorophenols suggest that occupational dermal exposure is a more significant concern than inhalation exposure
(Kleinman et al. 1986).
Except for the single death following dermal 2,4-DCP exposure (Kintz et al. 1992) no health effects data for
humans exposed exclusively to chlorophenols were located. Available occupational data indicate that chemicals
involved in the production of phenoxy-based herbicides, and/or the end-use products themselves, may be
associated with the development of cancers of the hematopoietic and lymphatic systems (Eriksson et al. 1981;
Hardell et al. 1981). Positive results for carcinogenicity do not show a consistent trend across
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worker groups and cannot be specifically associated with a single contaminant or group of contaminants
(including trichlorophenols). No epidemiological evidence of adverse health effects associated with drinking
chlorophenol-contaminated water was located.
Most of the available animal data, which include several recent, well-conducted studies, have involved the oral
route of administration. After acute exposure, the higher chlorophenols, in particular, have effects on basal
metabolism that are typical of uncouplers of mitochondrial oxidative phosphorylation. Experimental results
suggest that the acute toxicity of tetrachlorophenols is the greatest, followed by the monochlorophenols and then
the trichlorophenols, with the dichlorophenols being the least toxic isomers (Borzelleca et al. 1985a). The
adverse effects sometimes reported after repeated exposures do not indicate a well-defined toxic syndrome.
Intermediate to high chlorophenol doses have been associated with marginal effects on the immune,
lymphoreticular, reproductive, and developmental systems, and a range of effects on the liver. Further research
to help define the experimental conditions and mechanisms associated with these noncarcinogenic findings, and
how they may relate to chlorophenol-exposed humans, is required. 2,4,6-TCP is an animal carcinogen that has
produced leukemia in rats and hepatocellular carcinoma and adenomas in mice (NCI 1979). Furthermore, other
chlorophenols have tumor promoting capabilities.
2.11.2 Identification of Data Needs
Acute-Duration Exposure. Information from animal studies indicates that most chlorophenols produce lethality
in experimental animals following a single-dose oral exposure of 89-5,000 mg/kg (Ahlborg and Larsson 1978;
Borzelleca et al. 1985a; Kobayashi et al. 1972; NTP 1989; Vernot et al. 1977). The limited inhalation and
dermal data tend to corroborate these findings (Carreon et al. 1980a; Duchosal and Biedermann 1991). The most
characteristic clinical sign after lethal or high sublethal doses of monochlorophenols is convulsions (Borzelleca
et al. 1985a, 1985b). Physiological changes associated with the uncoupling of oxidative phosphorylation
increase with the increasing degree of chlorination (Cascorbi and Ahlers 1989; Farquharson et al. 1958; Izushi et
al. 1988; Mitsuda et al. 1963; Narasimhan et al. 1992; Shannon et al. 1991; Stockdale and Selwyn 1971).
Following acute oral exposure, the order of toxicity as indicated by LD50s was tetrachlorophenols >
monochlorophenols > dichlorophenols > trichlorophenols (Borzelleca et al. 1985a; Deichmann and Mergard
1948). Maternal toxicity, but not fetal toxicity, was observed in rats treated by gavage with 2,4-DCP at 100
mg/kg/day on gestation days 6-15 (Rodwell et al. 1989). No maternal or fetal effects were observed at 25
mg/kg/day. The lowest acute oral LOAEL for the chlorophenols that was identified was 2.58 mg/kg/day for
electron microscopic changes in hepatocytes
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(foamy cytoplasm, clustering of mitochondria, and endoplasmic reticulum) that were not observed at
1.28 mg/kg/day (Phornchirasilp et al. 1989a). Based on the NOAEL of 1.28 mg/kg/day for liver effects
following 4-CP exposure, an acute-duration oral MRL of 0.01 mg/kg/day was calculated for the
chlorophenols. Data are insufficient and are needed for the derivation of an acute inhalation MRL for the
chlorophenols. Additional experiments to assess dose-response relationships are needed because of reporting
deficiencies and methodological differences to obtain data for an inhalation MRL. These data are needed to
assess risk to workers exposed during accidental releases. The report of a worker who died after splattering pure
2,4-DCP on portions of his right arm and leg while disposing industrial wastes (Kintz et al. 1992) demonstrates
the toxicity of chlorophenols via dermal exposure. More comprehensive dermal toxicity studies analyzing both
acute toxicity incidence and localized effects are also needed. Finally, additional studies examining the liver
effects following oral exposure to chlorophenols other than 4-CP are needed to confirm that the MRL based on
4-CP exposure is truly protective of liver effects following exposure to these other compounds.
Intermediate-Duration Exposure. Occupational studies have typically involved individuals exposed to
chlorophenols for intermediate- or chronic-duration periods. The results of these studies are described under the
section Chronic-Duration Exposure and Cancer. Intermediate-duration oral administration of chlorophenols to
experimental animals generally produces no effects or marginal effects on systemic, immunological,
reproductive, and developmental end points (Bercz et al. 1990; Borzelleca et al. 1985a; Carlson 1978; Exon and
Koller 1982, 1983, 1985; Hattula et al. 1981). Immunological effects (a decrease in delayed type
hypersensitivity) appears to be the most sensitive target of 2,4-DCP toxicity (Exon and Koller 1985; Exon et al.
1984), and an intermediate oral MRL (0.003 mg/kg/day) based on a NOAEL for immunological effects has been
derived for the chlorophenols. Data are insufficient and are needed for the derivation of an intermediate-duration
exposure. The liver is the organ most consistently affected by the chlorophenols. Effects noted include enzyme
induction (Phornchirasilp et al. 1989a), increased liver weight (Bercz et al. 1990; Exon and Koller 1985),
hypertrophy (American Biogenics 1988), and centrilobular degeneration and focal necrosis (Hattula et al. 1981;
McCollister et al. 1961). Data on intermediate-duration dermal exposure of chlorophenols in humans or animals
are not available and are needed.
Additional studies examining the immunological effects following oral exposure to chlorophenols other than
2,4-DCP are needed to confirm that the intermediate-duration MRL based on 2,4-DCP exposure is truly
protective of liver effects following exposure to the other compounds. Mechanistic and toxicokinetic studies
may provide useful information about the rate of formation and time course of potential intermediates
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associated with chlorophenol-induced hepatotoxicity. Further development of dose-response relationships, with
respect to biomarkers of hepatic injury, is needed. These data may provide information about both mechanism of
action and potential adverse effects expected at the exposure concentrations associated with NPL sites.
Additional experiments to assess dose-response relationship are needed to obtain an intermediate inhalation
MRL. Studies focusing on organ function, in addition to histopathological analysis, would be particularly
important. Because the higher chlorinated compounds, in particular, contain toxic impurities (particularly
dioxins and dibenzofurans), the impurities of each test compound should be minimized since the effects of the
contaminants could override the effects from the substance tested. Studies specifically designed to examine the
interaction of dioxins and dibenzofurans with chlorophenols should also be completed.
Chronic-Duration Exposure and Cancer. Dermal or inhalation exposure to the chlorophenols used in phenoxy
herbicide production may be associated with cancer induction (Eriksson et al. 1981, 1990; Hardell et al. 1981;
Hoar et al. 1986). Most investigators, however, have found only weak trends or no evidence of an association
(Coggon et al. 1991; Kogevinas et al. 1992; Lynge 1985; Pearce et al. 1988; Smith et al. 1984; Woods et al.
1987). Many of the latter studies included a multinational cohort analysis of workers involved in similar
production processes. Current experimental methodology is not sufficiently sensitive to determine those
exposure factors, if any, that may be associated with the expression of cancer. Other investigators have observed
a possible association between chlorophenol exposure in production workers and the onset of hepatic
abnormalities, including porphyria (Bleiberg et al. 1964; Calvert et al. 1992). These results suggest the
possibility of biomonitoring individuals living near hazardous waste sites for serological evidence of hepatic
dysfunction. No data were located regarding the chronic effects of oral chlorophenol exposure in humans.
Available chronic studies with rats and mice, and evidence of clastogenicity, have indicated that 2,4,6-TCP
may produce carcinogenicity in animal models through mechanisms other than direct gene mutation
(Armstrong et al. 1993; Jansson and Jansson 1992; NCI 1979). Limited experimental data on mouse skin and
orally exposed rats suggest that 2-CP and 2,4-DCP may have tumor promoting capabilities, but are not
complete carcinogens (Boutwell and Bosch 1959; Exon and Koller 1985). Additional animal studies designed
to determine the conditions under which chlorophenols induce cancer, including supporting evidence for a
clastogenic or epigenetic role, are needed. Because of significant information gaps, data are not sufficient to
determine a chronic-duration MRL for chlorophenols by either the oral or inhalation route of exposure. Such
data should be obtained so that chronic-duration MRLs for chlorophenols can be calculated.
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Genotoxicity. There are no human studies on the genotoxicity of the eight chlorophenols. In general,
chlorophenols have been negative for mutagenicity in most prokaryotic assays (George et al. 1992; Haworth et al.
1983; Lawlor et al. 1979; Rapson et al 1980; Seuferer et al. 1979; Zeiger et al. 1988). Further mutagenicity studies
in these test systems are not needed. Neither 2-CP nor 2,4-DCP induced an increased incidence of SCEs in mouse
testicular or bone marrow cells (Borzelleca et al. 1985a). In other eukaryotic tests, 2,4,6-TCP has been associated
with structural chromosomal aberrations in both somatic and germ cells (Armstrong et al. 1993; Jansson and
Jansson 1992). Evidence of mutational activity in both in vivo (Fahrig et al. 1978) and in vitro (Fahrig et al. 1978;
Hattula and Knuutinen 1985; McGregor et al. 1988) assays is also available for 2,4,6-TCP. The implications of
these findings for cancer induction needs further research, including the use of both mammalian cell cultures and
additional in vivo clastogencity assays in mammals.
Reproductive Toxicity. No occupational or epidemiological studies of potential reproductive effects in exposed
individuals are available. Only one animal study comprehensively addresses the reproductive effects of
chlorophenols. Blackburn et al. (1986) did not find reproductive effects in male or female rats exposed to 2,4,6-
TCP by gavage at doses that caused other systemic effects (e.g., decreased body weight gain). There is limited
evidence that 2-CP, 2,4-DCP, and 2,4,6-TCP may reduce litter sizes when administered to rats in drinking water
(Exon and Koller 1985). This effect was significant only at p≤0.1 and was observed at doses that caused other
effects (e.g., increased liver weights, decreased delayed-type hypersensitivity). An increase in early embryo loss is
suggested by a teratology study of 2,3,4,6-TeCP (RTI 1987). However, the rats were dosed on gestation days 6-15
and not earlier in gestation; thus, further studies regarding the effect of 2,3,4,6- TeCP on pre- and early
implantation are needed. No data are available on the reproductive toxicity of chlorophenols after inhalation or
dermal exposure in humans or animals.
Developmental Toxicity. Pregnant women may be exposed to chlorophenols occupationally, through the drinking
water, or by living near a hazardous waste site. No data are currently available to assess the potential effects of
postimplantation exposure on the developing offspring of these women. Results from animal studies showed minor
effects occurring at doses that are maternally toxic (Blackburn et al. 1986; Exon and Koller 1985; Rodwell et al.
1989; RTI 1987; Schwetz et al. 1974). Frank teratogenic effects have not been observed following exposure of
animals during organogenesis. No data are available on the developmental toxicity of chlorophenols after
inhalation or dermal exposure in humans or animals.
Mechanistic studies indicated that cultured hepatocytes ameliorated the adverse developmental effects
associated with in vitro 4-CP exposure (Oglesby et al. 1992). This finding is apparently attributable to
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increased rates of detoxification in the hepatocyte cell cultures. In addition, results from mammalian embryo
assay indicate that monochlorophenols are not potent developmental toxicants or teratogens (Mayura et al.
1991). In vivo studies involving exposure around the implantation period may help corroborate these in vitro
data. Studies on developmental effects of postnatal exposure will also be useful.
Immunotoxicity. No experimental data involving the immunotoxic effects of human exposure to
chlorophenols are available. Oral studies in rats suggest that a low dose of 2,4-DCP (3 mg/kg/day) is
associated with a decreased delayed-type hypersensitivity response and an increased humoral immune
response with decreased thymus weights following intermediate exposure (Exon et al. 1984). Both erythroid and
myeloid elements of the bone marrow are depleted after oral administration with 500 mg/kg/day of 2,4-DCP for
13 weeks in rats (NTP 1989). Oral administration of other chlorophenols has been associated with elevated
spleen weights but not with significant effects on humoral or cell-mediated components (Borzelleca et al. 1985a;
Exon and Koller 1983, 1985). The implications of these findings for individuals exposed near NPL hazardous
waste sites can only be fully assessed with in vivo functional tests of immunocompetence, graft rejection, or
immunosurveillance in appropriate animals. Additional animal studies are also needed to provide dose-response
and/or threshold information. No data are available on the immunotoxicity of chlorophenols after inhalation
exposure in animals. Single dermal exposure of 50 mL of 2,4,5-TCP on one shaved flank of mice indicated
2,4,5-TCP can be a skin sensitizer (Kimber and Weisberger 1991). More data on immunotoxicity of
chlorophenols by all the routes of exposure are needed.
Neurotoxicity. Within 20 minutes of being accidentally splashed with 2,4-DCP on his right arm and leg, a
worker experienced seizures, collapsed, and died shortly thereafter (Kintz et al. 1992). At single oral doses >300
mg/kg monochlorophenols and dichlorophenols, chlorophenols can produce a variety of neurological effects,
including tremors, myoclonic convulsions, a hunched posture, dyspnea, collapse, and coma (Borzelleca et al.
1985a, 1985b; Duchosal and Biedermann 1991; Kobayashi et al. 1972; Phornchirasilp et al. 1989b; Spencer and
Williams 1950; Wil Research Laboratories 1982). Convulsions are common after high-dose (intraperitoneal
dose of 99 mg/kg) 2-CP administration and apparently are less frequent with increasing halogen substitution on
the phenol ring (Angel and Rogers 1972). Other investigators have not observed either clinical or
histopathological signs of neurological dysfunction after intermediate-duration exposure to doses up to 1,300
mg/kg/day of 2,4-DCP, trichlorophenols, or tetrachlorophenols (Bercz et al. 1990; NCI 1979; NTP 1989). Acute
administration of monochlorophenols has reportedly been associated with hyperactivity and decreased brain
weight (Borzelleca et al. 1985a). However, the investigators provided no detailed results, and the conclusions
remain questionable. As acute high-dose exposures resulting from
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accidents are possible, further studies regarding the dose-response relationship of neurotoxic effects following
exposure to chlorophenols are needed. The need is greatest for studies on neurotoxicity following dermal
exposure.
Epidemiological and Human Dosimetry Studies. As indicated above, accurate human dosimetry
studies may not be possible because environmental and occupational chlorophenols typically exist only in
association with other chlorinated organics. Consequently, it would be difficult to ascribe any observed health
effect to a single chemical or a single group of isomers. Additional studies in workers, such as sawmill
employees, that are exposed specifically to chlorophenols are needed. Careful monitoring of chlorophenol air
concentrations and skin exposure combined with kinetic measures of urinary output for specific isomers may
provide important correlative data for human dosimetry.
Biomarkers of Exposure and Effect
Exposure. Currently, no specific biomarkers for chlorophenols are known. The presence of chlorophenols or
their metabolites in urine is not necessarily diagnostic for chlorophenol exposure because these compounds are
also detectable in urine after exposure to other pesticides (Hill et al. 1989; Karapally et al. 1973; Shafik et al.
1973) and hexachlorocyclohexanes (Engst et al. 1976; Koransky et al. 1975). Well-designed animal metabolism
studies involving the kinetics of urinary chlorophenol conjugate excretion after exposure to a battery of
chlorinated organics are needed to provide data regarding the usefulness of urinary measures as biomarkers of
exposure for individuals living near hazardous waste sites.
Effect. No carcinogenic or noncarcinogenic effect in exposed humans has been associated with a specific
chlorophenol or a group of chlorophenols. With the possible exceptions of convulsions following
monochlorophenol exposure (Angel and Rogers 1972; Borzelleca et al. 1985a, 1985b; Farquharson et al. 1958),
clearly defined end points of toxicity in animals are not known. Furthermore, these end points that are associated
with chlorophenol exposure are not specific to chlorophenols. When in direct contact with skin and eyes, the
chlorophenols demonstrate varying degrees of corrosiveness (Bioassay Systems 1982; Rhodia 1978; Younger
Labs 1975). Other effects of chlorophenols, including effects on the immune system (Exon et al. 1984) and
reproduction (Exon and Koller 1985), are also not specific to chlorophenols.
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Further studies designed to identify specific biomarkers of effects of chlorophenols would facilitate medical
surveillance of exposed populations leading to early detection of potentially adverse health effects and possible
treatment.
Absorption, Distribution, Metabolism, and Excretion. Studies in sawmill workers indicate that
trichlorophenol and tetrachlorophenol are well absorbed during occupational exposure (Fenske et al. 1987;
Pekari et al. 1991). The dermal route had a greater absorption potential than the inhalation route. The
investigators determined that elimination half-lives were directly proportional to the degree of chlorination for
the tri-, tetra-, and pentachlorophenols. Concentrations of 2,4-DCP were measured in the blood, urine, bile, and
stomach contents of a worker who collapsed (within 20 minutes) and died shortly after being splashed with pure
2,4-DCP on his right arm and leg (Kintz et al. 1992). Attempts to attain additional data in humans are limited by
ethical considerations and by the fact that measurements of chlorophenol levels in the blood and urine of
manufacturing workers may not be specific for chlorophenol exposure.
The limited amount of data available from animal oral studies indicates that these chemicals are rapidly
absorbed, conjugated to polar metabolites in the liver and kidney, and excreted in the urine (Bahig et al. 1981;
Bray et al. 1952a, 1952b; Korte et al. 1978; Spencer and Williams 1950). Absorption also occurs after in vivo
(Carreon et al. 1980a, 1980b; Hencke and Lockwood 1978) and in vitro (Hughes et al. 1993; Huq et al. 1986)
dermal application. Rate constants for in vivo preparations were not located. Tissue burden is apparently short-
lived, with plasma elimination half-lives of approximately 10 minutes after intravenous 2,4-DCP administration
(Somani and Khalique 1982), and peak tissue concentrations occurring approximately 30 minutes after
intraperitoneal 2,4,6-TCP dosing (Pekari et al. 1986). Plasma protein binding is significant after administration
of the higher chlorophenols; in humans, the extent of binding increases with the increasing degree of
chlorination (Pekari et al. 1991).
Studies concerning the inhalation absorption and oral absorption of chlorophenols from different media (e.g.,
water, soil) and the effect of ionization on dermal absorption are needed for estimating exposure at a hazardous
waste site.
More systematic information about absorption and elimination kinetics are needed. Furthermore, time series
studies using radiolabelled chlorophenols would help identify residence times in individual organs, which may
provide insight into potential target organs in human populations.
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Semiquinones and quinones may be potentially toxic but short-lived metabolites after oral exposure (Juhl et al.
1991; Phornchirasilp et al. 1989b). The extent and type of Phase II detoxification reactions is apparently species-
and isomer-related (Bahig et al. 1981; Bray et al. 1952a, 1952b; Pekari et al. 1986; Somani and Khalique 1982;
Spencer and Williams 1950). Broad-based experimentation to determine dose-effect relationships for hepatic
adaptive and toxic effects are needed. Part of this experimentation may involve estimation of the rate constants
for the formation of both potentially toxic intermediates and Phase II conjugates. Metabolic studies for
determining rate differences in conjugate formation between oral, inhalation, and dermal exposure may also
suggest route-specific differences in the expression of toxicity.
Comparative Toxicokinetics. Toxicokinetic studies with chlorophenols have been conducted in humans, mice,
rats, rabbits, and dogs (Azouz et al. 1953; Bray et al. 1952a, 1952b; Exon and Koller 1982; Fenske et al. 1987;
Hattula et al. 1981; Phomchirasilp et al. 1989a; Somani and Khalique 1982; Spencer and Williams 1950). The
results of these studies provide a limited profile of toxicokinetics information after oral exposure. These results
do not adequately characterize the metabolic rate differences between the various isomers. More comprehensive
toxicokinetic studies using radiolabelled isomers administered at several dose levels in two rodent species and
one or more nonrodents are needed. These data may be supplemented by hepatic and renal biopsy data and
urinary metabolite analysis obtained in exposed individuals.
Methods for Reducing Toxic Effects. The P-448 inducer 3-MC, and possibly other PAHs, apparently
increase the Phase 11 conjugation rates of phenolic substrates (Jansen et al. 1992; Wishart 1978a, 1978b). This
observation implies that certain chemicals may decrease the body burden of chlorophenols by accelerating the
elimination process. Despite this capability, PAH-induced P-448 metabolism may actually increase the extent of
hepatic injury through the formation of metabolites capable of undergoing covalent binding (Arrhenius et al.
1977). Research into the development of therapeutic agents that accelerate chlorophenol elimination through
Phase II detoxification reactions, but that do not produce bioreactive metabolites (such as semiquinones), may
be advisable.
Children’s Susceptibility No data are available on the health effects of chlorophenols on exposed
children. Since the metabolic enzymes for detoxification may have age dependent expression, there is a need for
such data.
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There is inadequate experimental evidence to evaluate whether pharmacokinetics of chlorophenols are
different in children. There are also limited data to show whether chlorophenols are stored in maternal
tissues. There are no direct data on whether chlorophenols cross the placenta or accumulate in breast milk.
There is no experimental evidence to evaluate whether metabolism of chlorophenols or their mechanism of
action is different in children. However, in humans, activity of UDP-glucuronosyltransferase (responsible for
glucuronide conjugates) does not reach adult levels until about 6-8 months of age, although the development of
this activity is isoform specific. Activity of sulfotransferases (responsible for sulfate conjugates) seems to
develop earlier, although again, it is isoform specific. The activity of some sulfotransferase isoforms may be
greater than that of adults during infancy and early childhood (Leeder and Kearns 1997). It will be helpful to
have data on the metabolism and mechanism of action of chlorophenols in children to determine whether
children are more vulnerable than adults to the health effects from exposure to chlorophenols. There are no
biomarkers of exposure or effect that have been validated in children or adults exposed as children. There are no
data to determine whether there are any interactions with other chemicals that are unique to children or whether
interactions observed in adults occur in children.
Child health data needs relating to exposure are discussed in 5.8.1 Data Needs: Exposures of Children.
2.11.3   On-going Studies
Dr. Corwin Hansch of Pomona College in California is developing quantitative structure-activity
relationships for a variety of chlorinated organics, including the monochlorophenols. The principal end point of
concern is teratogenicity in mice and rats. This work is currently being prepared for publication.
No other information regarding on-going research on the health effects of chlorophenols in humans or
animals were located.
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3.1    CHEMICAL IDENTITY
Information regarding the chemical identity of the chlorophenols is located in Table 3-l.
3.2    PHYSICAL AND CHEMICAL PROPERTIES
Information regarding the physical and chemical properties of the chlorophenols is located in Table 3-2. Except
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4.1   PRODUCTlON
Table 4-1 lists the facilities in each state that manufacture or process chlorophenol, the intended use, and the range
of maximum amounts of chlorophenol that are stored on site. There are currently 4 facilities that produce or
process chlorophenols in the United States The data listed in Table 4-1 are derived from the Toxics Release
Inventory (TR196 1998). Only certain types of facilities were required to report. Therefore, this is not an
exhaustive list.
The chlorinated phenols are manufactured by chlorination of phenol, or for the higher chlorinated phenols, the
chlorination of lower chlorinated phenols at high temperatures (WHO 1989). The manufacture of the
tetrachlorinated phenols requires a catalyst (e.g., iodine, ferric chloride). 2,4,5-TCP, 2,3,4,5-TeCP, and 2,3,5,6-
TeCP have also been produced by the alkaline hydrolysis of hexachlorobenzene (WHO 1989). Both processes of
chlorophenol production result in the formation of impurities. The impurities include polychlorinated dibenzo-p-
dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), polychlorinated phenoxyphenols, polychlorinated
diphenyl ethers, polychlorinated benzenes, and polychlorinated biphenyls. Because the higher chlorinated phenols
are produced at higher temperature, the contamination of the higher chlorinated phenols is greater than that of the
lower chlorinated phenols (WHO 1989).
Recent data about the production of the chlorinated phenols are very limited. The Toxics Release
Inventory has grouped all chlorophenols together for 1996 data. The BASF Corp. in Beaumont, Texas is the largest
manufacture or processor of chlorophenols with 100,000-999,000 pounds on site (TR1996 1998). 2,3,4,6-TeCP is
not produced commercially in the United States (HSDB 1998). Pentachlorophenol, which generally contains about
4% tetrachlorophenols and 0.1% trichlorophenols (Kalliokoski and Kauppinen 1990), is also not produced in the
United States (TR1996 1998). Additional data concerning the production of the chlorinated phenols were not
available.
4.2    IMPORT/EXPORT
Recent data concerning the import/export of chlorophenols were not available. The latest year for which HSDB
(1998) has United States import data on a given chlorophenol is listed below.
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2-CP 1983 33,300 kg
4-CP 1975 33,900 kg
2,4-DCP   1977 500 kg
2,4,5-TCP   1981     216,000 kg
2,4,6-TCP      1980   250 kg
4.3   USE
All the chlorophenols have been used as biocides. The monochlorophenols have been used as antiseptics (HSDB
1998), although in this role they have largely been replaced by other chemicals (WHO 1989). Specifically, 4-CP
has been used as a disinfectant for home, hospital, and farm uses (WHO 1989) and as an antiseptic in root canal
treatment (Gurney and Lantenschlager 1982). 2,4-DCP has been used for mothproofing and as a miticide (WHO
1989), while the higher chlorophenols have been used as germicides, algicides, and fungicides.
The principal use of the monochlorophenols has been as intermediates for the production of higher
chlorinated phenols (WHO 1989). The largest uses for 2,4-DCP and 2,4,5-TCP have also been used as an
intermediate, especially in the production of the herbicides 2,4-dichlorophenoxyacetic acid (2,4-D) and 2,4,5-
trichlorophenoxyacetic acid (2,4,5-T) (WHO 1989). In the United States, 2,4-D is still in use, while 2,4,5-T was
taken off the market in 1985. 2,4,6-TCP has been used as an intermediate in the production of higher chlorinated
phenols especially 2,3,4,6-TeCP and pentachlorophenol (WHO 1989).
2,4,6-TCP and the tetrachlorophenols have also been used directly as wood preservatives (HSDB 1998). In this
role, the tetrachlorophenols are generally used as a mixture and are applied to lumber in an aqueous solution
(WHO 1989). Commercial pentachlorophenol, which is more frequently used as a wood preservative, also
contains about 4% tetrachlorophenols and 0.1% trichlorophenols (Kalliokoski and Kauppinen 1990). North
America and Scandinavia are the main regions of the world where chlorophenols have been used as wood
preservatives. The use of these compounds has been banned in Sweden since 1978, and production was banned
in Finland in 1984 (Kalliokoski and Kauppinen 1990).
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4.4 DISPOSAL
Chlorophenols are listed as toxic substances under Section 313 of the Emergency Planning and Community
Right to Know Act (EPCRA) under Title III of the Super-fund Amendments and Reauthorization Act (SARA)
(EPA 1995). Disposal of wastes containing chlorophenols is controlled by a number of federal regulations (see
Chapter 7).
The recommended method of disposing of large amounts of higher chlorinated phenols is incineration,
preferably after mixing with another combustible fuel (HSDB 1998). Necessary precautions include the
assurance of complete combustion in order to prevent the formation of toxic phosgene gas and the use of an acid
scrubber to remove any halo-acids produced upon combustion (Sittig 1985).
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5.1 OVERVIEW
One or more of the eight chlorophenols discussed in the profile has been identified in at least 171 of the 1,467
hazardous waste sites that have been proposed for inclusion on the EPA National Priorities List (NPL) (HazDat
1998). However, the number of sites evaluated for chlorophenols is not known. The frequency of these sites can
be seen in Figure 5-l.
The majority of known environmental releases of chlorophenols were to surface water (Scow et al. 1982). The
principal point source of water pollution by chlorophenols is industrial waste discharge; another point discharge
is the leaching of chlorophenols from landfills. Chlorophenols enter the atmosphere through volatilization, with
mono- and dichlorophenols being the most volatile. The primary nonpoint source pollution of chlorophenols
comes from the application of pesticides that are made from chlorophenols and the chlorination of waste water
containing phenol.
Once released to the environment, chlorophenols are subject to a series of physical, chemical, and biological
transformations. Sorption, volatilization, degradation, and leaching are the primary processes governing their
fate and transport. The pH in water and in soil and sediment is a major factor affecting the fate and transport of
chlorophenols in these media, since the degree to which the compounds ionize increases with increasing pH. In
addition, physiochemical properties of chlorophenols such as water solubility, Henry’s law constant, organic
carbon sorption coefficient, volatilization rate, and photolysis rate determine transport processes. Important
environmental parameters influencing these processes include organic matter content and clay content in soil,
sediment, and water, as chlorophenols are in general preferentially adsorbed to these soil constituents. In
general, as the number of chlorine molecules increase, there is a reduction in vapor pressure,
an increase in boiling point, and a reduction in water solubility of the chlorophenols (Solomon et al. 1994).
Therefore, increasing chlorination increases the tendency of these compounds to partition into sediments and
lipids and to bioconcentrate. Chlorophenols are subject to abiotic and biotic degradation and transformations.
However, compounds containing chlorine in the meta positions show greater resistance to microbial attack.
The general population may be exposed to chlorophenols through ingestion of chlorinated drinking water and
food contaminated with the compounds and inhalation of contaminated air. Exposure to 4-CP could also occur
through its use as a root canal packing. Populations with potentially unusually high exposure to
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chlorophenols generally include employees of facilities that manufacture or use chlorophenols and their
derivatives and those who live in the vicinity of chlorophenol-containing waste disposal sites and waste
incinerators.
5.2     RELEASES TO THE ENVIRONMENT
5.2.1   Air
According to the Toxic Chemical Release Inventory, in 1996, releases of chlorophenols to the air from three
large processing facilities were 2148 kg (4,775 pounds) (TRI96 1998). Table 5-l lists amounts released from
these facilities. The TRI data should be used with caution because only certain types of facilities are required to
report. This is not an exhaustive list.
Both monochlorophenols and 2,4-DCP are volatile, and volatilization may be the major dispersal mechanism of
these chemicals into the atmosphere. Trichlorophenols and tetrachlorophenols are slightly volatile. However,
only a small fraction (approximately 5%) of chlorophenols (based on 2-CP, 2,4-DCP, and 2,4,6- TCP) are
emitted to the atmosphere (Scow et al. 1982). These releases are primarily in vapor form and are principally
associated with chlorophenol production and its use in the manufacture of end-use products (Scow et al. 1982).
Releases of chlorophenols to the atmosphere may also occur through the incineration of chlorinated wastes. 2,4-
DCP has been detected in atmospheric emissions from the combustion of municipal solid waste, hazardous
waste, coal, wood, and 2,4-DCP-based herbicides (Gomez et al. 1988; Junk et al. 1986; Oberg et al. 1989;
Paasivirta et al. 1985). Trichlorophenols have been detected in flue gas condensates and fly ash from municipal
incinerators (Viau et al. 1984). Di-, tri- and tetrachlorophenols have also been detected in fly ash from wood, oil,
and coal-fired power plants at concentrations in the ng/g level (Paasivirta et al. 1985).
Chlorophenols have been detected in air samples collected at 2 of the 1,467 current or former NPL hazardous
waste sites (HazDat 1998).
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5.2.2 Water
According to the Toxic Chemical Release Inventory, in 1996, releases of chlorophenols to the water from three
large processing facilities were 6 kg (13 pounds) (TR196 1998). There were no releases of chlorophenols into
publicly owned treatment works (POTWs) in 1996 (TR196 1998). Table 5-l lists amounts released from these
facilities. The TRI data should be used with caution because only certain types of facilities are required to
report. This is not an exhaustive list.
The majority (85%) of known environmental releases of three chlorophenols (2-CP, 2,4-DCP, and
2,4,6-TCP) were to surface water (Scow et al. 1982). The estimated 1977 water emissions of 2,4-DCP were
741,000 pounds from U.S. production facilities (Scow et al. 1982). Industrial waste discharge is a major point
source of water pollution by mono- and dichlorophenols (Krijgsheld and Van der Gen 1986). Monochlorophenol
concentrations of between 10-20 µg/L have been released in waste water produced during the manufacture of
specialty chemicals (Buikema et al. 1979; Hites et al. 1979), and 5.3 µg/L of 4-CP was detected in a bleaching
effluent released to surface water from a straw mill (Folke and Lindgaard-Jorgensen 1985). 2,4-DCP or 2,4,6-
TCP were also detected in effluents discharged from industries that manufacture iron and steel, electrical
components, photographic equipment/supplies, pharmaceuticals, and organic chemicals/plastics and from paper
pulp and paperboard mills (EPA 1981; Paasivirta et al. 1985). Oikari et al. (1985) reported that concentrations of
2,4,6-TCP and 2,3,4,6-TeCP were higher downstream from a pulp and paper mill than upstream from the
facility. Free chlorophenols were still present in water 11 km downstream from the mill. However, the release of
chlorophenols to water from pulp bleaching mills is being reduced as the use of elemental chlorine for bleaching
is being phased out in favor of the use of chlorine dioxide (Solomon et al. 1994). Compared to chlorine, chlorine
dioxide bleaching results in the production of fewer chlorophenols, and the chlorophenols that are produced
contain fewer chlorine molecules.
Other sources of discharge of chlorophenols into aquatic systems include sewage treatment plants and
drinking water treatment, which can result in the chlorination of phenol. In a study of 40 Canadian potable water
treatment facilities, 4-CP, 2,4-DCP, and 2,4,6-TCP are the three halogenated phenols found most frequently in
samples taken from chlorinated water supplies (Sithole and Williams 1986). The frequency of detection ranged
from 1 to 12 out of 40 samples. Mean values were <7 Νg/L and the maximum values <130 Νg/L. 2-CP has also
been detected in treated drinking water in the Netherlands (1 µg/L) (Buikema et al.
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1979). The maximum monochlorophenol concentrations measured in river water range from 2-6 µg/L
(Krijgsheld and van der Gen 1986).
2-CP has been detected in the leachate from a municipal landfill, while 2,4-DCP was found in the leachate from
an industrial landfill (Brown and Donnelly 1988). 2-CP was detected in the runoff from 1 of 15 cities, while
neither 2,4-DCP nor 2,4,6-TCP were detected in the runoff from 3 cities (Cole et al. 1984). Analysis of
groundwater taken from 479 waste disposal sites found that 2,4-DCP was detected at 19 sites, 2-CP at 14 sites,
and 2,4,5-TCP at 2 sites, while 2,3,4,6-TeCP was not detected at any of the sites (Plumb 1991).
The detection of 2,4,6-TCP in industrially unpolluted surface water in Sweden at concentrations up to
10 ng/L suggests that this compound can be formed by natural chlorination of humic substances (Grimvall et al.
1991). A laboratory investigation (Hodin et al. 1991) reported that the addition of chloroperoxidase from the
fungus Culduriomyces fumugo, hydrogen peroxide, and potassium chloride to bog water (pH adjusted to 3 with
100 mM phosphate) did result in the production of 2,4,6-TCP. Chloroperoxidase could also chlorinate added
phenol to form 2-CP and 4-CP. These results suggest that chloroperoxidase-mediated chlorination of natural
organic matter does contribute to the levels of chlorophenols (especially 2,4,6-TCP) that are found in surface
water.
Chlorophenols have been detected in groundwater and surface water collected at 98 and 25 of the
1,467 current or former NPL hazardous waste sites, respectively (HazDat 1998).
5.2.3 Soil
According to the Toxic Chemical Release Inventory, in 1996, there were no releases of chlorophenols to soil
(TRI96 1998); however, an estimated 5,246 kg (11,658 pounds) are disposed of in off site facilities. In addition,
about 51,099 kg (113,554 pounds) are disposed of by underground injection. Therefore, manufacturing and
processing industries are sources of release in soils surrounding the disposal sites. Table 5-l lists amounts
released from these facilities. The TRI data should be used with caution because only certain types of facilities
are required to report. This is not an exhaustive list.
Releases of chlorophenols to soils may occur through several processes such as disposal of manmade wastes
(e.g., landfills), atmospheric deposition, and accidental releases (e.g., spills) (Scow et al. 1982). Smith (1985)
has found that the herbicide 2,4-dichlorophenoxyacetic acid can be degraded to 2,4-DCP following
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soil application. Unspecified trichloro- and tetrachlorophenols have been identified at sites cornposting yard
waste and municipal solid waste (Malloy et al. 1993). The investigators (Malloy et al. 1993) suggested that the
source was pentachlorophenol on treated wood in chipped form that had been added as a bulking agent. The use
of chlorophenols as a wood preservative (predominantly 2,3,4,6-TeCP) has also resulted in the contamination of
soil around sawmills where these compounds were used (Kitunen et al. 1985, 1987; Valo et al. 1984).
Chlorophenols have been detected in soil, sediment, and leachate collected at 65, 31, and 12 of the
1,467 current or former NPL hazardous waste sites, respectively (HazDat 1998).
5.3      ENVIRONMENTAL FATE
5.3.1   Transport and Partitioning
The environmental fate and transport of chlorophenols are controlled by their physical and chemical
properties and environmental conditions. As shown in Table 3-2, all chlorophenols are solids at room
temperature except 2-CP, which is a liquid. In general, as the number of chlorine molecules increase, there is a
reduction in vapor pressure, an increase in boiling point, and a reduction in water solubility (Solomon et al.
1994). Therefore, increasing chlorination increases the tendency of the chlorophenols to partition into sediments
and lipids and to bioconcentrate.
The higher vapor pressures of the monochlorophenols suggest that among the chlorophenols, these
compounds are most likely to be found in air. Specific data concerning monochlorophenols in air were not
identified. The vapor pressures of the chlorophenols suggest that the compounds will not partition from the
vapor phase to the particulate phase (Eisenreich et al. 1981). That 2,4-DCP and other chlorophenols do not
partition into the particulate phase is supported by the identification of 2,4-DCP, 2,4,5-TCP, 2,4,6-TCP, and
2,3,4,6-TeCP in rain but not on rain filters (Leuenberger et al. 1985). This study indicates that gas scavenging
rather than particle scavenging is the more important process for removing chlorophenols from the air
(Leuenberger et al. 1985). Estimated rain/air partition coefficients at 8°C are 2.2 x 104 for 2,4-DCP and 1.8 x 104
for 2,4,5-TCP and 2,4,6-TCP combined (Leuenberger et al. 1985).
The rate of chemical evaporation from an aqueous solution largely depends on a chemicals vapor pressure and
water solubility (Henry’s law constant). Among the chlorophenols discussed in this profile, 2-CP has
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the highest vapor pressure and, therefore, is mostly likely to evaporate from water (Krijgsheld and Van der Gen
1986). In laboratory studies, evaporation half-lives of 2-CP and 4-CP from water 0.38 cm deep were 1.35-1.6 hours
and 12.8-17.4 hours, respectively (Chiou et al. 1980). Since the evaporation rate is inversely related to the depth of
water, extrapolation of these data indicates that-2-CP evaporation in water 1 meter deep would require
approximately 15 days. The amount of volatilization of 2-CP from fine sandy soil (0.087% organic carbon),
applied in spiked municipal waste water, was too small to be directly measured (Piwoni et al. 1986).
Volatilization of 2,4-DCP from water is expected to be slow and, therefore, not a major removal process from
surface waters. Using the Henry’s law constant, a half-life of 14.8 days was calculated for evaporation from a
model river 1 meter deep with a current of 1 meter/second and a wind velocity of 3 meters/second, neglecting
adsorption to sediment (Thomas 1982). The biological treatment of waste water containing 2,4-DCP has shown
that none of the chemical is removed by stripping (Stover and Kincannon 1983). Volatilization from near-surface
soil is also not expected to be a significant removal process.
The Henry’s law constants for 2,4,5-TCP (0.0039) and 2,4,6-TCP (0.0043) are similar to 2,4-DCP (0.0033).
Therefore, the volatilization of these trichlorophenols should be similar to that of 2,4-DCP. In 2-hour laboratory
studies, the volatilization rates of 2,4,6-TCP from water and three soil types were determined by Kilzer et al.
(1979). These rates, expressed as the percentage of applied compound per milliliter of water evaporated from
humus, loam, sand, and water, were 0.15,0.73, 1.05, and 1.4%, respectively, in the first hour after the addition of
50 ppb 2,4,6-TCP. Similar rates were reported during the second hour. In wind tunnel experiments, Sugiura et al.
(1984) estimated a half-life of 48 hours for loss of 2,4,6-TCP from water through volatilization. An estimated 58%
of 2,4,6-TCP in a nutrient solution in which tomatoes were grown was lost to the air (from photolysis and/or
volatilization) over a period of 30 days (Fragiadakis et al. 1981).
Experimental studies examining the volatilization of tetrachlorophenols were not located. Based on lower Henry’s
law constants and a greater potential to exist as the dissociated compound in the environment, tetrachlorophenols
would be less likely to volatilize from water and soil than the lower chlorinated chlorophenols .
In addition to vapor pressure and solubility, pKa and log Kow (octanol water partition coefficients) are other
important properties which determine the transport and partitioning of chemicals. The lower chlorophenols have
higher pKa values (7.42-8.49). Therefore, in natural waters these compounds will exist primarily as the
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undissociated compounds, and adsorption to sediments at a pH of not more than one unit greater than the pKa can
be predicted based on the organiccontent of the sediments and the octanol/water partition coefficient (Schellenberg
et al. 1984). In contrast, the pKa values of the tetrachlorophenols are lower (5.48-6.96) so that at ambient pH values
these compounds are present predominantly in the ionized form, and the adsorption to sediemtns will also be
dependant on the ionic strength of the wat (Schellenberg et al. 1984).
In general, a chemical will preferentially partition into organic matter if its log Kow is > 1 (Scow et al. 1982). Log
Kows for the chlorophenols are all > 2 (see Table 3-2); therefore, the chlorophenols will all tend to partition into
sediments. Despite this prediction, a modeling study completed by Yoshida et al. (1987) suggests that most of the
2,4,6-TCP released to surface waters would remain in the water rather than absorb to sediments. They estimated
that in a river receiving daily inputs of the compounds, 72% would be in the water and 28% in the sediment. In a
deep, otherwise unpolluted lake, 84% would be in the water and 16% in the sediment. Laboratory sorption
experiements with natural sediments containing up to 10% organic matter have been conducted using 2-CP and
2,4-DCP (Isaacson and Frink 1984). Sediment sorption capacity was extensive (up to 0.3 mmol/g), and up to 90%
of the adsorption was irreversible.
Chlorophenols are capable of binding to soil organic matter via covalent bond formation, resulting from
biologically or chemically catalyzed reactions. In a batch sorption experiment, the binding of 4-CP to soil requires
oxygen and soil bioactivity, indicating a biologically mediated oxidative coupling reaction. The addition of
hydrogen peroxide, which may be an oxygen source, caused a 4.4 fold increase in 4-CP binding (Bhandari et al.
1996).
As the number of chlorines on phenols increases, sorption of chlorophenols to organic material in soil increases.
For example, at two sawmills in Finland where chlorophenol wood preservative (primarily 2,3,4,6-TeCP) was
used, soil was contaminated to a depth of 80 to 100 cm to the same extent as at the surface (Valo et al. 1984). As
soil depth increased, the concentration of dichlorophenols increased. The investigators attributed this observation to
a greater transport of dichlorophenols through the soil and to the relatively increased degradation of the higher
chlorinated phenols. An experimental study that examined the movement of 2-CP and 2,4,5-TCP through two soil
types (organic carbon 2.1 mg C/g soil or 1.5 mg C/g soil) found that the relative velocity of the chlorophenol
through soil into water was 3.5-4 times greater for 2-CP compared to 2,4,5-TCP (Kjeldsen et al. 1990). The
chlorophenols moved slowest in the soil with the greatest organic carbon content.
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Chlorophenol groundwater contamination will occur if sufficient quantities of the chemical are present to exceed
the sorption capacity of the vadose zone saturated soils (Scow et al. 1982). Contamination is most likely in soils
with low organic carbon content or high pH. Once in groundwater, sorption of chlorophenols by the solid
aquifer matrix may be estimated based on log Kow and organic carbon content, provided that the organic carbon
content exceeds 0.1% and the aquifer pH is not sufficiently high for significant dissociation to occur
(Schellenberg et al. 1984; Schwarzenbach and Westall 1985). In a natural gradient tracer test conducted within
an unconsolidated aquifer, sorption was not an important factor, compared to dispersion and degradation, in the
attenuation of 4-CP concentrations (Sutton and Barker 1985). The authors attributed this finding to the low
organic carbon content of the aquifer sand unit, which prevented significant hydrophobic sorption.
The bioaccumulation potential of 2-CP, 4-CP, 2,4-DCP, 2,4,5-TCP, 2,4,6-TCP, and 2,3,4,6-TeCP was
reviewed by Loehr and Krishnamoorthy (1988). Based on bioconcentration values and log octanol/water
partition coefficients, they concluded that all chlorophenols studied had the potential for accumulation in aquatic
organisms. Logs of bioconcentration factors ranged from 0.81-2.33 for 2-CP, 1.79-3.28 for 2,4,5-TCP, and 1.95-
2.3 for 2,3,4,6-TeCP. Values of bioconcentration factors for 4-CP, 2,4-DCP, and 2,4,6-TCP were predicted
mathematically (Veith et al. 1980).
Research on biomagnification of chemical residues within the aquatic food chain indicates that the potential for
residue accumulation by fish through food chains is relatively insignificant (<10%) for most compounds when
compared to the tissue residues resulting from the bioconcentration process (i.e., direct uptake from water)
(Barrows et al. 1980). These data suggest that only those chemicals that are relatively persistent in fish tissues
appear to have any potential for significant transfer through food chains (Barrows et al. 1980). A very short
tissue half-life of <l day was measured after bluegill sunfish exposure to 2-CP was terminated (Veith et al.
1980). Therefore, due to their relatively low bioconcentration factors (<1,000) and short biological half-lives
(<7 days), monochlorophenols will probably not biomagnify within aquatic food chains (Barrows et al. 1980).
Data regarding the biomagnification of the higher chlorophenols were not located.
Isensee and Jones (1971) studied the uptake of 2,4-DCP from solution and soil by oats and soybeans. The
compound was taken up by the plants, with the concentrations decreasing as the plants matured. At maturity,
2,4-DCP in oat seeds was below detection (<0.001 µg/g) and in soybeans was 0.003 µg/g. Data regarding the
uptake of other chlorophenols by plants were not located.
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The bioaccumulation of 2,3,4,6-TeCP was examined in earthworms (Lumbricus rubellus and Aporrectodea
caliginosa tuberculata) at a sawmill that had been closed 28 years before sampling (Haimi et al. 1992). At a
distance of 5 meters from the dipping basin, 2,3,4,6-TeCP concentrations were 430 and 1,980 µg/g fat in
Lumbricuss and Aporrectodea, respectively, while soil concentrations were 336 µg/g dry soil. The difference
between the two species was attributed to greater ingestion of contaminated soil by Aporrectodea. Additional
data regarding bioaccumulation of chlorophenols in terrestrial organisms was not identified. It is not known
whether 2,3,4,6-TeCP biomagnifies up the terrestrial food chain. Based on physical properties (i.e., greatest log
octanol water partition coefficient), the tetrachlorophenols, rather than lower chlorinated phenols, would have
the greatest potential to biomagnify.
5.3.2 Transformation and Degradation
5.3.2.1 Air
Limited data on the environmental transformations of atmospheric chlorophenols are available. Although
chlorophenols absorb primarily in deep ultraviolet, some absorption in the solar visible spectrum is possible
because of the overlap between this spectrum and the ultraviolet spectrum (Bunce and Nakai 1989). Bunce and
Nakai (1989) found that photolysis and hydroxyl (OH) radical attack were complementary processes for 4 of the
chlorophenols. As indicated below, a greater percentage of 2-CP and 4-CP were degraded by hydroxyl attack
compared to photolysis, while with increasing chlorination, photolytic degradation increased and hydroxyl
attack decreased. Tetrachlorophenols were not tested in this study.
Photolytic degradation Hydroxyl Radical Attack




2,4,5-TCP 2.3  8
5.3.2.2 Water
Both direct photolysis and the reaction of chlorophenols with hydroxyl radicals and singlet oxygen produced by
ultraviolet radiation may be important processes of chlorophenol degradation near the water surface. Photolysis
of monochlorophenols in water results in dechlorination, with the position of the chlorine on the ring strongly
influencing the transformation (Boule 1982). In the molecular form, 2-chlorophenol is
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converted into pyrocatechol. However, in the anionic form, it is reduced in a cyclopentadienic acid and
dimerizes. For 3-chlorophenol, the photochemical product is resorcinol regardless of the pH. For 4-chlorophenol,
hydroquinone is formed along with polyphenolic oligomers (Boule 1982). The photolysis rates of 2-CP in natural
waters depends on pH, season, and dissolved organic material (Kawaguchi 1992a, 1992b). In all cases the
reaction rate is first order. Based on empirical data, these investigators proposed that direct photolysis of 2-CP
may only occur in natural waters at pH between 7 and 9. Indirect photolysis in lake waters was only significant
in summer months; in sea waters, indirect photolysis has a more significant role in the spring and fall.
Kawaguchi et al. (1992a, 1992b) also found that the dissolved organic matter in pond water does not contribute
to indirect photolysis as significantly as a humic acid solution.
The photocatalytic degradation process with titanium dioxide particles has been shown to be feasible for
achieving a high degree of removal of 2-chlorophenol in water (Ku et al. 1996), with almost complete
disappearance in only a few hours of illumination time. However, the demineralization of reaction intermediates
requires a longer time, and was found to be more effective for acidic solutions. Increasing the light intensity
would significantly increase the decomposition rate of 2-chlorophenol at pH 3, but not pH 11. The higher
removals at acidic conditions may be due to the increased amounts of undissociated 2-chlorophenol species
adsorbed on the TiO2 surface; the TiO2 acting as a catalyst in the photochemical degradation.
The reaction of hydroxyl radicals with monochloro- and dichlorophenols was studied by Kochany and Bolton
(1991) using spin trapping with electron paramagnetic resonance detection of spin adducts. The reaction rate of
4-CP (3.2/1010 M-1s-1) and 2,4-DCP (3.8/1010 M-1s-1) with hydroxyl radicals was greater than the reaction rate of
2-CP (1.92/1010 M-1s-1). The observation that chlorophenols with meta-substitution have even slower reaction
rates (1.04/1010 M-1s-1for 3-CP, 0.9/1010 M-1s-1 for 3,5-DCP) indicates that for the monochloro- and
dichlorophenols, the location of chlorine rather than the number of chlorines is more important in determining
the reaction rate. Higher chlorinated phenols were not examined in this study. Chlorophenols may also be
removed via reaction with photochemically produced singlet oxygen in natural waters. The estimated half-life for
the reaction of 2,4-DCP at pH 7 and 2,4,6-TCP with singlet oxygen at pH 5.5 under midday sun (assuming a
singlet oxygen concentration of 4x10-14) using experimentally determined rate constants is 62 hours (Scully and
Hoigne 1987). The rate of reaction of singlet oxygen with 2,4-DCP and 2,4,6-TCP increased significantly as the
solution pH was raised from 5.5 to 9 (Scully and Hoigne 1987). This observation is consistent with a study by
Tratnyek and Hoigne (1991) who found that the reaction of phenolate ions with singlet oxygen was about one
order of magnitude greater than the reaction of the undissociated chlorophenol. The compounds examined in this
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study were 2-CP, 4-CP, 2,4-DCP, and 2,4,6-TCP. Although tetrachlorophenols are most likely to exist as ions in
natural waters, it is not known whether the ions react more readily with singlet oxygen than do the undissociated
tetrachlorophenol compounds.
Hwang et al. (1986) studied the photolysis and microbial degradation of 4-CP, 2,4-DCP, and 2,4,5-TCP in both
estuarine and distilled water. Photolysis was the primary transformation process for 2,4-DCP and 2,4,5-TCP, with
the rate of photolysis decreased in the order 2,4,5-TCP, 2,4-DCP, and 4-CP. The rate of photolysis of 2,4-DCP was
greater in estuarine compared to distilled water, suggesting a photosensitized reaction, The type of water had no
effect on the photolysis of 4-CP and 2,4,5-TCP. Unlike the polychlorinated phenols, microbial degradation was the
primary transformation process for 4-CP (Hwang et al. 1986).
There are numerous studies regarding the microbial degradation of chlorophenols in water and sediments
(Abrahamsson and Klick 1991; Aly and Faust 1964; Banerjee et al. 1984; Genther et al. 1989; Hwang et al.
1986; Vaishnav and Korthals 1988), as well as numerous studies concerning the degradation of these
compounds by sludge (Armenante et al. 1992; Battersby and Wilson 1989; Boyd and Shelton 1984; Liu and
Pacepavicius 1990; Tabak et al. 1981). Although as a group chlorophenols are poorly biodegradable and
persistent in the environment, several studies have shown that aerobic degradation of chlorophenol congeners
is possible (Steiert et al. 1988; Armenante et al. 1992). The aerobic degradation of chlorphenols by
microorganisms requires the participation of the enzyme’s oxygenases to incorporate atmospheric oxygen into
their substrates. For fission of the benzene nucleus, the ring is usually first dihydroxylated by an oxygenase
such that two hydroxyl groups are situated either ortho or para to one another on the ring (Steiert and
Crawford 1985). Subsequent ring fission occurs through another oxygenase-catalyzed reaction involving the
insertion of dioxygen into the aromatic nucleus. The crucial step in the biodegradation of chlorophenols is the
removal of the chlorine substituents. For the catabolism of the lesser substituted phenols (mono- and
dichlorophenols), dioxygenase from chlorophenol-degrading bacteria usually opens the dihydroxylated
aromatic ring before dechlorination takes place (Steiert and Crawford 1985). With more highly substituted
phenols, some of the chlorosubstituents must be removed before ring cleavage since the halogen atoms
deactivate the aromatic nucleus to electrophilic attack by dioxygenases.
It has been reported that 4-CP can be partially or completely degraded by several aerobic bacteria such as
Pseudomonas sp. B13 (Knackmuss 1978) and Azobactirium sp. GPl (Wieser 1997). The catabolic
degradation routes for mono- or dichlorophenols are known to be meta- and modified ortho-pathways (Bae
et al. 1996). In these pathways, 4-CP is hydroxylated to 4-chlorocatechol which then undergoes intradiol
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cleavage before the chloro-substituent is removed. In addition, 4-CP degradation by Azobactirium
ureufaciens CPR706 was reported via a pathway in which the chloro-substituent of 4-CP was replaced
with an incoming hydroxyl group to form hydroquinone (Bae et al. 1996). After 4-CP degradation was
completed, the accumulated hydroquinone disappeared from the medium via ring fission forming the 4-
hydroxymuconic semialdehyde intermediate. The general observation of these studies is that
compounds with a chlorine in the meta- and/or para- position are the most resistant to degradation
(Abrahamsson and Klick 1991). In addition, if the bacteria have not been cultured in the presence of a
chlorophenol, they require an adaption period before the compounds can be degraded. For example,
degradation of 2,4-DCP was observed in natural water collected from a river following lag times of 2.5
and 8.3 days for 2 separate collections (Banerjee et al. 1984). The rates of degradation of 4-CP, 2,4-CP,
and 2,3,4,5-TeCP in river water were 6.5 x 10-6, 2.3x10-6, and 1.4x10-7 moles/hour, respectively
(Banerjee et al. 1984). A study by Liu and Pacepavicius (1990) indicates that the position, rather than
the number of chlorine atoms, is more important in determining the biodegradation of chlorophenols.
The biodegradation of chlorophenols was studied in both aerobic and anaerobic systems using a
pentachlorophenol-degrading bacterial culture. The results, shown in Table 5-2, indicate lag time to
degradation, and half-life tended to be shorter for compounds with a chlorine in the 4 position and
longer for compounds with a chlorine at the 5 position. Anaerobic degradation of the chlorophenols
required a longer lag time and the half-lives were longer.
Reductive dehalogenation of chlorinated aromatic compounds whereby chlorines are being replaced by
hydrogens occurs extensively under anaerobic conditions (Steiert and Crawford 1985). Anaerobic
dehalogenation of 2-chlorophenol, a common intermediate of polychlorophenol degradation, by mixed
cultures was reported (Theme1 et al. 1996). Acetate was found to be the major end product, with phenol and
benzoate as intermediate products, but CO, was not found to be an end product.
A study of anaerobic degradation of chlorophenols in waste water in an upflow anaerobic sludge blanket reactor
indicated that the higher chlorophenols were converted to lower chlorinated compounds via reductive
dechlorination reactions (Woods et al. 1989). The rate of these reactions was dependent on the position of the
chlorine; chlorines adjacent to the hydroxyl group were preferentially removed, and meta chlorines were removed
following acclimation, with no evidence for the removal of para chlorines. Woods et al. (1989) also found no
evidence for the dechlorination of monochlorophenols in this system.
4-chlorophenol was demonstrated to be quickly removed from formulated waste water catalyzed by
horseradish peroxidase (Zhang et al. 1997) to form radicals or quinones, which might be subsequently
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polymerized to form less soluble large molecules and precipitated from aqueous phase. The flocculant might
increase the removal percentage of the pollutant through enhancing the sedimentation of the reaction products The
optimum pH for the removal efficiency of chlorophenol was 9.0. The analytical method would, thus, have to
quantify both salt and acid forms of the chlorophenol.
5.3.2.3 Sediment and Soil
Chlorophenol isomers undergo biodegradation in soils under aerobic conditions. Aerobic microorganisms that can
degrade chlorophenols have been isolated from soil bacterial cultures. Pseudomonas picketti DTP0602, which used
2,4,6-TCP as the sole source of carbon and energy, was isolated from mixed cultures of soil bacterial populations
that had been acclimatized to 2,4,6-TCP (Kiyohara et al. 1992). This bacterial species dechlorinates the chlorine
atom at position 4 of various CPs to yield their corresponding hydroquinones and may involve oxygenation. Two
different enzyme systems for hydroxylation at the ortho and para positions of the phenol ring may be present in
this bacterial species. The para-hydroxylation system, which may use a monooxygnease, possibly involves the
dechlorination of a 4-position chlorine atom of CPs. 2,4,6-Trichlorophenol-4-monooxygenase, a dehalogenating
enzyme, was also isolated from TCP-degrading soil bacterium Azotobacter sp., strain GPl (Wieser et al. 1997).
NADH, flavin adenine dinucleotide, and O2 are required as cofactors. 2,6-dichlorohydroquinone and Cl- ions were
identified as reaction products. TCP was the best substrate for this enzyme. However, the majority of other
chlorophenols converted by the enzyme bear a chloro substituent in the 4-position. 2,6-dichlorophenol, also
accepted as a substrate, was hydroxylated in the 4-position to 2,6-dichlorohydroquinone in a nondehalogenating
reaction. It was also reported that the addition to the culture medium of a vitamin solution containing biotin, folk
acid, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride, niacin, pantothenic acid, cyanocobalamin, p-
aminobenzoic acid, and thioctic acid can increase the aerobic degradation and dechlorination of 2-CP and 4-CP by
Pseudomonas picketti strain LDl culture by 1l-16% (Kafkewitz et al. 1996).
The extent and rate of biodegradation depend on numerous factors, including soil pH, organic carbon content,
biomass, and the chlorophenol isomer and its concentration. In neutral clay-loam soil at 20°C under aerobic
conditions, 2-CP was degraded the fastest (Baker and Mayfield 1980). Decomposition rates were as follows: 100%
of the 2-CP in 1.5 days, 95% of the 2,4,6-TCP in 3 days, 83% of the 4-CP in 20 days, 81% of the 2,4-DCP in 40
days, and 72 and 31% of the 2,4,5-TCP and 2,3,4,5-TeCP, respectively, in 160 days (Baker and Mayfield 1980).
Dasappa and Loehr (1991) examined the loss of 2-CP, 4-CP, 2,4 DCP, and 2,4,6-TCP from a laboratory soil
microcosm. The loss from soil and the water soluble fraction were examined at two
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concentrations for each compound. The loss of chlorophenols from the water soluble fraction was about 1.5 times
greater than the loss from soil, and chemical loss was slower at higher initial concentrations. Mineralization of
2,4,5-TCP in soil not previously exposed to chloroorganics has been reported (Matus et al. 1996). The observation
of 2,3,4,6-TeCP in soil (157-338 µg/g dry soil) at a sawmill 28 years after it closed provides evidence that this
compound can persist in soil. Soil concentrations of 2,3,4,6-TeCP when the mill was closed were not stated. In
general, degradation or complete mineralization to carbon dioxide (CO2) is greater in soils with low organic carbon
content (Kjeldsen et al. 1990), slightly alkaline pH (Balfanz and Rehm 1991), increased temperatures (Baker and
Mayfield 1980; Baker et al. 1980; Balfanz and Rehm 1991), and increased inoculum concentrations (Balfanz and
Rehm 1991).
Microbial degradation of chlorophenols in soil under anaerobic conditions has not been observed consistently. For
2-CP, 4-CP, 2,4-DCP, 2,4,5-TCP, 2,4,6-TCP, and 2,3,4,5-TeCP, no statistically significant differences in
degradation rates between nonsterile and sterile clay loam soils occurred when both soil samples were incubated
under anaerobic conditions (Baker and Mayfield 1980).
In a study of the degradation of halogenated phenols in anoxic marine sediments, the main degradation
pathway was progressive dehalogenation with ortho > para > meta. Sediments which had been exposed to effluent
water from a paper and pulp mill showed a higher dehalogenation potential (Abrahamsson and Klick 1991).
Another study demonstrated that anaerobic degradation of chlorophenols with an estuarine sediment
inoculum was coupled to sulfate reduction, which was the electron sink. The relative rates of degradation
were 4-chlorophenol > 3 chlorophenol > 2 chlorophenol, 2,4-dichlorophenol (Haggblom and Young 1990).
5.4     LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT
5.4.1  Air
During seven rain events in Portland, Oregon, in 1984, 2,4-DCP was detected in the air in all seven events
at an average concentration of 1.5 ng/m3 (0.23 ppt), combined 2,4,5-TCP and 2,4,6-TCP were detected in
6/7 events at an average concentration of 0.15 ng/m3 (0.02 ppt), and 2,3,4,6-TeCP was detected in 5/7
events at an average concentration of 0.27 ng/m3 (0.03 ppt) (Leuenberger et al. 1985). Average
concentrations in rain for the seven events were 5.9, 1.1, 1.4, and 20 ng/m3 (0.89. 0.14,0.17, and 2.1 ppt) for
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2,4-DCP, 2,4,5-TCP, 2,4,6-TCP, and 2,3,4,6-TeCP, which were detected in 7/7, 4/7, 5/7, and 7/7 of the events
respectively. Additional data regarding ambient levels of chlorophenols in indoor or outdoor air were not
identified. However, data on 2-CP levels after the accidental derailment and rupture of a train tanker are
available. On the day of the accident, air concentrations ranging from 0.02 to 0.7 mg/m3 (0.04 to 0.19 ppm) were
detected in the immediate vicinity of the spill (Scow et al. 1982). Eighteen days after the spill, air levels were <2
µg/m3 (<0.5 ppb). No additional data are available regarding air emissions following accidental releases.
5.4.2 Water
Grimvall et al. (1991) measured 2,4,6-TCP in unpolluted surface waters in remote areas of southern Sweden and
in pulp bleaching plant recipient waters, Lake Vattern and the Baltic Sea. Concentrations up to 10 ng 2,4,6-
TCP/L were found in unpolluted waters, with concentrations of 2,4,6-TCP in Lake Vattern decreasing from 12
ng/L to 1 ng/L with increasing distance from the bleaching plant. 2,4,6-TCP concentrations in the Baltic Sea
were <l ng/L. This study suggests that 2,4,6-TCP can be formed by both industrial and natural chlorination of
humic substances, an observation that was confirmed in the laboratory (Haimi et al. 1992).
Analysis of chlorophenol concentrations downstream of paper mills along the Rainy River in Canada and
northern Minnesota did not identify 2-CP, 4-CP, 2,4,5-TCP, 2,3,5,6-TeCP, or 2,3,4,5-TeCP using methods with
detection limits as low as 50 ng/L (Merriman 1988). In water samples from northern Alberta, Canada, 2-CP was
not detected (detection limit 0.005 µg/L), while 2,4-DCP concentrations were <0.002-7.1 µg/L, and 2,4,6-TCP
concentrations were <0.002-17 µg/L (Morales et al. 1992). 2,4-DCP, 2,4,6-TCP, and 2,3,4,6-TeCP were
identified in water samples from at least one of the three sampling stations. A summary of STORET data of
priority pollutants in ambient water (Staples 1985) indicated that 2-CP was detected in 0.2% of 814 samples,
2,4-DCP was detected in 0.4% of 876 samples, and unspecified trichlorophenols were detected in 0.1% of 880
samples. Analysis of runoff from 15 United States cities for 2-CP, 2,4-DCP, and 2,4,6-TCP identified only 2-
CP, which was found in samples from only one city (Cole et al. 1984).
Chlorophenols are produced during the chlorination of organic material present in industrial and municipal
waste waters. Consequently, several investigators have detected these chemicals downstream of waste water
discharge points. Maximum surface water concentrations measured in 13 samples downstream from a
chlorinated waste water discharge in the Netherlands were (in µg/L) 0.6 for 2-CP, 2.1 for 4-CP, 0.33 for 2,4-
DCP, 0.32 for 2,4,5-TCP, 0.74 for 2,4,6-TCP, 0.02 for 2,3,4,5-TeCP, 0.2 for 2,3,4,6-TeCP, and 0.08 for
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2,3,5,6-TeCP (Wegman and van de Broek 1983). Maximum monochlorophenol concentrations of between 2 and 6
µg/L have been measured in European rivers (Krijgsheld and van der Gen 1986).
Chlorination of drinking water at treatment plants can result in detectable levels of chlorophenols if the
required precursors are available in the raw water (Krijgsheld and van der Gen 1986). In a study of Canadian
potable water treatment facilities conducted in the summer, maximum concentrations of 65, 127, 72, and
148 ng/L of 2-CP, 4-CP, 2,4-CP, and 2,4,6-TCP, respectively, were measured, while 2,3,4,5-TeCP was not
detected in the water (Sithole and Williams 1986).
5.4.3 Sediment and Soil
Chlorophenols have been detected in groundwater from waste disposal sites indicating that these compounds can
leach through soil (Plumb 1991). 2,4-DCP was detected most frequently, followed by 2,4,6-TCP, 2-CP, and 2,4,5-
TCP. 2,3,4,6-TeCP was not detected at any of the 479 sites. It was not reported how much of each chlorophenol
was disposed at each site, and soil concentrations at the sites were not reported. 2,4-DCP in the concentration range
of 3.2-79.7 µg/L, as well as other organic compounds, has been found in groundwater samples taken near an
abandoned creosote waste site in Conroe, Texas (Bedient et al. 1984). It is not clear whether soil samples were
analyzed for 2,4-DCP, although soil concentrations of other organic compounds were provided. Kitunen et al.
(1985) reported soil concentrations (in mg/kg wet weight) of 2.7- 47.4, 2, 4-DCP; 0.8-15.7, 2, 4, 5-TCP; 7.3-
1,258.3, 2, 4, 6-TCP; 231-1,776.4, 2, 3, 4,6-TeCP; and 0.9-2.2, 2, 3, 4, 5-TeCP in soil at an operating sawmill in
Finland where chlorophenols (predominantly 2,3,4,6-TeCP) were being used as a wood preservative. The highest
concentrations of chlorophenols were found at depths of 5-40 centimeters. Soil concentrations of 157-338 mg
2,3,4,6-TeCP/kg dry soil were found at a sawmill in Finland 28 years after it had closed, indicating that this
compound can persist for long periods (Haimi et al. 1992). Soil concentrations of 2,3,4,6-TeCP when the sawmill
was in operation were not reported, and soil concentrations of other chlorophenols discussed in this profile were
not measured.
A limited amount of data concerning chlorophenol sediment concentrations in areas of known surface water
contamination is available. 2-CP and 4-CP were not detected in sediments, while the maximum concentrations of
2,4-DCP, 2,4,5-TCP, 2,4,6-TCP, 2,3,4,5-TeCP, 2,3,4,6-TeCP, and 2,3,5,6-TeCP were 10, 15, 3.7, 9.8, 4.9, and 2.8
pg/kg, respectively (Wegman and van de Broek 1983). In the same study, none of the isomers appeared in sediment
samples collected from six locations in the vicinity of chemical and industrial waste water effluent discharge
points. These findings may be misleading because of the poor sensitivity
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(detection limit of 10 µg/kg) of the gas chromatography/electron capture detector (GC/ECD) analytical
procedure. No 2-CP, 2,4-DCP, or 2,4,6-TCP was detected in sediment samples from northern Alberta, Canada,
where water concentrations of these chlorophenols were low or not detectable (Morales et al. 1992). The limits
of detection in sediments were 0.02 µg/g for 2-CP and 0.01 µg/g for 2,4-DCP and 2,4,6-TCP.
5.4.4 Other Environmental Media
The use of the chlorophenoxy herbicides may result in contamination with 2,4-DCP and 2,4,5-TCP. For
example, Cook et al. (1983) analyzed the free and acid hydrolyzable residues of 2,4-DCP in millet resulting
from treatment with 2,4-dichlorophenoxyacetic acid. The total residues of 2,4-DCP ranged from not detected
(<0.02 ppm detection limit) to 0.031 ppm for postemergence and preharvest treatment. Only 15-19% of the 2,4-
DCP residues were in the free unaltered form, while the remaining residues were conjugated to sugars and
amino acids and converted to the free form by acid hydrolysis.
Few data were found on the levels of chlorophenols in U.S. foods. Most of the data or estimates are for
concentrations in fish or shellfish. Based on the EPA (1980a) estimated bioaccumulation factor (BCF) of 150 in
the edible portion of fish and assuming ambient water concentration of 30 ppb, tissue concentrations of 4.5 mg
2,4,6-TCP/kg bodyweight in fish were estimated by Scow et al. (1982). The authors stated that the 30 ppb value
for water represents a maximum case exposure. 2-CP, 2,4-DCP, and 2,4,6-TCP were not detected in 22
composite samples of fish collected from harbors and tributaries of the Great Lakes (DeVault 1985). 4-CP, 2,4-
DCP, and 2,4,6-TCP were not detected (detection limit 0.02 mg/kg) in fish from 13 Lake Michigan tributaries
(Camanzo et al. 1987) or in fish from northern Alberta, Canada, (detection limit 0.01 µg/g) (Morales et al.
1992). Fish in the Fraser River estuary downstream from a lumber mill were found to contain chlorophenols
including 2,4,5-TCP, 2,4,6-TCP, 2,3,5,6-TeCP, 2,3,4,6-TeCP, and 2,3,4,5-TeCP (Carey et al. 1988). Among the
chlorophenols discussed in this profile, 2,3,4,6-TeCP was the most predominant compound, and the highest
concentrations (49 ng/g) were found in sculpin, which had concentrations of about 400 times the concentration
found in water in the estuary. Trichlorophenol (combined 2,4,5 and 2,4,6 isomers) concentrations of 29-629 ppb
(wet weight) were measured in fish livers collected from the Pacific Ocean 6 km northwest of the discharge
zone for the Los Angeles County waste water treatment plant by Gossett et al. (1983). Concentrations in edible
tissues were not measured.
In addition to environmental contamination of food, another potential source for chlorophenol contamination of
food is migration from packaging materials. Shang-Zhi and Stanley (1983) reported levels of
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0.1-0.68 ppm 2,4,6-TCP and 0.14-0.55 ppm 2,3,4,6-TeCP in cardboard food containers. Analysis for other
chlorophenols was not completed. Shang-Zhi and Stanley (1983) indicated that the source of chlorophenol
contamination was polyvinyl acetate and starch adhesives used in carton manufacture.
5.5    GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
Oral exposure to chlorophenol-contaminated food and water is the main route of exposure to the general
population Water contaminated through chlorination is most likely to contain lower chlorinated phenols, while
higher chlorinated phenols are more likely to be found in fish. Exposure to 2,4-DCP through contaminated food
may result from the production of 2,4-DCP via degradation/metabolism of 2,4-dichlorophenoxy-based
herbicides applied to food crops (Scow et al. 1982; WHO 1989). Although food monitoring data are lacking,
exposure to 2,4-DCP through the ingestion of food is expected to be relatively minor. Estimates of total
chlorophenol intake reviewed by WHO (1989) ranged from 2.2 µg/person/day assuming contaminated water
and fish were the main sources of exposure, to about 10-40 µg/person/day assuming indoor rooms were treated
with a chlorophenol preservative.
The identification of chlorophenols in urine and fat of persons not occupationally exposed to chlorophenols
confirms general population exposure to these compounds. Analysis of urine from 197 children living near a
herbicide manufacturing plant in Arkansas for 2,4-DCP, 2,4,5-TCP, and 2,4,6-TCP, identified these compounds
in 27,54, and 11% of the samples, respectively (Hill et al. 1989). The 95th percentile concentrations (in ppb)
were 7 for 2,4-DCP, 7 for 2,4,5-TCP, and 4 for 2,4,6-TCP. In the National Health and Nutrition Examination
Survey (NHANES II), 2,4,5-TCP was detected (detection limit 5 ppb) in 3.4% of about 6,000 urine samples
taken from a representative sample of nonoccupationally exposed persons from 64 communities in the United
States during 1976-1980 (Kutz et al. 1992; Murphy et al. 1983). The maximum concentration detected was 56
ppb (Kutz et al. 1992). The investigators warn that because of the considerable variability among the recovery
rates over time and between laboratories, the level for 2,4,5-TCP may be underestimated. The average fat
concentrations of combined 2,3,4,6-TeCP and 2,3,5,6-TeCP and of 2,3,4,5-TeCP in autopsy specimens were 22
and 6 ng/g respectively in Kingston, Ontario, which is near the Great Lakes, relative to 7 ng/g for 2,3,4,6-TeCP,
2,3,5,6-TeCP, and 2,3,4,5-TeCP in tissue from persons living in Ottawa (Williams et al. 1984). 2,3,4,6-TeCP
was detected in 29/46 adipose samples from persons in Finland not   occupationally exposed to chlorophenols,
while 2,4,6-TCP was detected in only one adipose sample (Mussalo-Rauhamaa et al. 1989). The concentration
of 2,3,4,6-TeCP in adipose tissue ranged from
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<0.00l (the detection limit) to 0.031 µg/g. 2,3,4,6,-TeCP was also found in 2/13 liver samples, while
2,4,6-TCP was not detected (0.001 µg/g detection limit) in any liver samples.
Occupational exposure to chlorophenol isomers may occur during chemical production and during subsequent
use as intermediates in the synthesis of higher chlorinated phenols, phenolic resins, dyes, and drugs (Exon et al.
1984; Krijgsheld and Van der Gen 1986). Exposures result from inhalation and/or dermal contact and are most
likely associated with process, storage, or fugitive emissions at chemical manufacturing plants. NOES (1990)
estimates that 2,796 workers, principally clinical laboratory technicians at hospitals, are potentially exposed to
4-CP. Chemists comprise the majority of the 975 workers potentially exposed to 2-CP and the 852 workers
potentially exposed to 2,4,6-TCP, while janitors; engineers; and furnace, kiln, and oven operators are among the
895 workers potentially exposed to 2,4,5-TCP (NOES 1990). No estimates of the number of workers exposed to
the other chlorophenols discussed in this profile were available.
Occupational exposure to chlorophenols may also occur during the incineration of wastes containing
chlorinated chemicals (Angerer et al. 1992a, 1993) and through indirect exposure following worker inhalation
and subsequent metabolism of chlorobenzene (Kusters and Lauwerys 1990; Yoshida et al. 1986). In a study of
53 municipal waste incinerator workers’ urine, concentrations of 2,4-CP and 2,4,5-TCP were small but
significantly (p,0.05; nonparametric U-test of Wilcoxon, Mann, and Whitney) greater than the urinary
concentrations of these chlorophenols in 248 persons with no known occupational exposure to organic
chemicals (Angerer et al. 1992a, 1993). However, 4-CP and combined 2,3,4,6-TeCP and 2,3,5,6-TeCP urine
concentrations were small but significantly higher in the control group, which included 88 people from urban
communities, than in the incinerator workers. The investigators suggested that the higher 4-CP urine
concentrations in the urban population were a result of atmospheric exposure to chlorobenzene, but they did not
have an explanation for the higher tetrachlorophenol concentrations (Angerer et al. 1992a). Median and 95
percentile concentrations (µg/g creatinine) of chlorophenols in the urine from the two populations are shown
below.
Waste Incineration (n=53) Controls (n=248)
                                                        Median               95%            Median                95%
4-CP     1.2                        3.8                          1.7                      6.6
2,4-DCP/2,5-DCP                          10.5      86.6   3.9            46.4
2,4,5-TCP     1.2        3.2 0.8                   4.0
2,4,6-TCP     0.9        2.3 0.6              3.7
2,3,4,6-TeCP/2,3,5,6-TeCP     0.3        1.5 1.2             25.6
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An industrial hygiene investigation of workers exposed to chlorophenols at a sawmill indicated that dermal
exposure was the most important route (Lindroos et al. 1987). The workers were exposed to a wood preservative
that contained 80% 2,3,4,6-TeCP, 10-20% 2,4,6-TCP, and 5% pentachlorophenol. Median urinary
concentrations of total chlorophenols were 7.8 µmol/L in workers with the skin as the main route of exposure,
1.4 µmol/L in workers with combined inhalation and skin exposure, and 0.9 µmol/L in workers with inhalation
as the principal route of exposure.
As with the general population, occupational exposure to chlorophenols can also occur following accidents that
result in the release of these chemicals to the environment, such as the previously discussed train derailment. On
the day of the accident, 2-CP air concentrations of 0.02-0.7 mg/m3 (0.004-0.19 ppm) were detected in the
immediate vicinity (Scow et al. 1982). Eighteen days after the spill, air concentrations were reduced to
<2 µg/m3 (<0.5 ppb). Urine levels in the clean-up workers were 1.98 mg/L approximately 2 months following
the spill; however, the pathways, duration, and time of exposure were not recorded, so that the exposure levels
cannot be estimated (Scow et al. 1982).
Potential exposure to chlorophenols tends to be limited because of the pronounced odor and taste imparted by
the presence of these substances. For example, the odor of 2,4-DCP can be detected in water at 0.35 µg/L (Hoak
1957), and 2,4-DCP can be tasted in water at 8 pg/L (Burttschell et al. 1959). Odor thresholds as low as 0.3-9 15
µg/L in water have also been reported for chlorophenols (Hoak 1957). Although chlorophenols have low odor
thresholds in water, 2-CP, 4-CP, 2,4-DCP, and 2,4,6-TCP have been noted to affect the flavor of fish at
concentrations of about 2 to 43 times lower than the odor thresholds for these compounds in water (Persson
1984). Data for the other chlorophenols discussed in this profile were not available.
5.6   EXPOSURES OF CHILDREN
This section focuses on exposures from conception to maturity at 18 years in humans and briefly considers
potential pre-conception exposure to germ cells. Differences from adults in susceptibility to hazardous
substances are discussed in 2.6 Children’s Susceptibility.
Children are not small adults. A child’s exposure may differ from an adult’s exposure in many ways.
Children drink more fluids, eat more food, and breathe more air per kilogram of body weight, and have a larger
skin surface in proportion to their body volume. A child’s diet often differs from that of adults. The developing
human’s source of nutrition changes with age: from placental nourishment to breast milk or
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formula to the diet of older children who eat more of certain types of foods than adults. A child’s behavior and
lifestyle also influence exposure. Children crawl on the floor; they put things in their mouths; they may ingest
inappropriate things such as dirt or paint chips; they spend more time outdoors. Children also are closer to the
ground, and they do not have the judgement of adults in avoiding hazards (NRC 1993).
In a study that analyzed urine samples from 197 children living near a herbicide manufacturing plant in
Arkansas for 2,4-DCP, 2,4,5-TCP, and 2,4,6-TCP, these compounds were identified in 27,54, and 11% of the
samples, respectively (Hill et al. 1989). The 95th percentile concentrations (in ppb) were 7 for 2,4-DCP, 7 for
2,4,5-TCP, and 4 for 2,4,6-TCP. No measurements have been made of chlorophenols or their metabolite levels
in aminiotic fluid, meconium, cord blood, or neonatal blood that indicate prenatal exposure; nor have
measurements been made of chlorophenols or metabolite levels in breast milk. However, because of their
relative rapid metabolism and excretion in the urine, chlorophenols are not expected to accumulate in maternal
tissues.
There are no known unique exposure pathways for children to chlorophenols. However, 4-CP has been used at
home as disinfectant, and 2,4-DCP has been used for mothproofing and as a miticide (WHO 1989), while the
higher chlorophenols have been used as germicides, algicides, and fungicides. Thus, children may be exposed
via accidental ingestion. Because children like to play outdoors and put fingers in their mouths, they may also be
exposed via incidental ingestion and dermal contact of contaminated soil. The most likely way that children can
be exposed is via drinking water that has beetrdisinfected with chlorine. Exposure to 2,4-DCP through
contaminated food may result from the production of 2,4-DCP via degradation of the herbicide 2,4-
dichlorophenoxyacetic acid applied to food crops or via ingestion of fish contaminated with TeCP. However,
dietary exposure is expected to be minor as chlorophenols generally do not accumulate in animal tissues.
No studies have been found that examine the exposure of children from parents’ work clothes, skin, hair, tools,
or other objects removed from the workplace. Chlorophenols have been used as biocides. 2,4,6-TCP and the
tetrachlorophenols have also been used as wood preservatives. No known information is available at this time
concerning exposure from application of wood preservatives, herbicides, and other consumer products and this
exposure is unlikely to be significant.
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5.7    POPULATIONS WITH POTENTIALLY HIGH EXPOSURES
In comparison to members of the general population, workers in certain occupational groups have much greater
potential for exposure to high concentrations of chlorophenols (Scow et al. 1982). While quantitative data are
not available, workers involved in the production of either chlorophenols or chemicals synthesized from
chlorophenols are potentially the most heavily exposed (WHO 1989). Exposure may occur through both
inhalation and dermal absorption. Workers in plants that use chlorobenzene are also likely to be heavily exposed
to monochlorophenols via the metabolism of inhaled chlorobenzene to monochlorophenols (Kusters and
Lauwerys 1990; Ogata et al. 1991; Yoshida et al. 1986). However, most of the inhaled chlorobenzene was
metabolized to 4-chlorocatechol rather than chlorophenols, as the average exposed worker excreted three times
more 4-chlorocatechol than chlorophenols in the urine (Kustus and Lauwerys 1990; Yoshida et al. 1986) Thus,
exposure via metabolism of chlorobenzene is not an important route of exposure.
Workers at sawmills where the higher chlorinated phenols are used as wood preservatives have the highest
potential for being exposed to tetrachlorophenols (WHO 1989). The observation of higher urinary
concentrations of mixed tetrachlorophenols during hot humid weather when use of protective clothing was
minimal (geometric means 196.7 ppm hot humid weather; 98.5 ppm cooler weather) suggests that dermal
exposure is an important route of tetrachlorophenol exposure in these workers (Kleinman et al. 1986). The
higher volatility of tetrachlorophenols in warmer weather may have also contributed to the higher urinary
concentrations of mixed tetrachlorophenols found when the weather was hot. Higher general population
exposure may occur through dermal or oral contact with contaminated soils and/or groundwater in the vicinity
of disposal or accident sites and through dermal or oral contact with surface waters into which chlorinated
effluents have been discharged (Scow et al. 1982). In addition, inhalation and metabolism of chlorobenzene
found in urban air can result in higher exposure to monochlorophenols (Angerer et al. 1992b, 1993).
5.8    ADEQUACY OF THE DATABASE
Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether adequate
information on the health effects of the chlorophenols are available. Where adequate  information is not
available, ATSDR, in conjunction with the NTP, is required to assure the initiation of a program of research
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designed to determine the health effects (and techniques for developing methods to determine such health
effects) of the chlorophenols.
The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if met would
reduce the uncertainties of human health assessment. This definition should not be interpreted to mean that all
data needs discussed in this section must be filled. In the future, the identified data needs will be evaluated and
prioritized, and a substance-specific research agenda will be proposed.
5.8.1     Identification of Data Needs
Physical and Chemical Properties. The physical and chemical properties of chlorophenols have been
well studied, and reliable values for key parameters for most chlorophenols are available for use in
environmental fate and transport models (see Table 3-2). Therefore, further studies of the physical and
chemical properties of chlorophenols are not essential at the present time.
Production, Import/Export, Use, Release, and Disposal. According to the Emergency Planning and
Community Right-to-Know Act of 1986,42 U.S.C. Section 11023, industries are required to submit chemical
release and off-site transfer information to the EPA. The Toxics Release Inventory (TRI), which contains this
information for 1996, became available in May of 1998. This database will be updated yearly and should
provide a list of industrial production facilities and emissions.
Chlorophenols have a variety of different uses (HSDB 1998). 2,4-DCP is used as an intermediate in the
production of herbicides and the manufacture of compounds used in mothproofing, antiseptics, and seed
disinfectants. It is also used to produce miticides and wood preservatives. 4-CP is used as an intermediate in the
production of acaricides, rodenticides, and dyes; it is used most commonly as a local antiseptic for dental
procedures. 2-CP is used in the production of higher chlorinated phenols, dyestuffs, preservatives, and as a
disinfectant/bacteriocide/germicide. It is also used for extracting sulfur and nitrogen compounds from coal.
2,4,5-TCP is used as a fungicide/bactericide; an intermediate in the manufacture of herbicides, hide and leather
processing; and in swimming pool and sick-room related surfaces. 2,3,4,6-TeCP is used as a fungicide,
pesticide, a slimicide for paper mills, and a preservative. 2,3,4,5-TeCP and 2,3,5,6-TeCP are used primarily as
fungicides (HSDB 1998). Chlorophenols are potentially hazardous chemicals and are subject to a variety of
regulations (see Chapter 7).
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Data regarding the production methods for the chlorophenols are available; however, data regarding current
production and import/export of the chlorophenols are extremely limited (HSDB 1994; Krijgsheld and van de
Gen 1986; TR192 1994). No TRI data are currently available (domestic production or environmental release) for
the monochlorophenols, 2,4-DCP, or the tetrachlorophenols. General disposal information for chlorophenols is
adequately described in the literature. At low concentrations in aqueous media, microbial degradation followed
by adsorption on activated charcoal is the common disposal method (WHO 1989).
Environmental Fate. The behavior of chlorophenols in solid and aqueous media depends on numerous
physicochemical variables. These chemicals are partitioned to and transported in the air, soil, and water. The pH
of soil and water is a major factor controlling their partitioning among the media, their mobility, and their
ultimate fate in the environment. These processes are well characterized.
Atmospheric chlorophenols, primarily associated with production processes, are apparently removed by free
radical oxidation, photolysis, and both wet and dry deposition (Bunce and Nakai 1989; Scow et al. 1982). More
specific data regarding atmospheric dispersion and photochemical reaction rates are needed for occupational
settings. Volatilization of the higher chlorinated phenols from water and soil is expected to be a slow process,
but there were no experimental data located in the available literature. Experimental data are available pertaining
to many of the transformations of chlorophenols in the environment including biodegradation in water, soil, and
sediment and photodegradation in water. Confirmation of the estimated slow rate of volatilization in addition to
data regarding the overall half-lives for chlorophenols in air are needed to estimate potential inhalation exposure
near hazardous waste sites that contain chlorophenols. Data regarding the overall half-life in water and soil are
needed to estimate potential oral and dermal exposure to chlorophenols.
Bioavailability from Environmental Media. The observation of systemic effects following
inhalation, oral, and dermal exposure indicates that the chlorophenols are readily absorbed (see Chapter 2 for
more details). Systematic studies of the bioavailability of the chlorophenols from different media have not been
completed. Because the compounds are relatively lipophilic and become adsorbed to soil and sediments, a study
of the bioavailability of these compounds from soil relative to water following oral exposure are needed.
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Food Chain Bioaccumulation. Chlorophenols bioconcentrate in aquatic (fish) organisms to a limited
extent, with the greatest bioaccumulation (up to 400) observed for the tetrachlorophenols (Carey et al.
1988). The extent of bioconcentration is limited by relatively rapid metabolism and excretion (Veith et al. 1980).
Additional data on the bioaccumulation of chlorophenols within both aquatic and terrestrial
organisms are needed.
Exposure Levels in Environmental Media. Reliable monitoring data for the levels of chlorophenols
in contaminated media at hazardous waste sites are needed so that the information obtained on levels of
chlorophenols in the environment can be used in combination with the known body burden of
chlorophenols to assess the potential risk of adverse health effects in populations living in the vicinity of
hazardous waste sites. Few data are available concerning the levels of chlorophenols in ambient air or near
known sources of atmospheric pollution. Limited monitoring data on chlorophenol levels in surface water are
available. Additional monitoring for current data for better characterization of the ambient chlorophenol
concentrations in air, surface water, groundwater, soils, and sediment are needed. These data are particularly
needed in the vicinity of industrial and municipal chlorinated wastewater discharge points and hazardous waste
sites, where individuals may be exposed by oral and/or dermal contact, such that estimates of human intake can
be made.
Exposure Levels in Humans. This information is necessary for assessing the need to conduct health
studies on these populations. Limited data regarding chlorophenol levels in urine in humans and adipose tissue
are currently available. Toxicokinetic data on occupationally and environmentally exposed humans are needed
to determine whether there are biomarkers of exposure. Because chlorophenols are metabolites of other
chemicals, measurement of these compounds in biological samples (e.g., blood, urine) can provide an estimate
of internal dose but may not provide information about the dose of chlorophenols to which individuals were
exposed.
This information is necessary for assessing the need to conduct health studies on these populations.
Exposures of Children No exposure and body burden studies have been conducted on children;
therefore, it is not known whether children are different from adults in their weight-adjusted intake of
chlorophenols, or if unique exposure pathways for children exist. There is also no monitoring of
chlorophenol levels in food (crops, fish), nor in environmental media, following application of herbicides and
wood preservatives. Children whose parents work in manufacturing facilities that produce or use
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chlorophenols may also potentially be exposed to chlorophenols via parents’ work clothes, skin, hair, tools, or
other objects removed from the workplace; however, no studies exist on this means of exposure. A take home
exposure study may be warranted if such occupational exposure settings are identified. Measurement of
chlorophenols and their metabolites in breast milk will also help to determine whether children may be exposed
via milk ingestion.
There are no known specific means to decrease exposure, but since children may be more susceptible to
chlorophenols, it may be helpful to evaluate methods to do so.
Exposure Registries. No exposure registries for chlorophenols were located. These substances are not
currently compounds for which a subregistry has been established in the National Exposure Registry. These
substances will be considered in the future when chemical selection is made for subregistries to be established.
The information that is amassed in the National Exposure Registry facilitates the epidemiological research
needed to assess adverse health outcomes that may be related to exposure to these substances.
The development of an exposure registry would provide valuable data on exposure levels and frequency. In
addition to providing information on exposure levels and duration, a registry would be useful in identifying
sources of exposure such as hazardous waste sites and manufacturing and use facilities. Knowledge about
exposure levels and sources would be valuable in developing strategies to control unnecessary sources and these
exposures. The ability to correlate sources and exposure levels with health effects would be useful in identifying
disease conditions that may result from exposure to the chlorophenols.
5.8.2 On-going Studies
As part of the Third National Health and Nutrition Evaluation Survey (NHANES III), the Environmental Health
Laboratory Sciences Division of the National Center for Environmental Health, Centers for Disease Control,
will be analyzing human urine samples for 2,4-DCP, 2,4,5TCP, 2,4,6-TCP, and other phenolic compounds.
These data will give an indication of the frequency of occurrence and background levels of these compounds in
the general population. The measurement of these compounds is being used as a marker of pesticide exposure,
rather than just an indication of chlorophenol exposure.
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The purpose of this chapter is to describe the analytical methods that are available for detecting, and/or
measuring, and/or monitoring chlorophenols, their metabolites, and other biomarkers of exposure and effect to
these isomers. The intent is not to provide an exhaustive list of analytical methods. Rather, the intention is to
identify well-established methods that are used as the standard methods of analysis. Many of the analytical
methods used for environmental samples are the methods approved by federal agencies and organizations such
as EPA and the National Institute for Occupational Safety and Health (NIOSH). Other methods presented in this
chapter are those that are approved by groups such as the Association of Official Analytical Chemists (AOAC)
and the American Public Health Association (APHA). Additionally, analytical methods may be included that
modify previously used methods to obtain lower detection limits, and/or to improve accuracy and precision.
The principal methods used to analyze chlorophenols are gas chromatography with various detectors
including flame ionization, electron capture and selected ion monitoring mass spectrometry, and high pressure
liquid chromatography. Chlorophenols are highly polar with relatively low vapor pressures, which makes them
difficult to measure directly using gas chromatography. To prevent adsorption problems and to improve peak
shapes, chlorophenols are usually converted to less polar derivatives before analysis (Hajslova et al. 1988).
6.1    BIOLOGICAL MATERIALS
Methods for analysis of biological materials are summarized in Table 6-1. All methods require that the
sample be extracted with an organic solvent. If the extraction of urine is completed under acid conditions,
conjugates will be hydrolyzed so that total amounts (free + conjugates) of the various chlorophenols can be
measured (Hargesheimer and Coutts 1983). Removal of other organic compounds, using XAD-4 resin (Edgerton
et al. 1980; Wright et al. 1981) or a florisil column (Stein and Narang 1984), can improve the detection of
chlorophenols. Techniques that require less chromatographic separation are the tandem mass spectrometry
(MS/MS) methods described by Yost et al. (1984). These methods, especially the triple-stage quadrupole
method, were suggested for rapid screening of a large number of samples. Yost et al. (1984) estimated that to
analyze 25 samples by the more standard high-resolution gas chromatography/mass spectrometry method would
require 186 hours, while the same number of samples could be analyzed in 27 hours by the triple-stage
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Edgerton (1981) studied the stability of 2,4,6-TCP and 2,3,5,6-TeCP in human urine and found that the
compounds were stable for up to 40 days if frozen at -4°C. A loss of these compounds occurred if the
specimens were thawed and refrozen.
6.2 ENVIRONMENTAL SAMPLES
Methods for analysis of environmental samples are summarized in Table 6-2. All methods require extraction of
chlorophenols with an organic solvent, and most methods derivatize the chlorophenols before analysis. Samples
for chlorophenol determination should be collected into amber glass containers and stored in the refrigerator
(APHA 1992). It is also recommended that samples be extracted within 7 days of collection and analyzed within
40 days of extraction. Using gas chromatography with an electron capture detector, Hajslova et al. (1988)
compared detection limits and percentage of recovery for 2,4-DCP, 2,4,5-TCP, 2,4,6-TCP, and 2,3,5,6-TeCP
extracted from water with or without derivatization (acetates, methyl, and pentafluorobenzyl derivatives). All
three types of derivatization lowered sample detection limits and increased the percentage of recovery for the tri-
and tetrachlorophenols. The detection limit of 2,4-DCP was lowered from 5 to 0.03 mg/L only following
derivatization with pentafluorobenzyl bromine, although derivatization decreased recovery from 104 to 85%.
The APHA approved method for analyzing phenols including 2-CP, 2,4-DCP, and 2,4,6-TCP uses gas
chromatography and a flame ionization detector (APHA 1992). If there are interfering substances in the sample,
APHA (1992) recommends derivitization of the sample with pentafluorobenzyl bromide, followed by clean-up
through a silica gel column. Gas chromatography with an electron capture detector is then used to analyze the
derivatized chlorophenols.
6.3 ADEQUACY OF THE DATABASE
Section 104(I)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with the
Administrator of EPA and agencies and programs of the Public Health Service) to assess whether adequate
information on the health effects of the chlorophenols is available. Where adequate information is not available,
ATSDR, in conjunction with the NTP, is required to assure the initiation of a program of research designed to
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The following categories of possible data needs have been identified by a joint team of scientists from
ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that if met would
reduce the uncertainties of human health assessment. This definition should not be interpreted to mean that all
data needs discussed in this section must be filled. In the future, the identified data needs will be evaluated and
prioritized, and a substance-specific research agenda will be proposed.
6.3.1    Identification of Data Needs
Methods for Determining Biomarkers of Exposure and Effect
Exposure. Analytical methods are available to determine levels of chlorophenols in urine (Angerer et al. 1981;
Hargesheimer and Coutts 1983; Kusters and Lauwerys 1990; Van Roosmalan et al. 1980; Wright et al. 1981)
and other biological samples, including blood and tissue (Morales et al. 1992; Stein and Narang 1984).
Chlorophenols, especially the lower chlorinated compounds, are metabolites of a number of other compounds
including pesticides. Therefore, the value of urinary chlorophenols as a measure of exposure to chlorophenols,
per se, at hazardous waste sites, where exposure to many compounds can occur, is not clear. Further research on
the relationship between low-level exposure and levels of chlorophenols in biological media would be helpful in
assessing the risks and health effects of chronic low-level exposure.
Effect. There are no specific markers of the biological effects of chlorophenols. Acute exposure to
monochlorophenols results in myelonic convulsions (Angel and Rogers 1972; Borzelleca et al. 1985a, 1985b;
Farquharson et al. 1958), and exposure to chlorophenols also results in effects on the immune system (Exon et
al. 1984) and on reproduction (Exon and Koller 1985). Further studies are needed to relate levels of
chlorophenols in biological media to observed effects. One would doubt that these biological effects (myelonic
convulsions) are specific enough to be a food biomarker of effect.
Methods for Determining Parent Compounds and Degradation Products in Environmental
Media. Although there is limited information available about determining levels of chlorophenols in air
(Kauppinen and Lindroos 1985), the relatively low vapor pressure of these compounds suggests that, under
environmental conditions, exposure through air would be minimal. Sufficient information is available
concerning the measurement of the chlorophenols in water (Abrahamsson and Xie 1983; Alarcon et al. 1987;
APHA 1992; Bengtsson 1985; Hajslova et al. 1988; Realini 1981; Woodrow et al. 1986; Zigler and Phillips
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1967), soil (Buisson et al. 1984; Narang et al. 1983) and sediment (the media of concern for human exposure)
(Xie 1983).
Current analytical methods are sensitive enough to measure background levels in environmental media. The
precision, accuracy, reliability, and specificity of these methods are sufficiently documented
.
6.3.2 On-going Studies
No on-going studies regarding the development analytical methods for the chlorophenols were identified.
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The international, national, and state regulations and guidelines regarding chlorophenols in air, water, and other
media are summarized in Table 7-l. Occupational standards (OSHA) or guidelines (ACGIH) have not been set
for any of the eight chlorophenols discussed in this profile.
The chlorophenols as a group have been classified as an IARC group 2B carcinogen (IARC 1987). This
classification is based on limited evidence of carcinogenicity in humans exposed during the production of
chlorophenoxy herbicides and sufficient animal evidence of carcinogenicity for 2,4,6-TCP. The evidence of
carcinogenicity in aimals for 2,4,5-TCP was considered inadequate.
At relatively low concentrations, chlorophenols give water an unpleasant medicinal taste (EPA 1980a).
Based on taste thresholds, the EPA has developed ambient water quality criteria. A comparison of the
ambient water quality criteria with the health based RfD indicates that a water concentration resulting in the RfD
would be well above the taste threshold. For example, drinking two liters of water in a day
containing the ambient water quality criteria concentration of 2,4-DCP would result in a dose of 0.009
µg/kg/day relative to the RfD of 3 µg/kg/day.
An acute-duration oral MRL of 0.01 mg/kg/day has been derived for the chlorophenols based on a NOAEL for
liver effects in rats identified in the study of 4-CP by Phornchirasilp et al. (1989b). An intermediateduration oral
MRL of 0.003 mg/kg/day has been derived for the chlorophenols based on a NOAEL for immunological effects
observed in rats following treatment with 2,4-DCP (Exon and Koller 1985; Exon et al. 1984). These MRLs are
derived from the chlorophenol with the lowest duration-specific LOAEL and, therefore, should protect against
effects following exposure to all chlorophenols as well as exposure to mixtures of chlorophenols, if effects of
multiple chlorophenols are additive.
Rather than derive a single RfD for all the chlorophenols, the EPA has derived RfDs for individual
compounds for which data were available. The oral RfD for 2-CP is 0.005 mg/kg/day based on a decrease
(p<0.1) in litter size observed at 50 but not 5 mg/kg/day (Exon and Koller 1982, 1985). The oral RfDs for 2,4-
DCP and 2,4,5-TCP are 0.003 mg/kg/day and 0.1 mg/kg/day, respectively (IRIS 1998). These values are based
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2,4,6-TCP has been categorized as a group B2 carcinogen (probably human carcinogen) based on leukemias in
male rats and hepatocellular adenomas or carcinomas in male mice (NCI 1979), and no RfD has been derived
(IRIS 1998). An RfD of 0.03 mg/kg/day has been derived for 2,3,4,6-TeCP based on increased liver weights and
hypertrophy observed in rats treated by gavage at 100 but not 25 mg/kg/day (American Biogenics 1988).
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9. GLOSSARY
Acute Exposure -- Exposure to a chemical for a duration of 14 days or less, as specified in the Toxicological
Profiles.
Adsorption Coeffkient (Koc) -- The ratio of the amount of a chemical adsorbed per unit weight of organic
carbon in the soil or sediment to the concentration of the chemical in solution at equilibrium.
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or soil (i.e., the solid phase)
divided by the amount of chemical in the solution phase, which is in equilibrium with the solid phase, at a fixed
solid/solution ratio. It is generally expressed in micrograms of chemical sorbed per gram of soil or sediment.
Bioconcentration Factor (BCF) -- The quotient of the concentration of a chemical in aquatic organisms at a
specific time or during a discrete time period of exposure divided by the concentration in the surrounding water
at the same time or during the same period.
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or group of studies, that produces
significant increases in the incidence of cancer (or tumors) between the exposed population and its appropriate
control.
Carcinogen -- A chemical capable of inducing cancer.
Ceiling Value -- A concentration of a substance that should not be exceeded, even instantaneously.
Chronic Exposure -- Exposure to a chemical for 365 days or more, as specified in the Toxicological
Profiles.
Developmental Toxicity -- The occurrence of adverse effects on the developing organism that may result from
exposure to a chemical prior to conception (either parent), during prenatal development, or postnatally to the
time of sexual maturation. Adverse developmental effects may be detected at any point in the life span of the
organism.
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a result of prenatal exposure to a
chemical; the distinguishing feature between the two terms is the stage of development during which the insult
occurred. The terms, as used here, include malformations and variations, altered growth, and in utero death.
EPA Health Advisory -- An estimate of acceptable drinking water levels for a chemical substance based on
health effects information. A health advisory is not a legally enforceable federal standard, but serves as technical
guidance to assist federal, state, and local officials.
Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental concentration of a
contaminant from which one could escape within 30 min without any escape-impairing symptoms or
irreversible health effects.
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Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 days, as specified in the
Toxicological Profiles.
Immunologic Toxicity -- The occurrence of adverse effects on the immune system that may result from
exposure to environmental agents such as chemicals.
In vitro -- Isolated from the living organism and artificially maintained, as in a test tube.
In vivo -- Occurring within the living organism.
Lethal Concentration(Lo) ( LCLO) -- The lowest concentration of a chemical in air which has been reported to
have caused death in humans or animals.
Lethal Concentration(50) (LC50) -- A calculated concentration of a chemical in air to which exposure for a
specific length of time is expected to cause death in 50% of a defined experimental animal population.
Lethal Dose(LO) (LDLO) -- The lowest dose of a chemical introduced by a route other than inhalation that is
expected to have caused death in humans or animals.
Lethal Dose(50) (LD50) -- The dose of a chemical which has been calculated to cause death in 50% of a
defined experimental animal population.
Lethal Time(50) (LT50) -- A calculated period of time within which a specific concentration of a chemical is
expected to cause death in 50% of a defined experimental animal population.
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in a study, or group of
studies, that produces statistically or biologically significant increases in frequency or severity of adverse effects
between the exposed population and its appropriate control.
Malformations -- Permanent structural changes that may adversely affect survival, development, or function.
Minimal Risk Level -- An estimate of daily human exposure to a dose of a chemical that is likely to be without
an appreciable risk of adverse noncancerous effects over a specified duration of exposure.
Mutagen -- A substance that causes mutations. A mutation is a change in the genetic material in a body cell.
Mutations can lead to birth defects, miscarriages, or cancer.
Neurotoxicity -- The occurrence of adverse effects on the nervous system following exposure to chemical.
No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at which there were no statistically or
biologically significant increases in frequency or severity of adverse effects seen between the exposed
population and its appropriate control. Effects may be produced at this dose, but they are not considered to be
adverse.
Octanol-Water Partition Coefficient (Kow) -- The equilibrium ratio of the concentrations of a chemical in n-
octanol and water, in dilute solution.
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Permissible Exposure Limit (PEL) -- An allowable exposure level in workplace air averaged over an Shour
shift.
q1* -- The upper-bound estimate of the low-dose slope of the dose-response curve as determined by the
multistage procedure. The q1* can be used to calculate an estimate of carcinogenic potency, the incremental
excess cancer risk per unit of exposure (usually µg/L for water, mg/kg/day for food, and µg/m3 for air).
Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an order of magnitude) of the daily
exposure of the human population to a potential hazard that is likely to be without risk of deleterious effects
during a lifetime. The RfD is operationally derived from the NOAEL (from animal and human studies) by a
consistent application of uncertainty factors that reflect various types of data used to estimate RfDs and an
additional modifying factor, which is based on a professional judgment of the entire database on the chemical.
The RfDs are not applicable to nonthreshold effects such as cancer.
Reportable Quantity (RQ) -- The quantity of a hazardous substance that is considered reportable under
CERCLA. Reportable quantities are (1) 1 pound or greater or (2) for selected substances, an amount established
by regulation either under CERCLA or under Sect. 3 11 of the Clean Water Act. Quantities are measured over a
24-hour period.
Reproductive Toxicity -- The occurrence of adverse effects on the reproductive system that may result from
exposure to a chemical. The toxicity may be directed to the reproductive organs and/or the related endocrine
system. The manifestation of such toxicity may be noted as alterations in sexual behavior, fertility, pregnancy
outcomes, or modifications in other functions that are dependent on the integrity of this system.
Short-Term Exposure Limit (STEL) -- The maximum concentration to which workers can be exposed for up
to 15 min continually. No more than four excursions are allowed per day, and there must be at least 60 min
between exposure periods. The daily TLV-TWA may not be exceeded.
Target Organ Toxicity -- This term covers a broad range of adverse effects on target organs or
physiological systems (e.g., renal, cardiovascular) extending from those arising through a single limited
exposure to those assumed over a lifetime of exposure to a chemical.
Teratogen -- A chemical that causes structural defects that affect the development of an organism.
Threshold Limit Value (TLV) -- A concentration of a substance to which most workers can be exposed
without adverse effect. The TLV may be expressed as a TWA, as a STEL, or as a CL.
Time-Weighted Average (TWA) -- An allowable exposure concentration averaged over a normal S-hour
workday or 40-hour workweek.
Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route other than inhalation, which is
expected to cause a specific toxic effect in 50% of a defined experimental animal population.
Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD from experimental data. Ufs are
intended to account for (1) the variation in sensitivity among the members of the human population, (2) the
uncertainty in extrapolating animal data to the case of human, (3) the uncertainty in
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extrapolating from data obtained in a study that is of less than lifetime exposure, and (4) the uncertainty in using
LOAEL data rather than NOAEL data. Usually each of these factors is set equal to 10.
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ATSDR MINIMAL RISK LEVELS AND WORKSHEETS
The Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA) [42 U.S.C. 9601 et
seq.], as amended by the Super-fund Amendments and Reauthorization Act (SARA) [Pub. L. 99-4991, requires
that the Agency for Toxic Substances and Disease Registry (ATSDR) develop jointly with the U.S.
Environmental Protection Agency (EPA), in order of priority, a list of hazardous substances most commonly
found at facilities on the CERCLA National Priorities List (NPL); prepare toxicological profiles for each
substance included on the priority list of hazardous substances; and assure the initiation of a research program to
fill identified data needs associated with the substances.
The toxicological profiles include an examination, summary, and interpretation of available toxicological
information and epidemiologic evaluations of a hazardous substance. During the development of toxicological
profiles, Minimal Risk Levels (MRLs) are derived when reliable and sufficient data exist to identify the target
organ(s) of effect or the most sensitive health effect(s) for a specific duration for a given route of exposure. An
MRL is an estimate of the daily human exposure to a hazardous substance that is likely to be without
appreciable risk of adverse noncancer health effects over a specified duration of exposure. MRLs are based on
noncancer health effects only and are not based on a consideration of cancer effects. These substance-specific
estimates, which are intended to serve as screening levels, are used by ATSDR health assessors to identify
contaminants and potential health effects that may be of concern at hazardous waste sites. It is important to note
that MRLs are not intended to define clean-up or action levels.
MRLs are derived for hazardous substances using the no-observed-adverse-effect level/uncertainty factor
approach. They are below levels that might cause adverse health effects in the people most sensitive to such
chemical-induced effects. MRLs are derived for acute (1-14 days), intermediate (15-364 days), and chronic (365
days and longer) durations and for the oral and inhalation routes of exposure. Currently, MRLs for the dermal
route of exposure are not derived because ATSDR has not yet identified a method suitable for this route of
exposure. MRLs are generally based on the most sensitive chemical-induced end point considered to be of
relevance to humans. Serious health effects (such as irreparable damage to the liver or kidneys, or birth
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defects) are not used as a basis for establishing MRLs. Exposure to a level above the MRL does not mean that
adverse health effects will occur.
MRLs are intended only to serve as a screening tool to help public health professionals decide where to look
more closely. They may also be viewed as a mechanism to identify those hazardous waste sites that are not
expected to cause adverse health effects. Most MRLs contain a degree of uncertainty because of the lack of
precise toxicological information on the people who might be most sensitive (e.g., infants, elderly, nutritionally
or immunologically compromised) to the effects of hazardous substances. ATSDR uses a conservative (i.e.,
protective) approach to address this uncertainty consistent with the public health principle of prevention.
Although human data are preferred, MRLs often must be based on animal studies because relevant human
studies are lacking. In the absence of evidence to the contrary, ATSDR assumes that humans are more sensitive
to the effects of hazardous substance than animals and that certain persons may he particularly sensitive. Thus,
the resulting MRL may be as much as a hundredfold below levels that have been shown to be nontoxic in
laboratory animals.
Proposed MRLs undergo a rigorous review process: Health Effects/MRL Workgroup reviews within the
Division of Toxicology, expert panel peer reviews, and agencywide MRL Workgroup reviews, with
participation from other federal agencies and comments from the public. They are subject to change as new
information becomes available concomitant with updating the toxicological profiles. Thus, MRLs in the most
recent toxicological profiles supersede previously published levels. For additional information regarding MRLs,
please contact the Division of Toxicology, Agency for Toxic Substances and Disease Registry, 1600 Clifton
Road, Mailstop E-29, Atlanta, Georgia 30333.
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MINIMAL RISK LEVEL (MRL) WORKSHEET
Chemical Name:        4-Chlorophenol- Other chlorophenols - Mixture of chlorophenols
CAS Number:            106-48-9 (4-chlorophenol)
Date:                           July 1995
Profile Status:             Draft 4, pre-public comments
Route:                         [ ] Inhalation [x] Oral
Duration:                    [X] Acute [ ] Intermediate [ ] Chronic
Graph Key:                 14
Species:                       Rat
Minimal Risk Level: 0.01 [X] mg/kg/day [ ] ppm
Reference: Phornchirasilp et al. 1989b
Experimental design: (human study details or strain, number of animals per exposure/control groups, sex,
dose administration details):
Groups of 4-9 male Sprague-Dawley rats were treated by gavage with 4-CP in corn oil 2 times per day for 2
weeks at doses of 0, 0.32, 0.64, 1.28, 2.58, 5.2, 10.2, and 20.6 mg/kg/day. Liver effects were assessed by the
determination of liver weights; microsomal protein levels; cytochrome P-450 activity; and benzphetamine,
ethylmorphine, and aminopyrine n-demethylase activities. Electron microscopic examinations of hepatocytes
was also completed.
Effects noted in study and corresponding doses:
No significant alterations in relative liver weights were observed. A significant increase in microsomal
protein and cytochrome P-450 levels were observed in the 4-CP treated rats. The maximum increase (290%
of control) in cytochrome P-450 levels was observed in the 0.64 mg/kg group. Significant increases in the
activities of drug-metabolizing enzymes were also observed. Electron microscopic examination revealed
foamy cytoplasm and clustering of mitochondria and endoplasmic reticulum in the liver cells of rats exposed
to ≥2.58 mg/kg/day. Based on the electron microscopic changes, 2.58 mg/kg/day is considered a LOAEL,
and 1.28 mg/kg/day is considered a NOAEL.
Dose and end noint used for MRL derivation:
[x] NOAEL [ ] LOAEL
1.28 mg/kg/day lack of electron microscopic changes in hepatocytes
Uncertainty Factors used in MRL derivation:
[  ] 10 for use of a LOAEL
[x] 10 for extrapolation from animals to humans
[x] 10 for human variability
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Was a conversion used from nnm in food or water to a mg/body weight dose?
If so, explain: None
If an inhalation study in animals, list the conversion factors used in determining human equivalent dose:
Other additional studies or uertinent information which lend support? to this MRL:
There are no additional studies that examine liver effects following oral exposure to 4-CP, and studies
regarding liver effects of other chlorophenols use higher doses and do not examine hepatocytes with an
electron microscope. For example, decreases in microsomal NADPH-cytochrome c reductase activity and P-450
content were observed in rats treated with 2,4,5-TCP but not 2,4,6-TCP at 400 mg/kg/day for 14 days (Carlson
1978). Microscopic examinations were not completed.
Among the chlorophenols examined in the chlorophenol profile (2-CP, 2,4-DCP, 2,4,5-TCP, 2,4,6-TCP, 2,3,4,5-
TeCP, 2,3,4,6-TeCP, and 2,3,5,6-TeCP), the acute LOAEL for 4-CP was the lowest LOAEL identified.
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MINIMAL RISK LEVEL (MRL) WORKSHEET
Chemical Name:     2,4-Dichlorophenol- Other chlorophenols - Mixture of chlorophenols
CAS Number:         120-83-2 (2,4dichlorophenol)
Date:         July 1995
Profile Status:         Draft 4, pre-public comments
Route:        [ ] Inhalation [x] Oral
Duration:        [ ] Acute [x] Intermediate [ ] Chronic
Graph Key:        43
Species:        Rat
Minimal Risk Level: 0.003 [x] mg/kg/day [ ] ppm
Reference: Exon et al. 1984; Exon and Koller 1985
Experimental design: (human study details or strain, number of animals per exposure/control groups, sex, dose
administration details):
Groups of 10 female Sprague-Dawley rats were exposed to 2,4-DCP (99% pure) in the drinking water at 0,3, 30,
or 300 ppm from weaning through breeding at 90 days, parturition, and weaning of pups. Ten randomly selected
offspring/groups were then continued on the same treatment regimen as the dams for an additional 10 weeks.
IRIS (1994) indicates that doses were calculated by the authors, but the doses are not presented in the papers. To
be consistent with IRIS, a 10% drinking water intake factor was used so that estimated 2,4- DCP intakes were
0,0.3,3, and 30 mg/kg/day, at 0,3,30, and 300 ppm, respectively.
Effects noted in study and corresnondine doses:
At 30 mg/kg/day, there was a trend for decreased litter sizes (0,9.8±1.3; 30,6.2 ±1.6). Exon and Koller (1985)
indicated that this effect was significant at p≤0.1, but Exon et al. (1984) does not indicate a significant
difference. At 30 mg/kg/day significant (p≤0.05) increases in spleen and liver weights were observed, with no
effects on body weight noted. Histological examinations of the liver, spleen, and thymus did not reveal any
effects. Examination of immune functions showed a significant (p<0.05) decrease in delayed type
hypersensitivity response to bovine serum albumin in Freund’s complete adjuvant at 3 and 30 mg/kg/day, with
no effect at 0.3 mg/kg/day. Antibody production (in response to keyhole limpet hemocyanin) was significantly
increased only at 3 mg/kg/day. No significant effects on phagocytic activity were noted.
Dose and end point used for MRL derivation:
[x] NOAEL [ ] LOAEL
A NOAEL of 0.3 mg/kg/day for a lack of effect on delayed type hypersensitivity was used as the basis of the
MRL.
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Uncertainty Factors used in MRL derivation:
[ ]   10 for use of a LOAEL
[X] 10 for extrapolation from animals to humans
[X] 10 for human variability
Was a conversion used from ppm in food or water to a mg/bodv weight dose? Yes.
If so, explain:
A 10% water intake as used in IRIS was used to convert from ppm in water to a mg/kg/day dose.
If an inhalation study in animals, list the conversion factors used in determining human equivalent dose:
Other additional studies or pertinent information which lend support to this MRL:
No other studies of 2,4-DCP examine functional immunological end points. LOAELs identified in other
intermediate-duration studies were 500 mg/kg/day, associated with bone marrow hyperplasia in rats fed
2,4-DCP in the diet for 13 weeks (NTP 1989), and 325 mg/kg/day for minimal hepatocellular necrosis in
mice fed 2,4-DCP in the diet for 13 weeks (NTP 1989). For chronic exposure, LOAELs of 250 and 820
for reduced body weight in rats and mice were identified (NTP 1989). Therefore, the LOAEL of 3
mg/kg/day for a decrease in delayed type hypersensitivity is the lowest LOAEL, and the MRL is based on
the highest NOAEL of 0.3 mg/kg/day. This LOAEL may also be lower than other studies because it is the
only study in which 2,4-DCP was administered in water. Unfortunately, there are no studies available to
indicate whether there are differences in the absorbed dose following treatment in food relative to water.
2,4-DCP was not carcinogenic in rats or mice (NTP 1989).
An intermediate-duration NOAEL of 0.3 mg/kg/day for increased liver weights at 3 mg/kg/day was also
identified by Exon and Koller (1985). Effect levels below the NOAEL of 0.3 mg/kg/day was not identified






This chapter of the profile is a health effects summary written in non-technical language.  Its intended
audience is the general public especially people living in the vicinity of a hazardous waste site or
chemical release.  If the Public Health Statement were removed from the rest of the document, it would
still communicate to the lay public essential information about the chemical.
The major headings in the Public Health Statement are useful to find specific topics of concern.  The
topics are written in a question and answer format.  The answer to each question includes a sentence that
will direct the reader to chapters in the profile that will provide more information on the given topic.
Chapter 2
Tables and Figures for Levels of Significant Exposure (LSE)
Tables (2-1, 2-2, and 2-3) and figures (2-1 and 2-2) are used to summarize health effects and illustrate
graphically levels of exposure associated with those effects.  These levels cover health effects observed
at increasing dose concentrations and durations, differences in response by species, minimal risk levels
(MRLs) to humans for noncancer end points, and EPA's estimated range associated with an upper- bound
individual lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000.  Use the LSE tables and figures for a
quick review of the health effects and to locate data for a specific exposure scenario.  The LSE tables and
figures should always be used in conjunction with the text.  All entries in these tables and figures
represent studies that provide reliable, quantitative estimates of No-Observed-Adverse- Effect Levels
(NOAELs), Lowest-Observed- Adverse-Effect Levels (LOAELs), or Cancer Effect Levels (CELs).
The legends presented below demonstrate the application of these tables and figures.  Representative
examples of LSE Table 2-1 and Figure 2-1 are shown.  The numbers in the left column of the legends
correspond to the numbers in the example table and figure.
LEGEND
See LSE Table 2-1
(1) Route of Exposure  One of the first considerations when reviewing the toxicity of a substance using
these tables and figures should be the relevant and appropriate route of exposure.  When sufficient data











